data_1xj1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xj1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HB2' ' N ' ' A' ' 22' ' ' CYS . 23.9 p -166.09 140.03 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.402 0.62 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.84 160.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.602 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.14 -87.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.698 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 31.6 p-80 -157.98 138.38 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CE1' ' CD ' ' A' ' 49' ' ' PRO . 56.0 m-85 59.3 58.01 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.434 ' CG ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -121.15 171.27 8.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.643 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -79.42 120.71 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 0.0 111.188 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t -101.75 21.52 14.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.2 t -109.61 30.34 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -147.78 29.74 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.33 -170.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.21 -77.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -170.73 52.93 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.428 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 53.5 Cg_endo -68.77 114.28 3.48 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.642 2.228 . . . . 0.0 112.404 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -153.04 104.54 2.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.733 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.434 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 7.2 m -67.14 -175.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.833 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -148.55 145.86 28.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -115.7 104.53 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 t -109.11 93.83 4.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.35 168.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 177.37 8.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.02 -46.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.33 -107.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.04 -35.47 76.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.936 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.68 141.98 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.55 132.81 24.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -123.75 123.59 40.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.9 116.98 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 125.04 38.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -108.58 167.36 10.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 14.4 m-85 -140.85 111.24 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 50' ' ' PHE . 6.1 pt -103.24 166.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.9 m -103.5 107.39 18.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -94.15 135.15 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.03 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 -24.69 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.49 -35.95 63.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -113.06 0.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.506 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.92 26.04 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.58 63.81 4.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 12' ' ' GLN . 33.1 m -139.64 155.36 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' TYR . 49.0 t -90.1 121.26 32.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.209 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.2 m -125.29 166.51 20.29 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.216 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 45.5 Cg_exo -56.92 158.19 17.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.485 2.124 . . . . 0.0 112.347 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.427 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -176.44 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.62 164.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.515 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -163.61 132.53 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.227 0.537 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.67 167.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.194 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.52 -99.05 2.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.56 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.425 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.2 p-80 -144.29 125.68 14.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.44 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 62.0 m-85 61.44 52.42 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -107.1 175.37 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.564 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -79.64 127.55 32.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.5 t -103.44 -29.04 11.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.9 -30.59 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.204 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -105.56 37.87 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -166.81 172.3 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.08 -166.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt 64.21 132.87 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.54 -179.43 4.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.506 2.137 . . . . 0.0 112.384 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.0 m -97.61 119.18 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -170.5 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -137.35 132.72 33.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 10.2 mptt -100.98 81.06 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -124.9 123.4 39.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.93 41.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 55.91 -176.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 129.16 44.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.79 -74.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -135.45 -61.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 m -96.38 -175.48 3.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -102.07 102.76 13.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.91 30.04 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.85 141.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.86 115.09 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 106.96 16.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 37.4 m-85 -80.15 100.79 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.37 -174.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 m -122.85 98.01 5.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.866 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.04 122.35 29.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.66 13.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -40.8 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.71 -93.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.442 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.8 25.25 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.305 . . . . 0.0 111.009 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.37 61.02 7.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.6 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.3 157.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.298 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' TYR . 4.1 t -87.54 119.62 28.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG1' ' CD2' ' A' ' 11' ' ' TYR . 12.4 m -134.19 162.29 58.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 51.6 Cg_exo -54.48 153.36 23.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.56 2.173 . . . . 0.0 112.291 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.11 162.49 34.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.08 -177.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.806 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.436 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.12 136.41 58.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.161 0.505 . . . . 0.0 111.019 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.78 169.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.243 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.9 -75.4 1.26 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.564 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 11.3 p-80 -167.75 129.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CE2' HG12 ' A' ' 48' ' ' VAL . 84.1 m-85 61.4 68.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.419 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -131.8 168.84 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.873 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -79.72 125.71 30.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.064 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.28 31.71 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.34 -68.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.433 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.43 -35.1 63.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.47 174.58 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -170.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 11.7 ttpp -129.64 53.74 12.47 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.438 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.7 Cg_endo -87.46 102.08 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.607 2.205 . . . . 0.0 111.995 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.3 m -130.15 96.84 4.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 m -69.69 -178.48 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.945 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 t -109.86 162.89 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -133.02 122.69 24.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -97.14 120.17 37.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.33 127.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -126.27 120.71 30.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.45 -51.25 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.55 -56.08 0.87 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.94 -178.9 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -66.35 81.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -79.19 -179.3 6.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -81.44 -174.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 m -98.93 179.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 114.16 19.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 170.79 10.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 16.0 m-85 -149.6 103.13 3.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 50' ' ' PHE . 41.2 pt -98.81 163.02 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.233 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.7 t -100.81 108.63 20.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.09 126.95 41.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 23.45 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.16 37.4 1.55 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.52 -37.02 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.631 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -59.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.78 54.68 0.36 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.39 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.59 159.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 11' ' ' TYR . 7.2 t -89.61 119.42 30.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.273 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.421 HG12 ' CE2' ' A' ' 11' ' ' TYR . 11.6 m -122.07 163.29 32.54 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 52.2 Cg_exo -54.54 155.61 16.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.59 2.193 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CE2' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.07 169.56 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.82 105.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.459 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -145.0 130.56 18.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.401 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.47 164.09 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.181 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.05 -99.22 2.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.452 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 20.3 p-80 -140.07 125.9 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' CYS . 39.0 m-85 58.79 55.31 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.34 161.84 13.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.905 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -79.84 113.35 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -41.69 23.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -77.9 -53.91 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -45.2 95.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.12 126.76 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -93.28 80.26 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 30.8 mtpt -132.16 134.56 25.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 32.4 Cg_exo -57.98 142.63 96.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.422 2.081 . . . . 0.0 112.294 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 103.24 9.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.34 177.72 8.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.16 -174.1 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -160.01 140.33 11.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -139.24 134.79 33.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.71 116.18 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.5 mtm105 -133.14 82.94 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 28' ' ' TYR . 21.1 t80 -163.88 31.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.12 -162.93 36.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -169.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 170.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -155.25 80.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -119.31 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 m -104.24 153.09 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.59 147.77 44.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -145.17 115.72 7.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 19.2 m-85 -90.55 133.59 34.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pt -111.41 169.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.076 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -104.96 97.05 6.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 104.29 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.83 23.36 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -99.82 -52.05 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.96 -86.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.28 -32.08 6.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.31 69.29 0.69 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -146.7 162.56 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 111.294 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -88.19 108.44 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 1.7 m -111.17 160.43 29.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.206 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 29.5 Cg_endo -63.61 160.53 35.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -160.09 176.84 11.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.567 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 124.16 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.911 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.71 173.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.686 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' CG2' ' A' ' 8' ' ' ILE . . . -113.4 -32.23 2.2 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.056 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -179.03 140.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 63.6 79.27 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HB2' HG21 ' A' ' 8' ' ' ILE . 3.5 tt0 -107.08 140.0 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.692 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.77 93.79 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 p -119.73 35.97 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.13 -34.39 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -106.43 -28.63 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.02 -178.06 4.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.51 87.07 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 156.44 60.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.44 110.21 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.6 t -104.61 87.6 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.05 151.78 21.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 p -98.31 -170.78 2.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -143.73 108.28 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -145.63 123.69 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -178.67 76.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -132.33 102.31 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.91 164.04 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.38 -159.57 14.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -68.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.59 139.33 49.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 105.53 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.79 96.37 10.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 m -94.9 132.07 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -113.7 100.02 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 3.0 tptt -80.57 -167.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 12.2 m-85 -160.06 114.18 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.486 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.4 pt -113.01 156.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.281 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.2 t -89.81 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 117.42 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.982 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.77 24.72 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.968 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -104.31 -32.44 9.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.701 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.88 -76.32 1.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.4 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.04 27.77 1.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.51 60.62 8.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.647 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 6.8 t -129.02 159.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -97.09 104.32 16.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.75 164.61 14.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.366 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 42.8 Cg_exo -56.99 163.05 8.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.618 2.212 . . . . 0.0 112.614 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.486 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.19 -178.63 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.936 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.96 104.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.422 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -149.02 130.67 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 110.965 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.74 163.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.067 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.15 -88.5 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.466 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -157.13 127.74 6.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.354 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' HG11 ' A' ' 48' ' ' VAL . 41.5 m-85 61.09 62.89 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -105.43 145.12 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.92 115.54 19.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 p -122.92 31.76 5.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.68 -56.11 8.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.072 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -98.03 -25.64 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.17 93.12 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.049 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.47 142.96 38.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.43 9.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.98 119.08 5.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.533 2.155 . . . . 0.0 112.457 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.07 82.24 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.05 -178.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -102.55 133.1 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.69 107.96 20.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -111.39 131.37 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.88 53.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 161.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -116.22 145.5 43.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.23 30.81 0.48 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.05 32.91 19.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -172.76 36.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.48 -177.52 5.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -146.71 179.36 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -102.06 158.72 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 107.91 11.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.019 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -87.51 166.5 14.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 28.4 m-85 -138.42 109.45 6.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.464 HG12 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -102.87 153.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.83 93.57 9.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 125.45 29.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -120.02 23.71 10.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.965 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -97.12 39.5 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.14 -53.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -124.93 -63.9 1.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.29 61.39 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.4 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.99 167.16 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.209 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.06 112.78 24.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.554 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 11' ' ' TYR . 35.1 m -120.12 162.19 34.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.211 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.2 Cg_exo -54.15 154.95 16.67 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.607 2.205 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.03 168.47 25.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.54 106.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.02 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.485 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.886 0.375 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 129.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.201 0.524 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.7 155.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.01 -72.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -171.38 137.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.6 m-85 56.37 52.54 9.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -86.88 153.37 21.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -79.94 117.95 21.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.99 -24.49 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 t -90.2 49.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -178.66 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.65 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.42 41.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 147.72 71.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.21 125.69 11.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.414 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.9 m -82.72 75.29 9.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.13 155.27 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.51 161.01 25.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -145.1 108.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 t -94.11 125.77 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.2 m -75.79 126.86 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -100.04 43.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -128.1 113.94 16.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.81 -168.41 16.93 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.22 -60.74 2.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 p -79.07 160.17 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -114.25 90.61 3.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 142.97 26.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.2 t -105.35 140.62 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.81 121.69 45.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -97.55 167.92 10.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 39.1 m-85 -139.76 123.97 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.509 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.4 pt -117.12 140.22 40.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.161 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.01 91.58 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -82.24 124.98 30.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.84 23.59 10.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.16 37.03 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.79 -69.91 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.625 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.95 -59.11 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.87 59.04 0.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.47 166.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.54 105.96 18.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.415 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.7 m -110.88 161.88 23.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.363 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.32 149.71 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.655 2.237 . . . . 0.0 112.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.509 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.09 -167.27 1.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -169.59 95.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.84 120.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.196 0.522 . . . . 0.0 110.999 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.79 169.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.271 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.07 -37.74 1.78 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.277 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 178.75 144.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 62.09 68.34 0.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -96.88 151.19 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 107.11 12.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.889 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.08 29.48 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.06 -53.29 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.132 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -118.82 31.33 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.16 -173.13 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.23 32.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -66.05 148.19 98.49 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 133.21 22.25 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.522 2.148 . . . . 0.0 112.235 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.98 167.58 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 m -121.53 163.7 18.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 115.2 11.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 p -95.58 153.16 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 t 60.9 108.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -170.25 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.39 32.02 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.16 44.84 2.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 60.34 31.61 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.63 178.51 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -93.89 48.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.93 140.1 51.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.35 128.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -96.17 120.32 36.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -105.45 168.54 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.628 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -141.54 127.24 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.504 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -127.37 160.01 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.01 103.51 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.98 101.23 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.47 81.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -149.35 -47.13 0.14 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.59 -31.85 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -115.53 -65.79 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.969 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.7 43.51 1.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.17 173.67 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 111.346 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.0 t -90.42 105.55 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.419 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.5 m -112.26 162.88 19.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 75.9 Cg_exo -50.5 154.22 6.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.637 2.225 . . . . 0.0 112.534 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.504 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.06 -168.12 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.38 30.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.821 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 134.21 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.74 166.14 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.15 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.71 -83.89 1.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 27.2 p-80 -156.18 132.94 10.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CE2' HG11 ' A' ' 48' ' ' VAL . 67.3 m-85 59.48 66.42 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' CB ' HG12 ' A' ' 8' ' ' ILE . 1.8 tm0? -117.83 142.16 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -79.97 122.71 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 m -85.27 -36.92 20.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.47 -44.02 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -75.82 -31.08 59.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.98 100.78 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.44 105.72 8.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.85 157.64 71.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.72 136.16 44.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.612 2.208 . . . . 0.0 112.195 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.4 m -90.28 127.46 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.85 172.07 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.64 146.6 28.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 117.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 128.32 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.91 127.63 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -69.3 158.48 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.72 122.44 14.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.26 -79.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -56.16 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.73 175.93 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.48 65.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -126.61 137.61 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.3 t -129.22 139.57 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.018 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 163.06 40.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 177.71 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 27.7 m-85 -148.23 105.77 3.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -105.87 154.49 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 53.2 t -94.92 107.52 19.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -101.04 135.42 42.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -104.55 23.82 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.72 -58.26 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.35 -47.71 12.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.27 -47.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.33 72.9 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.32 165.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 3.8 t -94.03 113.72 25.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 11' ' ' TYR . 28.5 m -118.92 162.01 33.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.188 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 53.9 Cg_exo -52.62 140.64 55.15 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.626 2.217 . . . . 0.0 112.545 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.48 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.12 -172.33 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.55 138.29 8.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.831 0.348 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.51 131.29 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.848 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.59 156.68 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.129 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.96 -70.38 0.87 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.61 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 31.2 p-80 -173.01 133.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 59.08 57.01 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.821 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -95.85 157.06 16.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.888 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -79.87 113.35 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 -20.1 11.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.316 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.38 -32.6 58.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.259 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.59 -28.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.36 170.19 9.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -139.15 99.25 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -125.33 155.51 71.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.19 123.04 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 54.5 m -97.9 73.36 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.8 p -59.8 169.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.36 165.16 15.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.31 105.51 7.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 t -84.8 93.9 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 m -86.81 101.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.089 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.14 -176.03 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.54 93.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.04 -46.37 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.16 -53.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.777 0.322 . . . . 0.0 110.971 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.22 -65.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -143.56 132.85 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.39 107.17 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 m -109.75 122.0 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.71 138.63 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -117.96 109.98 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 52.9 m-85 -84.37 129.17 34.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.505 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -119.79 142.99 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -75.88 95.22 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.695 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.91 119.23 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -33.83 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -78.26 64.09 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.24 -53.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.442 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.1 -71.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.578 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.12 166.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.8 t -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.11 163.28 38.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.9 Cg_exo -54.15 156.57 12.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.601 2.201 . . . . 0.0 112.382 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.505 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.1 165.36 31.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.96 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.97 130.25 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.217 0.532 . . . . 0.0 111.03 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.81 167.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.254 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.24 -86.88 1.97 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.45 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.6 p-80 -158.14 132.4 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.971 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.416 ' CE2' HG12 ' A' ' 48' ' ' VAL . 70.7 m-85 59.45 55.89 3.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.78 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HB2' HG12 ' A' ' 8' ' ' ILE . 2.9 mm-40 -110.03 166.84 10.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -79.93 128.77 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.0 t -110.7 -30.83 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.64 -60.34 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -72.61 -38.79 67.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.54 128.21 54.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.75 38.53 1.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -78.23 127.36 81.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.52 148.67 42.44 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.415 2.077 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.4 m -103.43 105.44 15.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -178.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.48 28.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -117.51 -178.87 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -144.73 84.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.11 159.69 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.21 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 60.98 156.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -177.01 102.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.8 -94.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.413 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -97.62 -33.69 11.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 m -101.95 172.28 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.04 128.56 49.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.46 136.14 34.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.9 154.92 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -123.12 106.13 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.28 119.88 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 67.8 m-85 -88.77 115.0 25.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.0 pt -103.65 148.14 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.41 93.25 5.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 112.33 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -31.53 15.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.83 -30.55 69.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.798 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.43 -79.89 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.53 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.29 27.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 47.05 86.54 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.664 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.63 159.28 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.03 114.49 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 11' ' ' TYR . 5.2 m -122.03 161.81 40.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 57.3 Cg_exo -52.25 155.23 9.6 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.574 2.183 . . . . 0.0 112.542 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.13 -174.11 4.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.38 29.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.13 132.68 39.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 168.17 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.211 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.87 -79.92 1.02 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.613 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 33.5 p-80 -161.77 131.68 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' HG13 ' A' ' 48' ' ' VAL . 60.4 m-85 60.67 65.52 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -122.08 142.08 50.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -79.7 116.3 19.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -111.94 24.23 12.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.77 -56.61 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.19 30.99 3.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.96 115.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.76 100.8 12.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -141.81 142.61 25.91 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 144.21 32.25 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.583 2.189 . . . . 0.0 112.405 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.4 m -92.82 102.21 14.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.4 154.13 36.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -108.93 158.99 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -138.15 109.35 6.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.9 p -84.38 116.25 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 65.16 126.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.046 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -92.81 47.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 61.12 156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.79 -127.61 8.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.21 144.65 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 t -69.52 142.58 53.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -154.82 -178.36 7.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -80.21 -176.8 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.91 154.86 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.01 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -117.48 92.92 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.97 166.47 21.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 38.1 m-85 -143.03 106.06 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.444 HG12 ' CG ' ' A' ' 50' ' ' PHE . 4.3 pt -100.53 146.45 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.25 100.82 10.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -86.63 117.75 25.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.6 24.48 10.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.26 -26.76 42.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.53 -60.19 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.647 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -69.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.67 157.72 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.3 118.17 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 11' ' ' TYR . 16.8 m -120.09 161.84 36.54 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.257 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 70.5 Cg_exo -51.54 149.98 17.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.624 2.216 . . . . 0.0 112.438 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.04 -168.95 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.66 148.91 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.811 0.339 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 133.91 56.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.65 167.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.138 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -95.36 1.95 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.527 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 39.7 p-80 -147.39 126.74 13.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.982 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 47' ' ' CYS . 76.4 m-85 61.79 59.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -123.19 176.97 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.843 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 132.74 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.5 t -115.15 -7.69 12.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.414 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.82 50.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.875 0.369 . . . . 0.0 111.22 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -176.97 36.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.27 -165.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.58 34.61 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.476 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 44.3 pttt 44.32 51.24 7.92 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.768 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.8 Cg_endo -86.64 102.53 0.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.535 2.157 . . . . 0.0 112.135 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.9 m -126.36 105.35 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.8 m -73.03 177.16 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -115.49 129.19 56.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 93.35 7.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.6 t -113.8 115.13 27.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.38 152.58 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -64.65 177.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -60.84 129.35 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.22 -142.79 3.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.2 -67.31 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -99.9 146.23 26.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -106.66 109.5 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -141.81 133.68 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.35 122.47 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -98.58 108.91 21.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 -176.66 5.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m-85 -158.35 126.82 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.463 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -129.41 167.39 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.208 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.9 m -94.42 126.31 39.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.61 118.61 30.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ttm105 -116.57 24.11 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.44 -30.36 53.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.95 -49.0 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.49 -67.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.33 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.93 62.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 16.9 m -133.41 155.23 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 111.229 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' TYR . 48.6 t -85.45 115.93 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.228 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 27.4 m -119.92 163.76 26.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.9 Cg_exo -53.38 154.6 14.52 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.554 2.17 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.49 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -136.93 -46.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -170.09 126.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.187 0.518 . . . . 0.0 110.994 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.64 166.71 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.228 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.37 -68.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.518 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -173.86 120.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.434 ' CD2' HG11 ' A' ' 48' ' ' VAL . 21.9 m-85 62.02 62.19 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -108.19 166.69 10.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -79.82 122.04 26.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.34 -28.96 10.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.48 103.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.155 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.08 61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.16 137.61 20.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.14 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 95.18 48.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.77 152.04 29.93 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.511 2.141 . . . . 0.0 112.331 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.3 104.91 12.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.3 p -102.3 -176.5 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 p -107.19 165.74 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 -179.29 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -127.26 148.94 50.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.02 126.22 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.14 170.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -157.95 98.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.02 -84.07 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.23 -57.24 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 p -96.66 122.63 39.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.42 115.83 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -155.73 133.24 11.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.75 152.48 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -116.59 138.32 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 169.9 8.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 20.0 m-85 -150.43 107.77 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 50' ' ' PHE . 43.3 pt -99.72 160.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.193 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 m -98.99 97.2 8.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 111.72 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -27.31 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 52.91 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.58 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.25 -52.99 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.05 44.75 0.99 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.624 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.08 158.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -86.52 116.78 24.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 11' ' ' TYR . 3.7 m -121.65 164.17 26.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 45.6 Cg_exo -56.07 148.37 59.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.18 -169.38 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.94 94.44 2.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.698 0.285 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.38 130.54 46.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.201 0.525 . . . . 0.0 111.027 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.6 166.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.208 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.26 -75.11 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -169.86 134.44 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.419 ' CD2' HG12 ' A' ' 48' ' ' VAL . 26.8 m-85 59.22 53.27 5.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.012 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 6.9 tp60 -96.9 160.55 14.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.521 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -79.7 114.15 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.16 -47.98 8.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.799 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.18 129.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.84 29.93 19.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.15 86.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.87 146.23 33.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -173.52 148.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.34 120.95 7.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.7 m -81.3 100.6 9.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 165.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.054 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -125.04 161.55 26.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -131.23 108.03 9.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -137.28 162.54 33.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.64 92.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -89.55 167.59 12.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -64.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.05 101.89 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.4 85.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -104.79 137.21 42.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -174.37 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -160.06 171.64 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -136.62 145.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -120.48 121.06 37.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -111.58 165.88 11.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 12.8 m-85 -135.37 121.94 20.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -112.69 155.97 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 100.51 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.616 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.95 139.56 30.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -129.94 24.02 5.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.52 -59.47 2.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.67 -97.72 0.82 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.429 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -79.94 -56.51 4.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.9 84.81 0.88 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.58 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 16.8 m -150.64 161.74 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.909 0.385 . . . . 0.0 111.346 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.19 107.12 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.434 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.419 HG12 ' CD2' ' A' ' 11' ' ' TYR . 23.4 m -113.56 162.98 19.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.449 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 41.2 Cg_exo -57.38 160.35 13.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.22 -170.36 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -156.61 -45.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.59 133.39 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.211 0.529 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.68 167.04 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.156 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.09 -93.39 2.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -149.28 126.98 11.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.418 ' CE2' HG13 ' A' ' 48' ' ' VAL . 21.2 m-85 61.28 61.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.71 148.72 32.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.709 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -79.74 105.5 11.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.1 p -97.76 23.49 7.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.89 -47.88 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.48 -32.1 73.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.32 -175.05 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -127.2 85.31 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.954 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -115.76 139.9 25.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.6 143.87 31.07 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.522 2.148 . . . . 0.0 112.274 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.5 m -96.74 105.06 17.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -179.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.85 173.19 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -145.29 106.13 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 t -132.82 123.4 26.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.94 174.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -166.56 156.93 12.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.42 140.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.74 3.17 71.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.898 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.16 104.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 t -171.84 122.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 88.58 6.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -143.58 118.49 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.16 137.72 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -123.77 126.72 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 158.9 21.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -130.84 113.76 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pp -114.85 153.86 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.183 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.18 111.23 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.59 107.39 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -100.91 24.63 9.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 50.53 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.25 -33.46 1.02 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -147.98 -70.33 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.37 59.24 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.37 155.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.8 t -88.95 114.36 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 28.5 m -123.91 163.58 34.48 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.17 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.1 Cg_exo -53.91 153.26 20.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.55 2.167 . . . . 0.0 112.428 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.514 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.0 172.85 16.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 59.57 108.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.48 133.25 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.543 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.62 163.99 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.109 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.52 -87.9 1.96 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.549 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 4.2 p-80 -152.57 129.09 10.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' CE2' HG12 ' A' ' 48' ' ' VAL . 20.3 m-85 61.38 66.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 139.4 42.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -79.82 105.77 11.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -112.95 29.06 8.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.77 -63.83 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.8 31.07 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.68 130.24 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -102.37 114.06 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.1 150.77 73.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 119.7 6.58 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.577 2.185 . . . . 0.0 112.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.1 m -80.1 96.41 6.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.33 155.55 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -101.99 165.26 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.61 92.7 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.6 p -104.41 146.74 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.09 132.16 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.25 87.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.55 158.89 25.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.18 -46.13 3.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.508 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -99.52 157.53 16.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.8 m 60.33 177.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -137.16 95.02 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.92 74.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.21 135.06 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 113.72 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -170.52 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.815 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 19.7 m-85 -160.05 123.1 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.952 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.454 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -130.55 157.92 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.04 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.84 100.99 12.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.81 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -91.61 133.14 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 23.96 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.55 -41.01 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -67.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.01 33.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.831 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.05 64.1 4.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.563 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.05 154.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -93.66 102.05 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -108.35 160.91 25.33 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.08 159.59 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.631 2.221 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.02 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -154.74 -63.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.428 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m 63.59 131.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.278 0.561 . . . . 0.0 110.929 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.211 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.17 -98.0 2.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.432 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.6 p-80 -140.32 126.0 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.425 ' CD2' HG11 ' A' ' 48' ' ' VAL . 39.4 m-85 58.39 51.96 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.88 156.56 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 122.5 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.44 -53.49 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.1 135.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 m120 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.91 91.96 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.72 84.14 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.92 116.92 6.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.43 146.66 82.23 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -80.07 102.08 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 170.91 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -127.24 136.09 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -111.26 168.1 9.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -143.32 176.8 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 p -151.15 140.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 168.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -84.28 165.78 18.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.17 120.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.04 121.62 44.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.786 0.327 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -156.39 -50.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.98 35.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.47 31.29 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.91 171.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.85 110.33 12.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -99.86 106.05 17.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 44.5 m-85 -81.64 137.26 35.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.566 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -131.0 153.85 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.45 127.17 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.94 119.67 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 24.37 11.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.42 50.18 1.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.69 -65.78 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -127.31 -45.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.92 73.36 0.74 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.63 160.14 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 111.274 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.3 t -95.06 112.21 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 4.3 m -116.3 164.89 16.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 51.0 Cg_exo -54.18 146.93 47.01 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.43 2.086 . . . . 0.0 112.267 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.566 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.83 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -156.71 172.73 18.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.8 p -166.13 146.4 6.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.607 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.77 172.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.501 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.23 -99.58 0.85 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 20.0 p-80 -147.1 129.01 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' CYS . 74.7 m-85 61.12 59.97 1.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' CB ' HG12 ' A' ' 8' ' ' ILE . 4.3 mm-40 -116.42 171.74 7.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -79.55 114.78 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -116.06 -12.82 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.363 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.44 -33.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.221 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.28 29.67 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.014 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.55 148.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 37.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 126.66 84.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.33 154.0 75.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.25 175.26 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.77 -165.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.146 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -159.68 114.95 2.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.728 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 86.98 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.02 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 88.55 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.8 124.08 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.85 165.43 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -175.33 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.2 85.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 60.82 40.32 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 170.21 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 41.65 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -97.9 36.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.03 110.01 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.19 134.77 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.751 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -120.75 109.35 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 9.2 m-85 -81.81 138.11 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.2 pp -134.36 178.25 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 111.483 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.42 120.66 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.697 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -103.98 93.47 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.5 23.81 9.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 -51.5 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.59 -67.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -127.3 -46.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.72 52.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.588 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -143.27 156.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.401 . . . . 0.0 111.429 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -83.27 117.29 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.9 m -128.93 165.73 29.92 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.246 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 32.2 Cg_exo -58.36 165.89 6.8 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.566 2.177 . . . . 0.0 112.527 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -160.08 166.44 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.57 90.08 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.466 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.769 0.319 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.86 127.38 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.76 166.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.171 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.86 -78.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 21.9 p-80 -166.79 133.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 58.18 61.85 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 23.3 tp60 -105.82 159.25 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 115.71 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -84.24 -29.98 26.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -70.01 -38.44 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.98 -37.17 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.53 117.75 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.29 74.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -121.19 158.39 53.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 134.35 63.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.634 2.223 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.9 m -96.07 101.87 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.703 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.32 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.043 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -110.24 163.66 13.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 114.68 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -118.13 147.05 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.01 154.59 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -97.47 38.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.3 164.74 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.83 -94.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.56 -29.68 65.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.031 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 109.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.026 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mttt 60.23 175.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.95 -177.84 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.13 144.65 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.92 130.14 39.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -99.47 -165.57 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.4 m-85 -142.86 142.42 31.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.457 . . . . 0.0 111.645 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.528 HG23 ' CG ' ' A' ' 50' ' ' PHE . 5.1 pt -120.79 152.02 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 97.14 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.46 116.1 27.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.03 -31.3 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.95 -30.23 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.68 -98.88 0.23 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.66 -33.97 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.09 47.44 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -143.54 154.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 t -96.97 106.51 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 2.2 m -114.52 161.26 29.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.961 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 60.1 Cg_endo -73.06 151.37 49.81 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.319 2.013 . . . . 0.0 112.633 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CG ' HG23 ' A' ' 38' ' ' ILE . 1.6 p90 -149.35 170.48 18.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 -54.99 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.47 128.33 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.096 0.474 . . . . 0.0 111.006 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 170.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.367 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.01 -35.04 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -177.36 142.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 61.08 71.49 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -102.3 141.51 35.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.802 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 108.74 13.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.65 24.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.18 118.98 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 m120 59.66 54.04 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.59 145.88 2.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.17 32.6 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.05 112.71 29.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.98 132.28 48.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -93.16 92.27 7.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -178.62 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -178.34 4.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -144.05 95.34 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -124.13 116.36 22.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.38 128.05 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -122.61 91.85 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -152.64 81.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.14 179.96 18.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 150.72 27.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.8 t 60.33 102.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.53 123.17 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -84.33 134.92 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.29 113.85 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -82.67 126.03 31.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -129.84 169.99 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 34.1 m-85 -136.86 118.92 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.455 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.3 pt -107.24 147.73 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.277 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.71 92.04 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.706 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.03 126.46 31.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -105.53 24.04 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.41 -32.07 12.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.5 -64.7 1.06 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.525 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -156.52 27.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.001 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.15 62.33 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.582 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.68 158.5 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -94.31 105.86 17.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.733 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.47 162.24 21.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 52.3 Cg_exo -55.37 160.11 9.35 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.656 2.237 . . . . 0.0 112.516 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.08 173.64 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 60.19 163.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.964 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.856 0.36 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.75 135.68 50.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.232 0.539 . . . . 0.0 111.019 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 170.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.214 -179.532 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.58 -91.04 2.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.614 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 11.2 p-80 -152.18 128.69 10.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 48' ' ' VAL . 32.2 m-85 58.26 61.21 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -107.62 152.71 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -79.73 120.95 24.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.967 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 -34.49 20.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.9 -35.55 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -107.88 34.78 3.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.82 141.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.09 90.56 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' CG ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -157.62 137.18 8.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.925 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 145.94 65.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.373 2.049 . . . . 0.0 112.419 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.0 m -87.8 95.04 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 174.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.1 p -148.56 128.07 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -84.31 153.07 23.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -150.8 96.87 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.68 139.33 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 120.13 26.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -132.68 -48.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.82 -161.3 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.12 -53.87 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -71.04 124.26 23.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -80.68 137.62 36.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -114.83 95.14 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.33 113.54 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.86 100.93 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -98.57 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 39.0 m-85 -79.89 147.59 31.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -135.98 148.85 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.91 104.87 16.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.51 116.97 33.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -111.14 -30.27 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.0 -25.96 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 -43.45 3.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.58 -74.58 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.07 46.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.586 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.12 153.78 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.202 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.72 113.72 25.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 HG12 ' CE2' ' A' ' 11' ' ' TYR . 3.4 m -121.77 164.9 22.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.188 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.9 Cg_exo -54.98 159.75 9.01 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.56 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.95 160.37 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.782 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 86.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.433 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 m 62.59 130.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.216 0.531 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.76 170.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.331 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.33 -40.85 1.86 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.331 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -179.04 144.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.79 0.329 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 62.52 74.29 0.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -98.49 132.24 44.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -79.89 110.22 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.58 22.86 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.997 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.97 -31.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.56 30.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.99 -173.93 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.1 128.46 24.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.15 141.07 6.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.84 114.47 3.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.411 2.074 . . . . 0.0 112.428 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.9 t -93.03 82.79 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.818 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.03 -173.38 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.08 168.32 9.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.09 128.06 29.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -110.25 126.22 53.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.804 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.03 151.37 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.68 139.73 26.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -165.93 -54.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.68 -159.29 35.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.97 -55.22 17.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 t -120.48 138.97 53.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -149.85 123.77 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.58 161.21 20.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.55 144.63 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -100.56 133.86 44.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 178.97 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -152.61 129.08 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.453 ' CG1' ' CD1' ' A' ' 50' ' ' PHE . 2.8 pp -124.84 144.61 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.194 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.16 119.8 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.87 111.75 24.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.52 26.21 8.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.48 54.65 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.57 -24.72 8.41 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.799 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -120.11 -78.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.69 58.37 0.57 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.413 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 t -137.82 160.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 t -96.61 101.09 12.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -104.37 161.74 21.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 86.9 Cg_exo -46.75 144.67 7.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.672 2.248 . . . . 0.0 112.694 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CD1' ' CG1' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.01 -167.66 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -166.02 102.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 m -57.65 140.53 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 111.177 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 165.35 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.228 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.95 -76.77 1.06 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.46 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.8 p-80 -168.28 130.0 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 48' ' ' VAL . 29.5 m-85 59.28 60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.623 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.02 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -79.83 116.45 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 m -79.89 -39.51 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.28 136.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 58.96 31.06 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.38 149.67 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -124.22 37.13 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.12 125.44 48.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 132.85 23.71 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.516 2.144 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.03 94.94 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.4 m -84.79 -178.21 6.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 175.94 5.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -154.86 169.0 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -140.38 141.0 35.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.44 145.32 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.7 110.79 10.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -150.26 98.26 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.26 -116.53 8.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.47 -31.15 8.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.5 m -67.4 86.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 144.08 31.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -160.0 138.03 10.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.84 163.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -159.13 160.33 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.9 ttpp -126.06 179.9 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 40.1 m-85 -129.32 150.49 50.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.013 0.435 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.563 HG21 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -122.35 153.04 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.943 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.22 91.99 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.01 110.75 19.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -109.79 24.66 12.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.34 -50.97 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.59 -66.61 1.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.7 -47.2 0.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.07 78.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.42 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.29 154.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 104.55 16.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.404 HG13 ' CE2' ' A' ' 11' ' ' TYR . 5.6 m -109.84 157.74 36.85 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.226 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 62.5 Cg_endo -73.55 137.39 25.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.551 2.167 . . . . 0.0 112.64 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CG ' HG21 ' A' ' 38' ' ' ILE . 3.1 p90 -135.23 176.76 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.91 99.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.05 136.44 33.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.63 164.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.293 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.24 -68.18 0.66 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.394 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 22.1 p-80 -170.83 126.95 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 49' ' ' PRO . 22.1 m-85 57.07 60.53 2.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -114.38 169.52 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.576 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -79.5 121.06 24.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 t -122.52 -59.4 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.416 ' HB ' ' CA ' ' A' ' 45' ' ' GLY . 3.5 t -63.16 -26.32 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.143 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.35 -35.29 12.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.39 50.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.82 126.35 29.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -177.12 98.65 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.09 144.1 23.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.165 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -105.39 94.51 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.5 m -81.43 169.37 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -99.94 135.98 40.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -106.59 -179.51 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 t -152.37 121.52 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.98 123.37 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 60.19 161.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.79 158.71 26.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.31 -121.59 1.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.71 177.01 4.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.13 122.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -72.8 102.4 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -125.2 68.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.2 m -98.61 168.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.58 115.88 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.0 170.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.793 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 31.7 m-85 -154.0 129.56 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.424 HG21 ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -127.55 156.06 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.9 m -90.39 111.82 23.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.32 -172.22 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 60.93 81.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -33.02 72.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.697 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.53 -63.41 4.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.333 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -58.19 3.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.513 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . . . 96.52 77.28 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.9 179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -135.67 151.61 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -102.59 114.51 28.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.458 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 11' ' ' TYR . 8.8 m -111.79 162.43 21.18 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.312 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 52.0 Cg_exo -54.14 158.83 8.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.635 2.223 . . . . 0.0 112.454 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CG ' HG21 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -155.42 174.53 15.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t0 59.84 54.59 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HB2' ' N ' ' A' ' 22' ' ' CYS . 23.9 p -166.09 140.03 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.402 0.62 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.434 HG12 ' CG ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.84 160.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.602 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.14 -87.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.698 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 31.6 p-80 -157.98 138.38 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CE1' ' CD ' ' A' ' 49' ' ' PRO . 56.0 m-85 59.3 58.01 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.434 ' CG ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -121.15 171.27 8.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.643 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -79.42 120.71 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 0.0 111.188 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t -101.75 21.52 14.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.2 t -109.61 30.34 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.091 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -147.78 29.74 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.33 -170.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.21 -77.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -170.73 52.93 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.428 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 53.5 Cg_endo -68.77 114.28 3.48 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.642 2.228 . . . . 0.0 112.404 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -153.04 104.54 2.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.733 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.434 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 7.2 m -67.14 -175.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.833 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -148.55 145.86 28.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -115.7 104.53 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.8 t -109.11 93.83 4.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.35 168.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 177.37 8.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.02 -46.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.33 -107.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.04 -35.47 76.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.936 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.68 141.98 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.55 132.81 24.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -123.75 123.59 40.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -111.9 116.98 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 125.04 38.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -108.58 167.36 10.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 14.4 m-85 -140.85 111.24 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.427 HG12 ' CG ' ' A' ' 50' ' ' PHE . 6.1 pt -103.24 166.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.9 m -103.5 107.39 18.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -94.15 135.15 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.03 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 -24.69 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.49 -35.95 63.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -113.06 0.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.506 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.92 26.04 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.58 63.81 4.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 12' ' ' GLN . 33.1 m -139.64 155.36 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' TYR . 49.0 t -90.1 121.26 32.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.209 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.45 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.2 m -125.29 166.51 20.29 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.216 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 45.5 Cg_exo -56.92 158.19 17.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.485 2.124 . . . . 0.0 112.347 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.427 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -176.44 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.62 164.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.515 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -163.61 132.53 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.227 0.537 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.67 167.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.194 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.52 -99.05 2.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.56 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.425 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.2 p-80 -144.29 125.68 14.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.44 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 62.0 m-85 61.44 52.42 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -107.1 175.37 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.564 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -79.64 127.55 32.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.5 t -103.44 -29.04 11.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.9 -30.59 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.204 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -105.56 37.87 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -166.81 172.3 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.08 -166.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt 64.21 132.87 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.54 -179.43 4.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.506 2.137 . . . . 0.0 112.384 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.0 m -97.61 119.18 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -170.5 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -137.35 132.72 33.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 10.2 mptt -100.98 81.06 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -124.9 123.4 39.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.93 41.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 55.91 -176.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 129.16 44.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.79 -74.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -135.45 -61.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 m -96.38 -175.48 3.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -102.07 102.76 13.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.91 30.04 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.85 141.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.86 115.09 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 106.96 16.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 37.4 m-85 -80.15 100.79 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.37 -174.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.9 m -122.85 98.01 5.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.866 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.04 122.35 29.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.66 13.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -40.8 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.71 -93.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.442 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.8 25.25 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.305 . . . . 0.0 111.009 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.37 61.02 7.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.6 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.3 157.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.298 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' TYR . 4.1 t -87.54 119.62 28.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' CG1' ' CD2' ' A' ' 11' ' ' TYR . 12.4 m -134.19 162.29 58.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 51.6 Cg_exo -54.48 153.36 23.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.56 2.173 . . . . 0.0 112.291 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.11 162.49 34.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.08 -177.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.806 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.436 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.12 136.41 58.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.161 0.505 . . . . 0.0 111.019 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.78 169.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.243 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.9 -75.4 1.26 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.564 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 11.3 p-80 -167.75 129.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CE2' HG12 ' A' ' 48' ' ' VAL . 84.1 m-85 61.4 68.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.419 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -131.8 168.84 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.873 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -79.72 125.71 30.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.064 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.28 31.71 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -87.34 -68.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.433 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.43 -35.1 63.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.47 174.58 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -170.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 11.7 ttpp -129.64 53.74 12.47 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.438 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.7 Cg_endo -87.46 102.08 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.607 2.205 . . . . 0.0 111.995 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.3 m -130.15 96.84 4.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 m -69.69 -178.48 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.945 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 t -109.86 162.89 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -133.02 122.69 24.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -97.14 120.17 37.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.33 127.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -126.27 120.71 30.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.45 -51.25 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.55 -56.08 0.87 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.94 -178.9 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -66.35 81.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -79.19 -179.3 6.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -81.44 -174.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 m -98.93 179.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 114.16 19.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 170.79 10.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 16.0 m-85 -149.6 103.13 3.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.423 HD12 ' CE2' ' A' ' 50' ' ' PHE . 41.2 pt -98.81 163.02 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.233 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.7 t -100.81 108.63 20.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.09 126.95 41.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 23.45 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.16 37.4 1.55 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.52 -37.02 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.631 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -59.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.78 54.68 0.36 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.39 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.59 159.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 11' ' ' TYR . 7.2 t -89.61 119.42 30.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.273 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.421 HG12 ' CE2' ' A' ' 11' ' ' TYR . 11.6 m -122.07 163.29 32.54 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 52.2 Cg_exo -54.54 155.61 16.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.59 2.193 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CE2' HD12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.07 169.56 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.82 105.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.459 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -145.0 130.56 18.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.401 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.47 164.09 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.181 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -108.05 -99.22 2.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.452 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 20.3 p-80 -140.07 125.9 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' CYS . 39.0 m-85 58.79 55.31 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.34 161.84 13.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.905 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -79.84 113.35 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -41.69 23.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -77.9 -53.91 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -45.2 95.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.12 126.76 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -93.28 80.26 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 30.8 mtpt -132.16 134.56 25.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 32.4 Cg_exo -57.98 142.63 96.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.422 2.081 . . . . 0.0 112.294 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 103.24 9.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.34 177.72 8.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.16 -174.1 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -160.01 140.33 11.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -139.24 134.79 33.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.2 p -83.71 116.18 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 17.5 mtm105 -133.14 82.94 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 28' ' ' TYR . 21.1 t80 -163.88 31.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.12 -162.93 36.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -169.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 170.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -155.25 80.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -119.31 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 m -104.24 153.09 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.59 147.77 44.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -145.17 115.72 7.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 19.2 m-85 -90.55 133.59 34.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pt -111.41 169.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.076 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -104.96 97.05 6.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 104.29 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.83 23.36 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -99.82 -52.05 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.96 -86.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.28 -32.08 6.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.31 69.29 0.69 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 m -146.7 162.56 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 111.294 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -88.19 108.44 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.431 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 1.7 m -111.17 160.43 29.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.206 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 29.5 Cg_endo -63.61 160.53 35.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -160.09 176.84 11.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.567 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 124.16 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.911 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.513 HG21 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.71 173.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.686 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' ' CG2' ' A' ' 8' ' ' ILE . . . -113.4 -32.23 2.2 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.056 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -179.03 140.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 63.6 79.27 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.513 ' HB2' HG21 ' A' ' 8' ' ' ILE . 3.5 tt0 -107.08 140.0 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.692 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.77 93.79 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 p -119.73 35.97 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.13 -34.39 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -106.43 -28.63 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.02 -178.06 4.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.51 87.07 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 156.44 60.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.44 110.21 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.6 t -104.61 87.6 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.05 151.78 21.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 p -98.31 -170.78 2.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -143.73 108.28 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.7 t -145.63 123.69 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.1 p -178.67 76.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -132.33 102.31 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.91 164.04 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.38 -159.57 14.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -68.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.59 139.33 49.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 105.53 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.79 96.37 10.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 m -94.9 132.07 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -113.7 100.02 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 3.0 tptt -80.57 -167.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 12.2 m-85 -160.06 114.18 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.486 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.4 pt -113.01 156.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.281 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.2 t -89.81 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 117.42 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.982 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.77 24.72 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.968 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -104.31 -32.44 9.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.701 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.88 -76.32 1.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.4 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.04 27.77 1.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.51 60.62 8.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.647 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 6.8 t -129.02 159.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.2 t -97.09 104.32 16.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 m -110.75 164.61 14.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.366 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 42.8 Cg_exo -56.99 163.05 8.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.618 2.212 . . . . 0.0 112.614 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.486 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.19 -178.63 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.936 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.96 104.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.422 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -149.02 130.67 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 110.965 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.74 163.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.067 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -95.15 -88.5 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.466 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -157.13 127.74 6.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.354 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' HG11 ' A' ' 48' ' ' VAL . 41.5 m-85 61.09 62.89 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -105.43 145.12 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.92 115.54 19.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 p -122.92 31.76 5.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.68 -56.11 8.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.072 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -98.03 -25.64 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.17 93.12 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.049 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.47 142.96 38.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 170.43 9.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.761 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.98 119.08 5.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.533 2.155 . . . . 0.0 112.457 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.07 82.24 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.05 -178.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -102.55 133.1 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.69 107.96 20.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -111.39 131.37 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.88 53.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 161.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -116.22 145.5 43.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.23 30.81 0.48 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.05 32.91 19.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -172.76 36.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.48 -177.52 5.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -146.71 179.36 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -102.06 158.72 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -125.44 107.91 11.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.019 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -87.51 166.5 14.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 28.4 m-85 -138.42 109.45 6.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.889 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.464 HG12 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -102.87 153.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.83 93.57 9.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 125.45 29.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -120.02 23.71 10.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.965 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -97.12 39.5 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.14 -53.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -124.93 -63.9 1.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.29 61.39 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.4 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.4 m -138.99 167.16 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.209 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.06 112.78 24.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.554 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG11 ' CD2' ' A' ' 11' ' ' TYR . 35.1 m -120.12 162.19 34.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.211 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.2 Cg_exo -54.15 154.95 16.67 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.607 2.205 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.03 168.47 25.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.54 106.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.02 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.485 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.886 0.375 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 129.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.201 0.524 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.7 155.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.117 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.01 -72.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -171.38 137.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.6 m-85 56.37 52.54 9.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -86.88 153.37 21.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.847 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -79.94 117.95 21.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.99 -24.49 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.8 t -90.2 49.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -178.66 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.65 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.42 41.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.72 147.72 71.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.21 125.69 11.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.414 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.9 m -82.72 75.29 9.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.13 155.27 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.51 161.01 25.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -145.1 108.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 t -94.11 125.77 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.2 m -75.79 126.86 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -100.04 43.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -128.1 113.94 16.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.81 -168.41 16.93 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.22 -60.74 2.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 p -79.07 160.17 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -114.25 90.61 3.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 142.97 26.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 19.2 t -105.35 140.62 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.81 121.69 45.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.3 ttpp -97.55 167.92 10.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.426 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 39.1 m-85 -139.76 123.97 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.509 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.4 pt -117.12 140.22 40.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.161 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.01 91.58 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -82.24 124.98 30.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.84 23.59 10.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.16 37.03 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.79 -69.91 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.625 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.95 -59.11 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.87 59.04 0.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.6 m -142.47 166.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.54 105.96 18.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.415 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.7 m -110.88 161.88 23.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.363 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.32 149.71 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.655 2.237 . . . . 0.0 112.486 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.509 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.09 -167.27 1.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -169.59 95.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.84 120.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.196 0.522 . . . . 0.0 110.999 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.79 169.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.271 -179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -110.07 -37.74 1.78 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.277 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 178.75 144.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 62.09 68.34 0.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -96.88 151.19 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 107.11 12.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.889 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.08 29.48 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.4 t -111.06 -53.29 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.132 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -118.82 31.33 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.16 -173.13 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.23 32.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -66.05 148.19 98.49 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 133.21 22.25 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.522 2.148 . . . . 0.0 112.235 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.98 167.58 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 m -121.53 163.7 18.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 115.2 11.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.3 p -95.58 153.16 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.3 t 60.9 108.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -170.25 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.39 32.02 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.16 44.84 2.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 60.34 31.61 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.907 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.63 178.51 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -93.89 48.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.93 140.1 51.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.35 128.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -96.17 120.32 36.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -105.45 168.54 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.628 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -141.54 127.24 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.504 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -127.37 160.01 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.01 103.51 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.98 101.23 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.47 81.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -149.35 -47.13 0.14 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.59 -31.85 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -115.53 -65.79 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.969 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.7 43.51 1.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 5.5 m -143.17 173.67 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 111.346 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 8.0 t -90.42 105.55 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.419 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.405 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.5 m -112.26 162.88 19.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 75.9 Cg_exo -50.5 154.22 6.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.637 2.225 . . . . 0.0 112.534 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.504 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.06 -168.12 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.38 30.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.821 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 134.21 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.74 166.14 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.15 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.71 -83.89 1.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 27.2 p-80 -156.18 132.94 10.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CE2' HG11 ' A' ' 48' ' ' VAL . 67.3 m-85 59.48 66.42 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' CB ' HG12 ' A' ' 8' ' ' ILE . 1.8 tm0? -117.83 142.16 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -79.97 122.71 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 m -85.27 -36.92 20.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.47 -44.02 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -75.82 -31.08 59.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.98 100.78 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.44 105.72 8.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.85 157.64 71.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.72 136.16 44.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.612 2.208 . . . . 0.0 112.195 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.4 m -90.28 127.46 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.85 172.07 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.64 146.6 28.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 117.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 128.32 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.91 127.63 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -69.3 158.48 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.72 122.44 14.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.26 -79.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -56.16 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.73 175.93 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.48 65.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -126.61 137.61 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.3 t -129.22 139.57 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.018 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 163.06 40.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -103.87 177.71 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.425 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 27.7 m-85 -148.23 105.77 3.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -105.87 154.49 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 53.2 t -94.92 107.52 19.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -101.04 135.42 42.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -104.55 23.82 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.72 -58.26 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.35 -47.71 12.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.27 -47.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.33 72.9 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.32 165.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 3.8 t -94.03 113.72 25.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG11 ' CE2' ' A' ' 11' ' ' TYR . 28.5 m -118.92 162.01 33.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.188 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.425 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 53.9 Cg_exo -52.62 140.64 55.15 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.626 2.217 . . . . 0.0 112.545 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.48 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.12 -172.33 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.55 138.29 8.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.831 0.348 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.51 131.29 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.848 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.59 156.68 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.129 -179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.96 -70.38 0.87 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.61 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 31.2 p-80 -173.01 133.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 59.08 57.01 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.821 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -95.85 157.06 16.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.888 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -79.87 113.35 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 -20.1 11.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.316 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.38 -32.6 58.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.259 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.59 -28.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.36 170.19 9.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -139.15 99.25 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -125.33 155.51 71.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.19 123.04 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 54.5 m -97.9 73.36 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.8 p -59.8 169.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.36 165.16 15.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.31 105.51 7.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.9 t -84.8 93.9 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.9 m -86.81 101.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.089 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.14 -176.03 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.54 93.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.04 -46.37 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.16 -53.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.777 0.322 . . . . 0.0 110.971 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.22 -65.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -143.56 132.85 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.39 107.17 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.4 m -109.75 122.0 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.71 138.63 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -117.96 109.98 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 52.9 m-85 -84.37 129.17 34.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.505 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -119.79 142.99 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -75.88 95.22 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.695 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.91 119.23 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -33.83 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -78.26 64.09 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.24 -53.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.442 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.1 -71.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.578 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -144.12 166.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.8 t -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.9 m -125.11 163.28 38.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.9 Cg_exo -54.15 156.57 12.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.601 2.201 . . . . 0.0 112.382 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.505 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.1 165.36 31.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.96 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.97 130.25 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.217 0.532 . . . . 0.0 111.03 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.81 167.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.254 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -102.24 -86.88 1.97 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.45 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.436 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.6 p-80 -158.14 132.4 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.971 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.416 ' CE2' HG12 ' A' ' 48' ' ' VAL . 70.7 m-85 59.45 55.89 3.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.78 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.418 ' HB2' HG12 ' A' ' 8' ' ' ILE . 2.9 mm-40 -110.03 166.84 10.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -79.93 128.77 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.0 t -110.7 -30.83 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.64 -60.34 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -72.61 -38.79 67.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.54 128.21 54.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.75 38.53 1.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -78.23 127.36 81.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.52 148.67 42.44 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.415 2.077 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.4 m -103.43 105.44 15.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -178.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.48 28.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -117.51 -178.87 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -144.73 84.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.11 159.69 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.21 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 60.98 156.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -177.01 102.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.8 -94.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.413 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -97.62 -33.69 11.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 m -101.95 172.28 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.04 128.56 49.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.46 136.14 34.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.3 p -122.9 154.92 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -123.12 106.13 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -117.28 119.88 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.436 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 67.8 m-85 -88.77 115.0 25.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.45 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.0 pt -103.65 148.14 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.41 93.25 5.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 112.33 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.56 -31.53 15.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.83 -30.55 69.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.798 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.43 -79.89 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.53 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.29 27.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 47.05 86.54 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.664 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.63 159.28 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.03 114.49 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.416 HG12 ' CE2' ' A' ' 11' ' ' TYR . 5.2 m -122.03 161.81 40.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 57.3 Cg_exo -52.25 155.23 9.6 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.574 2.183 . . . . 0.0 112.542 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.45 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.13 -174.11 4.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.38 29.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.13 132.68 39.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 168.17 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.211 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.87 -79.92 1.02 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.613 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 33.5 p-80 -161.77 131.68 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CD2' HG13 ' A' ' 48' ' ' VAL . 60.4 m-85 60.67 65.52 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -122.08 142.08 50.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.9 pttp -79.7 116.3 19.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -111.94 24.23 12.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.1 t -76.77 -56.61 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.19 30.99 3.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.96 115.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.76 100.8 12.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -141.81 142.61 25.91 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 144.21 32.25 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.583 2.189 . . . . 0.0 112.405 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.4 m -92.82 102.21 14.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.4 154.13 36.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -108.93 158.99 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -138.15 109.35 6.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.9 p -84.38 116.25 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 65.16 126.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.046 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -92.81 47.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 61.12 156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.79 -127.61 8.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.21 144.65 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 t -69.52 142.58 53.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -154.82 -178.36 7.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -80.21 -176.8 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.91 154.86 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.01 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 tpm_? -117.48 92.92 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.2 tptm -79.97 166.47 21.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 38.1 m-85 -143.03 106.06 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.444 HG12 ' CG ' ' A' ' 50' ' ' PHE . 4.3 pt -100.53 146.45 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.25 100.82 10.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -86.63 117.75 25.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.6 24.48 10.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.26 -26.76 42.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.53 -60.19 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.647 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.05 -69.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 111.062 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.07 58.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.547 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.5 m -132.67 157.72 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.3 118.17 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 11' ' ' TYR . 16.8 m -120.09 161.84 36.54 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.257 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 70.5 Cg_exo -51.54 149.98 17.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.624 2.216 . . . . 0.0 112.438 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.444 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.04 -168.95 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.66 148.91 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.811 0.339 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 133.91 56.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.65 167.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.138 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.81 -95.36 1.95 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.527 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 39.7 p-80 -147.39 126.74 13.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.982 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.438 ' N ' ' O ' ' A' ' 47' ' ' CYS . 76.4 m-85 61.79 59.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.413 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -123.19 176.97 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.843 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 132.74 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.5 t -115.15 -7.69 12.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.414 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.82 50.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.875 0.369 . . . . 0.0 111.22 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -176.97 36.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.27 -165.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.58 34.61 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.476 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 44.3 pttt 44.32 51.24 7.92 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.768 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.8 Cg_endo -86.64 102.53 0.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.535 2.157 . . . . 0.0 112.135 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.9 m -126.36 105.35 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.8 m -73.03 177.16 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -115.49 129.19 56.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 93.35 7.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.6 t -113.8 115.13 27.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.38 152.58 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -64.65 177.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -60.84 129.35 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.22 -142.79 3.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.2 -67.31 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -99.9 146.23 26.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -106.66 109.5 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -141.81 133.68 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -123.35 122.47 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -98.58 108.91 21.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 -176.66 5.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m-85 -158.35 126.82 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.463 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -129.41 167.39 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.208 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.9 m -94.42 126.31 39.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.61 118.61 30.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ttm105 -116.57 24.11 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.44 -30.36 53.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.95 -49.0 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.49 -67.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.33 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.93 62.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 16.9 m -133.41 155.23 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 111.229 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' TYR . 48.6 t -85.45 115.93 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.228 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 27.4 m -119.92 163.76 26.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.9 Cg_exo -53.38 154.6 14.52 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.554 2.17 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.463 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.49 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -136.93 -46.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -170.09 126.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.187 0.518 . . . . 0.0 110.994 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.64 166.71 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.228 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.37 -68.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.518 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -173.86 120.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.434 ' CD2' HG11 ' A' ' 48' ' ' VAL . 21.9 m-85 62.02 62.19 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -108.19 166.69 10.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -79.82 122.04 26.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.34 -28.96 10.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.48 103.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.155 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.08 61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.16 137.61 20.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.042 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.14 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.33 95.18 48.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.77 152.04 29.93 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.511 2.141 . . . . 0.0 112.331 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -114.3 104.91 12.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.3 p -102.3 -176.5 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.0 p -107.19 165.74 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 -179.29 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -127.26 148.94 50.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.02 126.22 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.14 170.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -157.95 98.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.02 -84.07 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.23 -57.24 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 p -96.66 122.63 39.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.42 115.83 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -155.73 133.24 11.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.75 152.48 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -116.59 138.32 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.5 169.9 8.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 20.0 m-85 -150.43 107.77 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.422 HD11 ' CE1' ' A' ' 50' ' ' PHE . 43.3 pt -99.72 160.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.193 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 m -98.99 97.2 8.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 111.72 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -27.31 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 52.91 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.58 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.25 -52.99 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.05 44.75 0.99 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.624 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.08 158.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -86.52 116.78 24.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.434 HG11 ' CD2' ' A' ' 11' ' ' TYR . 3.7 m -121.65 164.17 26.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 45.6 Cg_exo -56.07 148.37 59.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.422 ' CE1' HD11 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.18 -169.38 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.94 94.44 2.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.698 0.285 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.38 130.54 46.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.201 0.525 . . . . 0.0 111.027 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.6 166.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.208 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.26 -75.11 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -169.86 134.44 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.419 ' CD2' HG12 ' A' ' 48' ' ' VAL . 26.8 m-85 59.22 53.27 5.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.012 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.433 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 6.9 tp60 -96.9 160.55 14.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.521 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -79.7 114.15 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.16 -47.98 8.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.799 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.18 129.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.84 29.93 19.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.15 86.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.87 146.23 33.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -173.52 148.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.809 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.34 120.95 7.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.7 m -81.3 100.6 9.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 165.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.054 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -125.04 161.55 26.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -131.23 108.03 9.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.0 t -137.28 162.54 33.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.64 92.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -89.55 167.59 12.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -64.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.05 101.89 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.4 85.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -104.79 137.21 42.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -174.37 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -160.06 171.64 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.6 p -136.62 145.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -120.48 121.06 37.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -111.58 165.88 11.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 12.8 m-85 -135.37 121.94 20.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -112.69 155.97 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 100.51 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.616 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.95 139.56 30.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -129.94 24.02 5.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.52 -59.47 2.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.67 -97.72 0.82 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.429 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -79.94 -56.51 4.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.9 84.81 0.88 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.58 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 16.8 m -150.64 161.74 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.909 0.385 . . . . 0.0 111.346 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.19 107.12 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.434 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.419 HG12 ' CD2' ' A' ' 11' ' ' TYR . 23.4 m -113.56 162.98 19.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.449 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 41.2 Cg_exo -57.38 160.35 13.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.22 -170.36 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -156.61 -45.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.59 133.39 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.211 0.529 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.68 167.04 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.156 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -104.09 -93.39 2.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -149.28 126.98 11.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.418 ' CE2' HG13 ' A' ' 48' ' ' VAL . 21.2 m-85 61.28 61.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.71 148.72 32.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.709 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -79.74 105.5 11.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.1 p -97.76 23.49 7.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -102.89 -47.88 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.105 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.48 -32.1 73.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.32 -175.05 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -127.2 85.31 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.954 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.8 mttt -115.76 139.9 25.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.6 143.87 31.07 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.522 2.148 . . . . 0.0 112.274 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.5 m -96.74 105.06 17.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -179.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.85 173.19 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -145.29 106.13 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.7 t -132.82 123.4 26.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.94 174.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -166.56 156.93 12.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.42 140.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.74 3.17 71.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.898 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.16 104.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 t -171.84 122.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 88.58 6.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -143.58 118.49 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.0 p -142.16 137.72 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -123.77 126.72 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 158.9 21.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -130.84 113.76 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pp -114.85 153.86 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.183 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.18 111.23 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.59 107.39 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -100.91 24.63 9.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 50.53 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.25 -33.46 1.02 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -147.98 -70.33 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 128.37 59.24 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.37 155.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.8 t -88.95 114.36 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 28.5 m -123.91 163.58 34.48 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.17 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.427 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.1 Cg_exo -53.91 153.26 20.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.55 2.167 . . . . 0.0 112.428 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.514 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.0 172.85 16.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 59.57 108.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.48 133.25 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.543 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.62 163.99 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.109 -179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.52 -87.9 1.96 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.549 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 4.2 p-80 -152.57 129.09 10.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' CE2' HG12 ' A' ' 48' ' ' VAL . 20.3 m-85 61.38 66.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 139.4 42.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -79.82 105.77 11.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -112.95 29.06 8.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.77 -63.83 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.087 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.8 31.07 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.68 130.24 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -102.37 114.06 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -135.1 150.77 73.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 119.7 6.58 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.577 2.185 . . . . 0.0 112.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.1 m -80.1 96.41 6.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.33 155.55 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -101.99 165.26 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.61 92.7 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 43.6 p -104.41 146.74 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.09 132.16 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.25 87.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.55 158.89 25.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.18 -46.13 3.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.508 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -99.52 157.53 16.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.8 m 60.33 177.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -137.16 95.02 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.92 74.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.7 m -96.21 135.06 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 113.72 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -170.52 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.815 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.407 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 19.7 m-85 -160.05 123.1 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.952 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.454 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -130.55 157.92 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.04 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.84 100.99 12.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.81 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -91.61 133.14 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 23.96 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.55 -41.01 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -67.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.01 33.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.831 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.05 64.1 4.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.563 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.2 t -130.05 154.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -93.66 102.05 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG12 ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -108.35 160.91 25.33 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.08 159.59 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.631 2.221 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.02 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -154.74 -63.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.428 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m 63.59 131.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.278 0.561 . . . . 0.0 110.929 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.211 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.17 -98.0 2.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.511 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.432 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.6 p-80 -140.32 126.0 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.425 ' CD2' HG11 ' A' ' 48' ' ' VAL . 39.4 m-85 58.39 51.96 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.88 156.56 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 122.5 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.44 -53.49 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.1 135.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 m120 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -155.91 91.96 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.72 84.14 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.92 116.92 6.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.43 146.66 82.23 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -80.07 102.08 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 170.91 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -127.24 136.09 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -111.26 168.1 9.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -143.32 176.8 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.1 p -151.15 140.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 65.26 168.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -84.28 165.78 18.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.17 120.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.04 121.62 44.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.786 0.327 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -156.39 -50.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.98 35.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.47 31.29 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.91 171.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.85 110.33 12.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -99.86 106.05 17.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.439 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 44.5 m-85 -81.64 137.26 35.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.566 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -131.0 153.85 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.45 127.17 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.94 119.67 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 24.37 11.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.42 50.18 1.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.69 -65.78 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -127.31 -45.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.92 73.36 0.74 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.63 160.14 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 111.274 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.3 t -95.06 112.21 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 4.3 m -116.3 164.89 16.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 51.0 Cg_exo -54.18 146.93 47.01 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.43 2.086 . . . . 0.0 112.267 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.566 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.83 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -156.71 172.73 18.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.8 p -166.13 146.4 6.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.607 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.422 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.77 172.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.501 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -87.23 -99.58 0.85 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.673 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 20.0 p-80 -147.1 129.01 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' CYS . 74.7 m-85 61.12 59.97 1.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' CB ' HG12 ' A' ' 8' ' ' ILE . 4.3 mm-40 -116.42 171.74 7.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -79.55 114.78 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -116.06 -12.82 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.363 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.44 -33.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.221 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.28 29.67 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.014 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.55 148.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 37.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.42 126.66 84.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.33 154.0 75.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.25 175.26 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.77 -165.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.146 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -159.68 114.95 2.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.728 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 86.98 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.02 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.0 p -110.51 88.55 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.8 124.08 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.85 165.43 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -175.33 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.2 85.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 60.82 40.32 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 170.21 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 41.65 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -97.9 36.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.2 p -118.03 110.01 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.19 134.77 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.751 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -120.75 109.35 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.455 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 9.2 m-85 -81.81 138.11 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.556 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.2 pp -134.36 178.25 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 111.483 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.42 120.66 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.697 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -103.98 93.47 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.5 23.81 9.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 -51.5 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.59 -67.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -127.3 -46.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.72 52.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.588 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -143.27 156.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.401 . . . . 0.0 111.429 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -83.27 117.29 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.9 m -128.93 165.73 29.92 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.246 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 32.2 Cg_exo -58.36 165.89 6.8 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.566 2.177 . . . . 0.0 112.527 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.556 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -160.08 166.44 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.57 90.08 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.466 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.769 0.319 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.86 127.38 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 HG12 ' CB ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.76 166.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.171 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.86 -78.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.454 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 21.9 p-80 -166.79 133.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 58.18 61.85 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 23.3 tp60 -105.82 159.25 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 115.71 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -84.24 -29.98 26.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -70.01 -38.44 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.98 -37.17 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.53 117.75 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.29 74.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -121.19 158.39 53.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 134.35 63.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.634 2.223 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.9 m -96.07 101.87 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.703 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.32 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.043 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -110.24 163.66 13.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 114.68 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -118.13 147.05 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.01 154.59 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.1 mtt-85 -97.47 38.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.3 164.74 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.83 -94.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.56 -29.68 65.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.031 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 109.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.026 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.7 mttt 60.23 175.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.95 -177.84 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.13 144.65 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.92 130.14 39.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.435 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -99.47 -165.57 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.4 m-85 -142.86 142.42 31.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.457 . . . . 0.0 111.645 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.528 HG23 ' CG ' ' A' ' 50' ' ' PHE . 5.1 pt -120.79 152.02 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 97.14 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.46 116.1 27.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.03 -31.3 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.95 -30.23 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.68 -98.88 0.23 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.66 -33.97 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 104.09 47.44 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -143.54 154.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 t -96.97 106.51 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 2.2 m -114.52 161.26 29.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.961 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 60.1 Cg_endo -73.06 151.37 49.81 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.319 2.013 . . . . 0.0 112.633 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.528 ' CG ' HG23 ' A' ' 38' ' ' ILE . 1.6 p90 -149.35 170.48 18.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 -54.99 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' HA2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.47 128.33 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.096 0.474 . . . . 0.0 111.006 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.58 170.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.367 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -118.01 -35.04 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.507 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -177.36 142.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 61.08 71.49 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.0 tm0? -102.3 141.51 35.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.802 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.88 108.74 13.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.65 24.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.18 118.98 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 m120 59.66 54.04 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.59 145.88 2.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.17 32.6 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.05 112.71 29.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.98 132.28 48.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -93.16 92.27 7.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -178.62 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -178.34 4.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -144.05 95.34 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.0 t -124.13 116.36 22.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.38 128.05 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -122.61 91.85 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -152.64 81.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.14 179.96 18.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 150.72 27.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.8 t 60.33 102.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.53 123.17 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -84.33 134.92 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.29 113.85 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -82.67 126.03 31.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -129.84 169.99 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.431 ' CE2' ' HG3' ' A' ' 49' ' ' PRO . 34.1 m-85 -136.86 118.92 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.455 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.3 pt -107.24 147.73 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.277 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.71 92.04 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.706 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.03 126.46 31.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -105.53 24.04 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.41 -32.07 12.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.5 -64.7 1.06 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.525 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -156.52 27.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.001 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.15 62.33 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.582 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -128.68 158.5 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 111.135 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.5 t -94.31 105.86 17.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.733 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 24.9 m -111.47 162.24 21.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 52.3 Cg_exo -55.37 160.11 9.35 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.656 2.237 . . . . 0.0 112.516 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.455 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.08 173.64 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 60.19 163.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.964 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.856 0.36 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.75 135.68 50.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.232 0.539 . . . . 0.0 111.019 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.403 ' CD1' ' CG ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 170.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.214 -179.532 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -109.58 -91.04 2.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.614 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 11.2 p-80 -152.18 128.69 10.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 48' ' ' VAL . 32.2 m-85 58.26 61.21 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -107.62 152.71 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -79.73 120.95 24.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.967 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 -34.49 20.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.9 -35.55 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -107.88 34.78 3.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -171.82 141.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.018 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.09 90.56 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' CG ' ' CD1' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -157.62 137.18 8.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.925 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 145.94 65.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.373 2.049 . . . . 0.0 112.419 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.0 m -87.8 95.04 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 174.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.1 p -148.56 128.07 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -84.31 153.07 23.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -150.8 96.87 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.68 139.33 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 120.13 26.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -132.68 -48.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.82 -161.3 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.12 -53.87 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -71.04 124.26 23.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -80.68 137.62 36.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -114.83 95.14 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.6 p -112.33 113.54 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.413 ' HG2' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.86 100.93 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -98.57 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 39.0 m-85 -79.89 147.59 31.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -135.98 148.85 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.91 104.87 16.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.51 116.97 33.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -111.14 -30.27 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.0 -25.96 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 -43.45 3.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.58 -74.58 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.07 46.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.586 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.12 153.78 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.202 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.72 113.72 25.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG12 ' CE2' ' A' ' 11' ' ' TYR . 3.4 m -121.77 164.9 22.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.188 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.9 Cg_exo -54.98 159.75 9.01 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.56 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.95 160.37 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.782 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 86.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.433 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 m 62.59 130.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.216 0.531 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.76 170.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.331 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -106.33 -40.85 1.86 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.331 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -179.04 144.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.79 0.329 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 62.52 74.29 0.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 tm0? -98.49 132.24 44.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -79.89 110.22 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.58 22.86 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.997 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.97 -31.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.56 30.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.99 -173.93 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.1 128.46 24.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.15 141.07 6.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.84 114.47 3.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.411 2.074 . . . . 0.0 112.428 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.9 t -93.03 82.79 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.818 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.03 -173.38 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.08 168.32 9.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.09 128.06 29.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -110.25 126.22 53.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.804 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.03 151.37 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.68 139.73 26.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -165.93 -54.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.68 -159.29 35.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.97 -55.22 17.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 t -120.48 138.97 53.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -149.85 123.77 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.58 161.21 20.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.55 144.63 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -100.56 133.86 44.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 178.97 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -152.61 129.08 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.453 ' CG1' ' CD1' ' A' ' 50' ' ' PHE . 2.8 pp -124.84 144.61 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.194 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.16 119.8 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.87 111.75 24.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.52 26.21 8.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.48 54.65 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.57 -24.72 8.41 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.799 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -120.11 -78.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.69 58.37 0.57 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.413 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 20.1 t -137.82 160.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.5 t -96.61 101.09 12.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.42 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -104.37 161.74 21.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 86.9 Cg_exo -46.75 144.67 7.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.672 2.248 . . . . 0.0 112.694 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CD1' ' CG1' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.01 -167.66 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -166.02 102.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 m -57.65 140.53 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 111.177 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 165.35 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.228 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -105.95 -76.77 1.06 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -180.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.46 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.8 p-80 -168.28 130.0 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' CE2' HG13 ' A' ' 48' ' ' VAL . 29.5 m-85 59.28 60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.623 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.04 157.02 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -79.83 116.45 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 m -79.89 -39.51 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.28 136.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 58.96 31.06 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.38 149.67 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -124.22 37.13 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.12 125.44 48.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 132.85 23.71 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.516 2.144 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.03 94.94 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.4 m -84.79 -178.21 6.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 175.94 5.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -154.86 169.0 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.8 t -140.38 141.0 35.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.44 145.32 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.7 110.79 10.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -150.26 98.26 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.26 -116.53 8.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.47 -31.15 8.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.5 m -67.4 86.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 144.08 31.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -160.0 138.03 10.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.6 m -102.84 163.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -159.13 160.33 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.9 ttpp -126.06 179.9 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 40.1 m-85 -129.32 150.49 50.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.013 0.435 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.563 HG21 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -122.35 153.04 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.943 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.22 91.99 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.01 110.75 19.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -109.79 24.66 12.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.34 -50.97 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.59 -66.61 1.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.7 -47.2 0.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.07 78.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.42 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.29 154.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 104.55 16.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.404 HG13 ' CE2' ' A' ' 11' ' ' TYR . 5.6 m -109.84 157.74 36.85 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.226 -179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 62.5 Cg_endo -73.55 137.39 25.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.551 2.167 . . . . 0.0 112.64 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CG ' HG21 ' A' ' 38' ' ' ILE . 3.1 p90 -135.23 176.76 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.91 99.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.05 136.44 33.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.63 164.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.293 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -107.24 -68.18 0.66 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.394 180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.435 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 22.1 p-80 -170.83 126.95 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 49' ' ' PRO . 22.1 m-85 57.07 60.53 2.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -114.38 169.52 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.576 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -79.5 121.06 24.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 t -122.52 -59.4 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.416 ' HB ' ' CA ' ' A' ' 45' ' ' GLY . 3.5 t -63.16 -26.32 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.143 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.35 -35.29 12.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.39 50.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.82 126.35 29.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 tttt -177.12 98.65 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.09 144.1 23.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.165 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -105.39 94.51 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.5 m -81.43 169.37 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -99.94 135.98 40.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -106.59 -179.51 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.5 t -152.37 121.52 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.98 123.37 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 60.19 161.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.79 158.71 26.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.31 -121.59 1.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.71 177.01 4.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.13 122.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -72.8 102.4 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -125.2 68.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.2 m -98.61 168.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.58 115.88 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.0 170.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.793 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 31.7 m-85 -154.0 129.56 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.424 HG21 ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -127.55 156.06 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.9 m -90.39 111.82 23.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.32 -172.22 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 60.93 81.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -33.02 72.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.697 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.53 -63.41 4.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.333 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -58.19 3.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.513 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . . . 96.52 77.28 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.9 179.493 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -135.67 151.61 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -102.59 114.51 28.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.458 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 HG12 ' CD2' ' A' ' 11' ' ' TYR . 8.8 m -111.79 162.43 21.18 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.312 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 37' ' ' PHE . 52.0 Cg_exo -54.14 158.83 8.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.635 2.223 . . . . 0.0 112.454 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.424 ' CG ' HG21 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -155.42 174.53 15.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t0 59.84 54.59 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' HG22 ' A' ' 6' ' ' THR . 38.5 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 20' ' ' PRO . 23.9 p -166.09 140.03 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.402 0.62 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.84 160.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.602 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.14 -87.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.698 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 31.6 p-80 -157.98 138.38 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 48' ' ' VAL . 56.0 m-85 59.3 58.01 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB2' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -121.15 171.27 8.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.643 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -79.42 120.71 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 0.0 111.188 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t -101.75 21.52 14.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 15' ' ' VAL . 15.2 t -109.61 30.34 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.091 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.78 29.74 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.33 -170.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.21 -77.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -170.73 52.93 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.434 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 53.5 Cg_endo -68.77 114.28 3.48 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.642 2.228 . . . . 0.0 112.404 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -153.04 104.54 2.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.733 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.433 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 7.2 m -67.14 -175.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.833 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -148.55 145.86 28.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -115.7 104.53 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 34' ' ' VAL . 1.8 t -109.11 93.83 4.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.35 168.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 177.37 8.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.02 -46.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.33 -107.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.04 -35.47 76.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.936 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.68 141.98 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.55 132.81 24.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -123.75 123.59 40.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -111.9 116.98 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 125.04 38.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -108.58 167.36 10.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 14.4 m-85 -140.85 111.24 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG12 ' CG ' ' A' ' 50' ' ' PHE . 6.1 pt -103.24 166.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.9 m -103.5 107.39 18.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -94.15 135.15 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.03 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 -24.69 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.49 -35.95 63.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -113.06 0.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.506 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.92 26.04 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.58 63.81 4.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 12' ' ' GLN . 33.1 m -139.64 155.36 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' TYR . 49.0 t -90.1 121.26 32.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.209 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.664 HG12 ' CD2' ' A' ' 11' ' ' TYR . 26.2 m -125.29 166.51 20.29 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.216 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 45.5 Cg_exo -56.92 158.19 17.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.485 2.124 . . . . 0.0 112.347 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -176.44 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.62 164.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.515 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -163.61 132.53 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.227 0.537 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.67 167.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.194 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.52 -99.05 2.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.56 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.2 p-80 -144.29 125.68 14.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD2' HG12 ' A' ' 48' ' ' VAL . 62.0 m-85 61.44 52.42 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.5 mm-40 -107.1 175.37 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.564 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 1.6 mmtp -79.64 127.55 32.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.5 t -103.44 -29.04 11.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.9 -30.59 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.204 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -105.56 37.87 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . . . -166.81 172.3 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.098 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.08 -166.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt 64.21 132.87 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.54 -179.43 4.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.506 2.137 . . . . 0.0 112.384 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.0 m -97.61 119.18 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -170.5 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -137.35 132.72 33.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 10.2 mptt -100.98 81.06 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -124.9 123.4 39.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 26' ' ' VAL . 14.3 p -95.93 41.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 55.91 -176.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 129.16 44.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.79 -74.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -135.45 -61.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 m -96.38 -175.48 3.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -102.07 102.76 13.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.91 30.04 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.85 141.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.86 115.09 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 106.96 16.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.432 ' CE1' ' HD3' ' A' ' 24' ' ' LYS . 37.4 m-85 -80.15 100.79 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -83.37 -174.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 1.9 m -122.85 98.01 5.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.04 122.35 29.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.66 13.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -40.8 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.71 -93.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.442 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.8 25.25 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.305 . . . . 0.0 111.009 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.37 61.02 7.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.6 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.3 157.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.298 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' TYR . 4.1 t -87.54 119.62 28.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.598 HG12 ' CD2' ' A' ' 11' ' ' TYR . 12.4 m -134.19 162.29 58.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 51.6 Cg_exo -54.48 153.36 23.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.56 2.173 . . . . 0.0 112.291 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.11 162.49 34.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.08 -177.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.806 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.436 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.12 136.41 58.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.161 0.505 . . . . 0.0 111.019 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.78 169.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.243 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.9 -75.4 1.26 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.564 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 11.3 p-80 -167.75 129.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.726 ' CD2' HG12 ' A' ' 48' ' ' VAL . 84.1 m-85 61.4 68.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.423 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -131.8 168.84 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.873 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -79.72 125.71 30.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.064 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.28 31.71 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.0 t -87.34 -68.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.433 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.43 -35.1 63.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.47 174.58 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -170.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 11.7 ttpp -129.64 53.74 12.47 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.438 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.7 Cg_endo -87.46 102.08 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.607 2.205 . . . . 0.0 111.995 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.3 m -130.15 96.84 4.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 m -69.69 -178.48 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.945 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 t -109.86 162.89 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -133.02 122.69 24.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 34' ' ' VAL . 3.0 t -97.14 120.17 37.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.33 127.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -126.27 120.71 30.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.45 -51.25 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.55 -56.08 0.87 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.94 -178.9 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -66.35 81.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -79.19 -179.3 6.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -81.44 -174.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 25' ' ' THR . 8.9 m -98.93 179.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 114.16 19.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 170.79 10.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 16.0 m-85 -149.6 103.13 3.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 50' ' ' PHE . 41.2 pt -98.81 163.02 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.233 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.7 t -100.81 108.63 20.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.09 126.95 41.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 23.45 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.16 37.4 1.55 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.52 -37.02 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.631 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -59.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 115.78 54.68 0.36 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.39 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.59 159.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.61 119.42 30.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.273 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.726 HG12 ' CD2' ' A' ' 11' ' ' TYR . 11.6 m -122.07 163.29 32.54 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.2 Cg_exo -54.54 155.61 16.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.59 2.193 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.07 169.56 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.82 105.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.459 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -145.0 130.56 18.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.47 164.09 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.181 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -108.05 -99.22 2.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 20.3 p-80 -140.07 125.9 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' CYS . 39.0 m-85 58.79 55.31 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.416 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.34 161.84 13.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.905 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HA ' HG12 ' A' ' 46' ' ' VAL . 1.1 mptp? -79.84 113.35 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -41.69 23.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -77.9 -53.91 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -45.2 95.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -112.12 126.76 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -93.28 80.26 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 30.8 mtpt -132.16 134.56 25.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 32.4 Cg_exo -57.98 142.63 96.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.422 2.081 . . . . 0.0 112.294 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 103.24 9.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.34 177.72 8.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.16 -174.1 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -160.01 140.33 11.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -139.24 134.79 33.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 11.2 p -83.71 116.18 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . 17.5 mtm105 -133.14 82.94 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 28' ' ' TYR . 21.1 t80 -163.88 31.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.12 -162.93 36.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -169.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 170.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -155.25 80.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -119.31 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 m -104.24 153.09 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.59 147.77 44.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -145.17 115.72 7.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 19.2 m-85 -90.55 133.59 34.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.421 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pt -111.41 169.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.076 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -104.96 97.05 6.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 104.29 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.83 23.36 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -99.82 -52.05 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.96 -86.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.28 -32.08 6.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.31 69.29 0.69 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 13' ' ' LYS . 11.0 m -146.7 162.56 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 111.294 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -88.19 108.44 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 1.7 m -111.17 160.43 29.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.206 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 29.5 Cg_endo -63.61 160.53 35.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -160.09 176.84 11.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.567 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 124.16 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.911 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.71 173.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.686 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -113.4 -32.23 2.2 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.056 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -179.03 140.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 63.6 79.27 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.875 ' HG3' HD13 ' A' ' 8' ' ' ILE . 3.5 tt0 -107.08 140.0 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.692 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.77 93.79 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 p -119.73 35.97 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.13 -34.39 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -106.43 -28.63 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.02 -178.06 4.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.51 87.07 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 156.44 60.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.44 110.21 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.6 t -104.61 87.6 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.05 151.78 21.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 p -98.31 -170.78 2.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -143.73 108.28 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.726 ' OG1' HG12 ' A' ' 34' ' ' VAL . 9.7 t -145.63 123.69 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.1 p -178.67 76.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -132.33 102.31 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.91 164.04 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.38 -159.57 14.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -68.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.59 139.33 49.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 105.53 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.79 96.37 10.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.726 HG12 ' OG1' ' A' ' 25' ' ' THR . 10.6 m -94.9 132.07 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -113.7 100.02 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 3.0 tptt -80.57 -167.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 12.2 m-85 -160.06 114.18 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.485 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.4 pt -113.01 156.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.281 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.2 t -89.81 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 117.42 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.982 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.77 24.72 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.968 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -104.31 -32.44 9.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.701 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.88 -76.32 1.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.4 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.04 27.77 1.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.51 60.62 8.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.647 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 47' ' ' CYS . 6.8 t -129.02 159.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -97.09 104.32 16.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.5 m -110.75 164.61 14.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.366 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 42.8 Cg_exo -56.99 163.05 8.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.618 2.212 . . . . 0.0 112.614 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.19 -178.63 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.936 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.96 104.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.422 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -149.02 130.67 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 110.965 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.74 163.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.15 -88.5 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.466 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -157.13 127.74 6.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.354 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD2' HG12 ' A' ' 48' ' ' VAL . 41.5 m-85 61.09 62.89 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -105.43 145.12 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.82 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -79.92 115.54 19.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 p -122.92 31.76 5.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -78.68 -56.11 8.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.072 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -98.03 -25.64 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.17 93.12 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.049 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.47 142.96 38.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.07 170.43 9.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.98 119.08 5.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.533 2.155 . . . . 0.0 112.457 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.07 82.24 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.05 -178.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -102.55 133.1 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.69 107.96 20.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -111.39 131.37 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.88 53.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 161.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -116.22 145.5 43.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.23 30.81 0.48 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.05 32.91 19.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -172.76 36.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.48 -177.52 5.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -146.71 179.36 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.2 p -102.06 158.72 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG22 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -125.44 107.91 11.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.019 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 11.9 tttt -87.51 166.5 14.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -138.42 109.45 6.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.465 HG12 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -102.87 153.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.83 93.57 9.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 125.45 29.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -120.02 23.71 10.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.965 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -97.12 39.5 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.14 -53.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -124.93 -63.9 1.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 118.29 61.39 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.4 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 13' ' ' LYS . 18.4 m -138.99 167.16 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.06 112.78 24.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.554 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 11' ' ' TYR . 35.1 m -120.12 162.19 34.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.211 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.2 Cg_exo -54.15 154.95 16.67 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.607 2.205 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.03 168.47 25.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.54 106.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.02 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.485 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.886 0.375 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 129.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.201 0.524 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.7 155.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.117 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.01 -72.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -171.38 137.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.485 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.6 m-85 56.37 52.54 9.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HG2' HD11 ' A' ' 8' ' ' ILE . 4.1 tp60 -86.88 153.37 21.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.661 ' HA ' HG12 ' A' ' 46' ' ' VAL . 4.0 tptt -79.94 117.95 21.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.99 -24.49 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' VAL . 29.8 t -90.2 49.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -178.66 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.65 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.42 41.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.635 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -78.72 147.72 71.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.21 125.69 11.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.414 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.9 m -82.72 75.29 9.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.13 155.27 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.51 161.01 25.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -145.1 108.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 34' ' ' VAL . 4.9 t -94.11 125.77 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 26' ' ' VAL . 10.2 m -75.79 126.86 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -100.04 43.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -128.1 113.94 16.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.81 -168.41 16.93 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.22 -60.74 2.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 p -79.07 160.17 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -114.25 90.61 3.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 142.97 26.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 25' ' ' THR . 19.2 t -105.35 140.62 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.81 121.69 45.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 6.3 ttpp -97.55 167.92 10.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 39.1 m-85 -139.76 123.97 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.512 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.4 pt -117.12 140.22 40.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.161 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.01 91.58 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -82.24 124.98 30.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.84 23.59 10.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.16 37.03 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.79 -69.91 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.625 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.95 -59.11 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.87 59.04 0.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.6 m -142.47 166.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.54 105.96 18.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.7 m -110.88 161.88 23.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.363 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 52.6 Cg_exo -53.32 149.71 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.655 2.237 . . . . 0.0 112.486 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.09 -167.27 1.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -169.59 95.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.84 120.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.196 0.522 . . . . 0.0 110.999 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.874 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.79 169.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.271 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -110.07 -37.74 1.78 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.277 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 178.75 144.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 62.09 68.34 0.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.874 ' HG3' HD13 ' A' ' 8' ' ' ILE . 5.7 tm0? -96.88 151.19 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.597 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.67 107.11 12.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.889 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.08 29.48 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 45' ' ' GLY . 20.4 t -111.06 -53.29 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.132 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -118.82 31.33 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.16 -173.13 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.23 32.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -66.05 148.19 98.49 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 133.21 22.25 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.522 2.148 . . . . 0.0 112.235 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.98 167.58 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 m -121.53 163.7 18.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 115.2 11.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.61 ' HA ' HG13 ' A' ' 34' ' ' VAL . 6.3 p -95.58 153.16 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 30' ' ' ASP . 22.3 t 60.9 108.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -170.25 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.39 32.02 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.16 44.84 2.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.544 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.2 m-20 60.34 31.61 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.63 178.51 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -93.89 48.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.93 140.1 51.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 25' ' ' THR . 22.0 t -107.35 128.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -96.17 120.32 36.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -105.45 168.54 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.628 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -141.54 127.24 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.557 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.7 pp -127.37 160.01 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.01 103.51 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 48' ' ' VAL . 1.2 t70 -89.98 101.23 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -115.47 81.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -149.35 -47.13 0.14 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.59 -31.85 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -115.53 -65.79 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.969 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 109.7 43.51 1.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 13' ' ' LYS . 5.5 m -143.17 173.67 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 111.346 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' CB ' ' HB3' ' A' ' 12' ' ' GLN . 8.0 t -90.42 105.55 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.419 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 40' ' ' ASP . 3.5 m -112.26 162.88 19.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 75.9 Cg_exo -50.5 154.22 6.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.637 2.225 . . . . 0.0 112.534 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.06 -168.12 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.38 30.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.821 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 134.21 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.74 166.14 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.15 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.71 -83.89 1.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 27.2 p-80 -156.18 132.94 10.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 59.48 66.42 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' CB ' HG12 ' A' ' 8' ' ' ILE . 1.8 tm0? -117.83 142.16 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 46' ' ' VAL . 2.7 mttp -79.97 122.71 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 m -85.27 -36.92 20.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.47 -44.02 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -75.82 -31.08 59.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -152.98 100.78 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.44 105.72 8.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -138.85 157.64 71.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.72 136.16 44.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.612 2.208 . . . . 0.0 112.195 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.4 m -90.28 127.46 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.85 172.07 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.64 146.6 28.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 117.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 128.32 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.91 127.63 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -69.3 158.48 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.72 122.44 14.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.26 -79.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -56.16 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.73 175.93 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.48 65.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -126.61 137.61 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.3 t -129.22 139.57 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.018 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 163.06 40.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -103.87 177.71 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.677 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 27.7 m-85 -148.23 105.77 3.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -105.87 154.49 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 53.2 t -94.92 107.52 19.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -101.04 135.42 42.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -104.55 23.82 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.72 -58.26 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.35 -47.71 12.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.27 -47.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.33 72.9 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 13' ' ' LYS . 28.5 m -140.32 165.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 3.8 t -94.03 113.72 25.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 28.5 m -118.92 162.01 33.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.188 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 53.9 Cg_exo -52.62 140.64 55.15 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.626 2.217 . . . . 0.0 112.545 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.12 -172.33 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.55 138.29 8.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' THR . 8.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.831 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.51 131.29 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.848 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.409 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.59 156.68 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.129 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.96 -70.38 0.87 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.61 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 31.2 p-80 -173.01 133.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 59.08 57.01 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.821 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.9 tp-100 -95.85 157.06 16.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.888 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HA ' HG12 ' A' ' 46' ' ' VAL . 5.4 mttt -79.87 113.35 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 -20.1 11.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.316 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.38 -32.6 58.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.259 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.59 -28.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.36 170.19 9.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -139.15 99.25 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -125.33 155.51 71.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 6' ' ' THR . 50.5 Cg_endo -69.19 123.04 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' SG ' HD13 ' A' ' 8' ' ' ILE . 54.5 m -97.9 73.36 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.8 p -59.8 169.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.36 165.16 15.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.31 105.51 7.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.515 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.9 t -84.8 93.9 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.9 m -86.81 101.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.089 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.14 -176.03 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.54 93.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.04 -46.37 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.16 -53.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.777 0.322 . . . . 0.0 110.971 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.22 -65.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -143.56 132.85 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.39 107.17 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HB ' ' A' ' 25' ' ' THR . 5.4 m -109.75 122.0 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.71 138.63 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -117.96 109.98 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 52.9 m-85 -84.37 129.17 34.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.51 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -119.79 142.99 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -75.88 95.22 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.695 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.91 119.23 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -33.83 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -78.26 64.09 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.24 -53.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.442 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.1 -71.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.578 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.9 m -144.12 166.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.8 t -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -125.11 163.28 38.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.9 Cg_exo -54.15 156.57 12.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.601 2.201 . . . . 0.0 112.382 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.1 165.36 31.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.96 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.97 130.25 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.217 0.532 . . . . 0.0 111.03 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.81 167.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.254 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -102.24 -86.88 1.97 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.45 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.6 p-80 -158.14 132.4 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.971 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 48' ' ' VAL . 70.7 m-85 59.45 55.89 3.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.78 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 8' ' ' ILE . 2.9 mm-40 -110.03 166.84 10.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -79.93 128.77 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.0 t -110.7 -30.83 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.64 -60.34 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -72.61 -38.79 67.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.54 128.21 54.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.75 38.53 1.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 8' ' ' ILE . 10.9 mttp -78.23 127.36 81.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.52 148.67 42.44 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.415 2.077 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.4 m -103.43 105.44 15.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -178.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.48 28.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -117.51 -178.87 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -144.73 84.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.11 159.69 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.21 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 60.98 156.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -177.01 102.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.8 -94.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.413 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -97.62 -33.69 11.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 m -101.95 172.28 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.04 128.56 49.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.46 136.14 34.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.3 p -122.9 154.92 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 6.6 tpt180 -123.12 106.13 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -117.28 119.88 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 67.8 m-85 -88.77 115.0 25.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.453 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.0 pt -103.65 148.14 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.41 93.25 5.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 112.33 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 -31.53 15.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.83 -30.55 69.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.798 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.43 -79.89 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.53 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.29 27.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 47.05 86.54 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.664 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.63 159.28 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.03 114.49 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 11' ' ' TYR . 5.2 m -122.03 161.81 40.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 57.3 Cg_exo -52.25 155.23 9.6 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.574 2.183 . . . . 0.0 112.542 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.13 -174.11 4.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.38 29.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.13 132.68 39.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.71 168.17 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.211 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.87 -79.92 1.02 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.613 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 33.5 p-80 -161.77 131.68 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 48' ' ' VAL . 60.4 m-85 60.67 65.52 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -122.08 142.08 50.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HA ' HG12 ' A' ' 46' ' ' VAL . 17.9 pttp -79.7 116.3 19.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -111.94 24.23 12.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 45' ' ' GLY . 26.1 t -76.77 -56.61 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.19 30.99 3.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.96 115.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.76 100.8 12.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -141.81 142.61 25.91 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 144.21 32.25 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.583 2.189 . . . . 0.0 112.405 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.4 m -92.82 102.21 14.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.4 154.13 36.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -108.93 158.99 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -138.15 109.35 6.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 34' ' ' VAL . 42.9 p -84.38 116.25 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 65.16 126.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.046 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -92.81 47.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 61.12 156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.79 -127.61 8.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.21 144.65 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 t -69.52 142.58 53.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -154.82 -178.36 7.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -80.21 -176.8 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG23 HG22 ' A' ' 25' ' ' THR . 11.1 p -79.91 154.86 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 4.4 tpm_? -117.48 92.92 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 1.2 tptm -79.97 166.47 21.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 38.1 m-85 -143.03 106.06 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 50' ' ' PHE . 4.3 pt -100.53 146.45 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.25 100.82 10.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -86.63 117.75 25.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -119.6 24.48 10.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.26 -26.76 42.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.53 -60.19 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.647 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.471 ' OE1' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -113.05 -69.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 111.062 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 135.07 58.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.547 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG13 ' OE1' ' A' ' 44' ' ' GLU . 33.5 m -132.67 157.72 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.3 118.17 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 16.8 m -120.09 161.84 36.54 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.257 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 70.5 Cg_exo -51.54 149.98 17.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.624 2.216 . . . . 0.0 112.438 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.04 -168.95 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.66 148.91 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.811 0.339 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 133.91 56.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.65 167.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.138 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.81 -95.36 1.95 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.527 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 39.7 p-80 -147.39 126.74 13.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.982 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.502 ' CD2' HG12 ' A' ' 48' ' ' VAL . 76.4 m-85 61.79 59.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -123.19 176.97 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.843 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 132.74 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.5 t -115.15 -7.69 12.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.414 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 15' ' ' VAL . 21.6 t -89.82 50.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.875 0.369 . . . . 0.0 111.22 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -176.97 36.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.27 -165.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.58 34.61 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 44.3 pttt 44.32 51.24 7.92 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.768 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.8 Cg_endo -86.64 102.53 0.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.535 2.157 . . . . 0.0 112.135 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.9 m -126.36 105.35 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.8 m -73.03 177.16 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -115.49 129.19 56.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 93.35 7.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.727 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.6 t -113.8 115.13 27.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.38 152.58 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -64.65 177.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -60.84 129.35 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.22 -142.79 3.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.2 -67.31 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -99.9 146.23 26.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -106.66 109.5 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -141.81 133.68 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.727 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -123.35 122.47 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -98.58 108.91 21.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 -176.66 5.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m-85 -158.35 126.82 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.8 pp -129.41 167.39 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.208 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.9 m -94.42 126.31 39.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.61 118.61 30.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . 2.8 ttm105 -116.57 24.11 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.44 -30.36 53.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.95 -49.0 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.49 -67.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.33 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.93 62.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.41 155.23 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 111.229 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' TYR . 48.6 t -85.45 115.93 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.228 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' A' ' 11' ' ' TYR . 27.4 m -119.92 163.76 26.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.9 Cg_exo -53.38 154.6 14.52 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.554 2.17 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.49 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -136.93 -46.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.502 HG23 ' HG2' ' A' ' 20' ' ' PRO . 20.6 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -170.09 126.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.187 0.518 . . . . 0.0 110.994 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.745 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.64 166.71 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.228 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.37 -68.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -173.86 120.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.9 m-85 62.02 62.19 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -108.19 166.69 10.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -79.82 122.04 26.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.34 -28.96 10.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.48 103.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.155 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.08 61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.889 ' HB1' ' HE2' ' A' ' 19' ' ' LYS . . . -149.16 137.61 20.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.14 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.889 ' HE2' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -121.33 95.18 48.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' HG23 ' A' ' 6' ' ' THR . 52.7 Cg_exo -54.77 152.04 29.93 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.511 2.141 . . . . 0.0 112.331 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.745 ' SG ' HD13 ' A' ' 8' ' ' ILE . 57.8 m -114.3 104.91 12.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.3 p -102.3 -176.5 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 36' ' ' LYS . 21.0 p -107.19 165.74 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 -179.29 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -127.26 148.94 50.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.02 126.22 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.14 170.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -157.95 98.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.02 -84.07 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.23 -57.24 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 p -96.66 122.63 39.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.42 115.83 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -155.73 133.24 11.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.75 152.48 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -116.59 138.32 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.5 169.9 8.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 20.0 m-85 -150.43 107.77 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 50' ' ' PHE . 43.3 pt -99.72 160.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.193 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 m -98.99 97.2 8.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 111.72 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -27.31 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 52.91 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.58 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.25 -52.99 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.05 44.75 0.99 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.624 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.08 158.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -86.52 116.78 24.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -121.65 164.17 26.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 45.6 Cg_exo -56.07 148.37 59.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.18 -169.38 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.94 94.44 2.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.698 0.285 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.38 130.54 46.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.201 0.525 . . . . 0.0 111.027 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.6 166.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.208 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.26 -75.11 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -169.86 134.44 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CD2' HG12 ' A' ' 48' ' ' VAL . 26.8 m-85 59.22 53.27 5.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.012 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 6.9 tp60 -96.9 160.55 14.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.521 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 46' ' ' VAL . 11.2 mttt -79.7 114.15 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.16 -47.98 8.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.799 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.18 129.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.84 29.93 19.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.15 86.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.87 146.23 33.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HB3' HD12 ' A' ' 8' ' ' ILE . 2.9 mttt -173.52 148.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.809 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.34 120.95 7.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.7 m -81.3 100.6 9.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 165.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.054 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -125.04 161.55 26.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -131.23 108.03 9.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.656 ' HB ' HG23 ' A' ' 34' ' ' VAL . 9.0 t -137.28 162.54 33.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.64 92.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -89.55 167.59 12.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -64.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.05 101.89 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.4 85.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -104.79 137.21 42.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -174.37 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -160.06 171.64 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.656 HG23 ' HB ' ' A' ' 25' ' ' THR . 10.6 p -136.62 145.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -120.48 121.06 37.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -111.58 165.88 11.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.402 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 12.8 m-85 -135.37 121.94 20.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -112.69 155.97 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 100.51 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.616 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.95 139.56 30.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -129.94 24.02 5.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.52 -59.47 2.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.67 -97.72 0.82 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.429 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -79.94 -56.51 4.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.9 84.81 0.88 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.58 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.8 m -150.64 161.74 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.909 0.385 . . . . 0.0 111.346 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.19 107.12 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.434 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG12 ' CD2' ' A' ' 11' ' ' TYR . 23.4 m -113.56 162.98 19.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.449 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 41.2 Cg_exo -57.38 160.35 13.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.22 -170.36 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -156.61 -45.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.59 133.39 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.211 0.529 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.68 167.04 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.156 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.09 -93.39 2.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -149.28 126.98 11.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.2 m-85 61.28 61.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HB3' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -111.71 148.72 32.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.709 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -79.74 105.5 11.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.1 p -97.76 23.49 7.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.2 t -102.89 -47.88 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.105 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.48 -32.1 73.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.32 -175.05 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -127.2 85.31 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.954 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' CB ' HD12 ' A' ' 8' ' ' ILE . 30.8 mttt -115.76 139.9 25.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.6 143.87 31.07 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.522 2.148 . . . . 0.0 112.274 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.5 m -96.74 105.06 17.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -179.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.85 173.19 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -145.29 106.13 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.405 ' HB ' HG23 ' A' ' 34' ' ' VAL . 1.7 t -132.82 123.4 26.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.94 174.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -166.56 156.93 12.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.42 140.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.74 3.17 71.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.898 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.16 104.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 t -171.84 122.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 88.58 6.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -143.58 118.49 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 25' ' ' THR . 11.0 p -142.16 137.72 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -123.77 126.72 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 158.9 21.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -130.84 113.76 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.5 pp -114.85 153.86 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.183 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 5.7 m -87.18 111.23 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.59 107.39 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -100.91 24.63 9.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 50.53 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.25 -33.46 1.02 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -147.98 -70.33 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 128.37 59.24 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.37 155.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.8 t -88.95 114.36 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.632 HG12 ' CD2' ' A' ' 11' ' ' TYR . 28.5 m -123.91 163.58 34.48 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.17 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.1 Cg_exo -53.91 153.26 20.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.55 2.167 . . . . 0.0 112.428 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.543 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.0 172.85 16.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 59.57 108.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.48 133.25 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.543 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.62 163.99 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.109 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.52 -87.9 1.96 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.549 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 10.5 p80 -152.57 129.09 10.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 61.38 66.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 139.4 42.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -79.82 105.77 11.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -112.95 29.06 8.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.425 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -62.77 -63.83 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.8 31.07 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.68 130.24 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -102.37 114.06 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.1 150.77 73.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 119.7 6.58 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.577 2.185 . . . . 0.0 112.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.1 m -80.1 96.41 6.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.33 155.55 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -101.99 165.26 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.61 92.7 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 43.6 p -104.41 146.74 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.09 132.16 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.25 87.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.55 158.89 25.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.18 -46.13 3.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.508 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -99.52 157.53 16.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.8 m 60.33 177.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -137.16 95.02 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.92 74.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 25' ' ' THR . 16.7 m -96.21 135.06 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 113.72 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -170.52 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.815 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 19.7 m-85 -160.05 123.1 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.952 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -130.55 157.92 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.04 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.84 100.99 12.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.81 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -91.61 133.14 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 23.96 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.55 -41.01 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -67.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -160.01 33.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.831 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 59.05 64.1 4.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.563 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 44' ' ' GLU . 16.2 t -130.05 154.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -93.66 102.05 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.35 160.91 25.33 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.08 159.59 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.631 2.221 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.02 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -154.74 -63.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.428 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m 63.59 131.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.278 0.561 . . . . 0.0 110.929 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.659 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.211 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.17 -98.0 2.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.511 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.6 p-80 -140.32 126.0 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CD2' HG12 ' A' ' 48' ' ' VAL . 39.4 m-85 58.39 51.96 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -92.88 156.56 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.619 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.93 122.5 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.44 -53.49 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.1 135.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 m120 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -155.91 91.96 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.72 84.14 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.659 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.92 116.92 6.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.43 146.66 82.23 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -80.07 102.08 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 170.91 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -127.24 136.09 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -111.26 168.1 9.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -143.32 176.8 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.836 HG22 ' HG2' ' A' ' 27' ' ' ARG . 14.1 p -151.15 140.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.836 ' HG2' HG22 ' A' ' 26' ' ' VAL . 1.0 OUTLIER 65.26 168.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -84.28 165.78 18.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.17 120.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.04 121.62 44.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.786 0.327 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -156.39 -50.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.98 35.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.47 31.29 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.91 171.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.85 110.33 12.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -99.86 106.05 17.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 44.5 m-85 -81.64 137.26 35.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -131.0 153.85 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.45 127.17 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.94 119.67 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 24.37 11.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.42 50.18 1.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.69 -65.78 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -127.31 -45.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.92 73.36 0.74 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 13' ' ' LYS . 29.0 m -138.63 160.14 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 111.274 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.3 t -95.06 112.21 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.628 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.3 m -116.3 164.89 16.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 51.0 Cg_exo -54.18 146.93 47.01 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.43 2.086 . . . . 0.0 112.267 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.588 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.83 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -156.71 172.73 18.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.8 p -166.13 146.4 6.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.607 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.575 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.77 172.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.501 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.538 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -87.23 -99.58 0.85 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.673 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 20.0 p-80 -147.1 129.01 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' CYS . 74.7 m-85 61.12 59.97 1.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.425 ' CB ' HG12 ' A' ' 8' ' ' ILE . 4.3 mm-40 -116.42 171.74 7.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -79.55 114.78 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -116.06 -12.82 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.363 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.44 -33.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.221 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.28 29.67 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.014 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.55 148.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 37.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.575 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.42 126.66 84.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.33 154.0 75.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.25 175.26 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.77 -165.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.146 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -159.68 114.95 2.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.728 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 86.98 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.02 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 34' ' ' VAL . 67.0 p -110.51 88.55 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.8 124.08 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.85 165.43 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -175.33 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.2 85.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 60.82 40.32 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 170.21 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 41.65 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -97.9 36.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.2 p -118.03 110.01 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.19 134.77 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.751 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -120.75 109.35 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 9.2 m-85 -81.81 138.11 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.2 pp -134.36 178.25 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 111.483 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.42 120.66 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.697 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -103.98 93.47 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.5 23.81 9.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 -51.5 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.59 -67.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -127.3 -46.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.72 52.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.588 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -143.27 156.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.401 . . . . 0.0 111.429 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -83.27 117.29 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.9 m -128.93 165.73 29.92 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.246 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 32.2 Cg_exo -58.36 165.89 6.8 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.566 2.177 . . . . 0.0 112.527 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.56 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -160.08 166.44 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.57 90.08 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.466 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.769 0.319 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.86 127.38 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.76 166.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.171 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.86 -78.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.463 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 21.9 p-80 -166.79 133.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 48' ' ' VAL . 24.1 m-85 58.18 61.85 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.694 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' CB ' HG12 ' A' ' 8' ' ' ILE . 5.1 tp-100 -105.82 159.25 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 115.71 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -84.24 -29.98 26.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -70.01 -38.44 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.98 -37.17 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.53 117.75 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.29 74.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -121.19 158.39 53.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 134.35 63.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.634 2.223 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.9 m -96.07 101.87 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.703 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.32 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.043 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -110.24 163.66 13.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 114.68 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' HG13 ' A' ' 34' ' ' VAL . 10.2 t -118.13 147.05 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 32' ' ' LYS . 21.5 t -81.01 154.59 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 26' ' ' VAL . 2.1 mtt-85 -97.47 38.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.3 164.74 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.83 -94.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.56 -29.68 65.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.031 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 109.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.026 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 26' ' ' VAL . 9.7 mttt 60.23 175.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.95 -177.84 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.6 t -80.13 144.65 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.92 130.14 39.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -99.47 -165.57 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.4 m-85 -142.86 142.42 31.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.457 . . . . 0.0 111.645 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 50' ' ' PHE . 5.1 pt -120.79 152.02 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 97.14 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.46 116.1 27.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -106.03 -31.3 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.95 -30.23 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.68 -98.88 0.23 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.66 -33.97 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 41' ' ' ARG . . . 104.09 47.44 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -143.54 154.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 t -96.97 106.51 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 11' ' ' TYR . 2.2 m -114.52 161.26 29.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.961 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 60.1 Cg_endo -73.06 151.37 49.81 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.319 2.013 . . . . 0.0 112.633 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.948 ' CD1' HG23 ' A' ' 38' ' ' ILE . 1.6 p90 -149.35 170.48 18.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 -54.99 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.47 128.33 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.096 0.474 . . . . 0.0 111.006 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.894 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.58 170.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.367 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -118.01 -35.04 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.507 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -177.36 142.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 61.08 71.49 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.894 ' HG3' HD13 ' A' ' 8' ' ' ILE . 9.0 tm0? -102.3 141.51 35.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.802 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -79.88 108.74 13.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.65 24.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.18 118.98 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 m120 59.66 54.04 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -170.59 145.88 2.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.17 32.6 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.05 112.71 29.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.98 132.28 48.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -93.16 92.27 7.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -178.62 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -178.34 4.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -144.05 95.34 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.0 t -124.13 116.36 22.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.38 128.05 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -122.61 91.85 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -152.64 81.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.14 179.96 18.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 150.72 27.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.8 t 60.33 102.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.53 123.17 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -84.33 134.92 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.4 t -89.29 113.85 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -82.67 126.03 31.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -129.84 169.99 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 34.1 m-85 -136.86 118.92 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.454 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.3 pt -107.24 147.73 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.277 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.71 92.04 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.706 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.03 126.46 31.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -105.53 24.04 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.41 -32.07 12.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.5 -64.7 1.06 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.525 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -156.52 27.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.001 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.15 62.33 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.582 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 47' ' ' CYS . 12.8 t -128.68 158.5 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 t -94.31 105.86 17.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 24.9 m -111.47 162.24 21.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.3 Cg_exo -55.37 160.11 9.35 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.656 2.237 . . . . 0.0 112.516 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.08 173.64 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 60.19 163.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.964 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.856 0.36 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.75 135.68 50.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.232 0.539 . . . . 0.0 111.019 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.728 HD12 ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 170.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.214 -179.532 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.58 -91.04 2.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.614 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 27.2 p80 -152.18 128.69 10.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 58.26 61.21 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -107.62 152.71 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.712 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.4 mttp -79.73 120.95 24.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 -34.49 20.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.9 -35.55 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -107.88 34.78 3.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -171.82 141.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.09 90.56 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -157.62 137.18 8.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.925 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 145.94 65.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.373 2.049 . . . . 0.0 112.419 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.0 m -87.8 95.04 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 174.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.1 p -148.56 128.07 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -84.31 153.07 23.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -150.8 96.87 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.68 139.33 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 120.13 26.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -132.68 -48.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.82 -161.3 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.12 -53.87 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -71.04 124.26 23.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -80.68 137.62 36.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -114.83 95.14 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.6 p -112.33 113.54 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.86 100.93 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -98.57 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 39.0 m-85 -79.89 147.59 31.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.586 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -135.98 148.85 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.91 104.87 16.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.51 116.97 33.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -111.14 -30.27 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.0 -25.96 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 -43.45 3.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.58 -74.58 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.07 46.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.586 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.12 153.78 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.202 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.72 113.72 25.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 m -121.77 164.9 22.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.188 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.9 Cg_exo -54.98 159.75 9.01 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.586 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.95 160.37 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.782 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 86.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.433 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 m 62.59 130.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.216 0.531 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.829 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.76 170.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.331 -179.439 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.33 -40.85 1.86 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.331 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -179.04 144.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.79 0.329 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 62.52 74.29 0.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.829 ' HG3' HD13 ' A' ' 8' ' ' ILE . 8.6 tm0? -98.49 132.24 44.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -79.89 110.22 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.58 22.86 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.997 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.97 -31.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.56 30.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.99 -173.93 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.1 128.46 24.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.15 141.07 6.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.84 114.47 3.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.411 2.074 . . . . 0.0 112.428 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.9 t -93.03 82.79 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.818 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.03 -173.38 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.08 168.32 9.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.09 128.06 29.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -110.25 126.22 53.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.804 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.03 151.37 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.68 139.73 26.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -165.93 -54.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.68 -159.29 35.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.97 -55.22 17.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 t -120.48 138.97 53.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -149.85 123.77 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.58 161.21 20.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.55 144.63 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -100.56 133.86 44.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 178.97 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -152.61 129.08 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -124.84 144.61 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.194 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.16 119.8 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.87 111.75 24.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.52 26.21 8.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.48 54.65 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.57 -24.72 8.41 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.799 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -120.11 -78.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.69 58.37 0.57 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.413 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 47' ' ' CYS . 20.1 t -137.82 160.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.5 t -96.61 101.09 12.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -104.37 161.74 21.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 86.9 Cg_exo -46.75 144.67 7.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.672 2.248 . . . . 0.0 112.694 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.01 -167.66 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -166.02 102.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 m -57.65 140.53 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 111.177 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.51 165.35 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.228 -179.493 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -105.95 -76.77 1.06 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.8 p-80 -168.28 130.0 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.28 60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.04 157.02 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -79.83 116.45 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 m -79.89 -39.51 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.28 136.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 58.96 31.06 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.38 149.67 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -124.22 37.13 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.12 125.44 48.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 132.85 23.71 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.516 2.144 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.03 94.94 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.4 m -84.79 -178.21 6.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 175.94 5.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -154.86 169.0 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.433 ' HB ' HG12 ' A' ' 34' ' ' VAL . 9.8 t -140.38 141.0 35.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.44 145.32 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.7 110.79 10.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -150.26 98.26 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.26 -116.53 8.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.47 -31.15 8.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.5 m -67.4 86.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 144.08 31.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -160.0 138.03 10.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.6 m -102.84 163.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -159.13 160.33 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.9 ttpp -126.06 179.9 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 40.1 m-85 -129.32 150.49 50.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.013 0.435 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.884 HG23 ' CD1' ' A' ' 50' ' ' PHE . 3.2 pt -122.35 153.04 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.943 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.22 91.99 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.01 110.75 19.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -109.79 24.66 12.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.34 -50.97 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.59 -66.61 1.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.7 -47.2 0.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.07 78.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.42 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.29 154.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 104.55 16.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.84 157.74 36.85 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 62.5 Cg_endo -73.55 137.39 25.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.551 2.167 . . . . 0.0 112.64 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 38' ' ' ILE . 3.1 p90 -135.23 176.76 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.91 99.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.05 136.44 33.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.63 164.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.24 -68.18 0.66 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.394 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 22.1 p-80 -170.83 126.95 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.513 ' CD2' HG12 ' A' ' 48' ' ' VAL . 22.1 m-85 57.07 60.53 2.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -114.38 169.52 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.576 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -79.5 121.06 24.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 t -122.52 -59.4 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.431 ' HB ' ' CA ' ' A' ' 45' ' ' GLY . 3.5 t -63.16 -26.32 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.143 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.35 -35.29 12.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.39 50.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.82 126.35 29.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HG2' HD12 ' A' ' 8' ' ' ILE . 14.2 tttt -177.12 98.65 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.09 144.1 23.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.165 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -105.39 94.51 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.5 m -81.43 169.37 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -99.94 135.98 40.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -106.59 -179.51 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.502 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.5 t -152.37 121.52 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.98 123.37 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 60.19 161.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.79 158.71 26.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.31 -121.59 1.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.71 177.01 4.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.13 122.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -72.8 102.4 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -125.2 68.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -98.61 168.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.58 115.88 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.0 170.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.793 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 31.7 m-85 -154.0 129.56 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -127.55 156.06 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.9 m -90.39 111.82 23.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.32 -172.22 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 60.93 81.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -33.02 72.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.697 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.53 -63.41 4.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.333 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -58.19 3.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.513 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . . . 96.52 77.28 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.9 179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -135.67 151.61 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -102.59 114.51 28.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.458 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.513 HG12 ' CD2' ' A' ' 11' ' ' TYR . 8.8 m -111.79 162.43 21.18 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.312 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' CE1' ' A' ' 11' ' ' TYR . 52.0 Cg_exo -54.14 158.83 8.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.635 2.223 . . . . 0.0 112.454 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.603 ' CG ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -155.42 174.53 15.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t0 59.84 54.59 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' HG22 ' A' ' 6' ' ' THR . 38.5 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 20' ' ' PRO . 23.9 p -166.09 140.03 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.402 0.62 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.84 160.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.602 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.14 -87.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.698 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 31.6 p-80 -157.98 138.38 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 48' ' ' VAL . 56.0 m-85 59.3 58.01 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB2' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -121.15 171.27 8.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.643 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -79.42 120.71 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 0.0 111.188 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t -101.75 21.52 14.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 15' ' ' VAL . 15.2 t -109.61 30.34 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.091 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -147.78 29.74 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.33 -170.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.21 -77.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -170.73 52.93 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.434 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 53.5 Cg_endo -68.77 114.28 3.48 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.642 2.228 . . . . 0.0 112.404 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -153.04 104.54 2.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.733 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.433 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 7.2 m -67.14 -175.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.833 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -148.55 145.86 28.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -115.7 104.53 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 34' ' ' VAL . 1.8 t -109.11 93.83 4.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.35 168.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 177.37 8.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.02 -46.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.33 -107.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.04 -35.47 76.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.936 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.68 141.98 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.55 132.81 24.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -123.75 123.59 40.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -111.9 116.98 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 125.04 38.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -108.58 167.36 10.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 14.4 m-85 -140.85 111.24 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG12 ' CG ' ' A' ' 50' ' ' PHE . 6.1 pt -103.24 166.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.9 m -103.5 107.39 18.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -94.15 135.15 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.03 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 -24.69 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.49 -35.95 63.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -113.06 0.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.506 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.92 26.04 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.58 63.81 4.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 12' ' ' GLN . 33.1 m -139.64 155.36 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' TYR . 49.0 t -90.1 121.26 32.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.209 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.664 HG12 ' CD2' ' A' ' 11' ' ' TYR . 26.2 m -125.29 166.51 20.29 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.216 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 45.5 Cg_exo -56.92 158.19 17.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.485 2.124 . . . . 0.0 112.347 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -176.44 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.62 164.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.515 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -163.61 132.53 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.227 0.537 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.67 167.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.194 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.52 -99.05 2.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.56 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.2 p-80 -144.29 125.68 14.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD2' HG12 ' A' ' 48' ' ' VAL . 62.0 m-85 61.44 52.42 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.5 mm-40 -107.1 175.37 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.564 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 1.6 mmtp -79.64 127.55 32.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.5 t -103.44 -29.04 11.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.9 -30.59 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.204 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -105.56 37.87 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . . . -166.81 172.3 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.098 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.08 -166.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt 64.21 132.87 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.54 -179.43 4.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.506 2.137 . . . . 0.0 112.384 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.0 m -97.61 119.18 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -170.5 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -137.35 132.72 33.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 10.2 mptt -100.98 81.06 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -124.9 123.4 39.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 26' ' ' VAL . 14.3 p -95.93 41.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 55.91 -176.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 129.16 44.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.79 -74.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -135.45 -61.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 m -96.38 -175.48 3.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -102.07 102.76 13.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.91 30.04 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.85 141.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.86 115.09 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 106.96 16.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.432 ' CE1' ' HD3' ' A' ' 24' ' ' LYS . 37.4 m-85 -80.15 100.79 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -83.37 -174.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 1.9 m -122.85 98.01 5.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.04 122.35 29.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.66 13.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -40.8 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.71 -93.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.442 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.8 25.25 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.305 . . . . 0.0 111.009 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.37 61.02 7.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.6 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.3 157.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.298 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' TYR . 4.1 t -87.54 119.62 28.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.598 HG12 ' CD2' ' A' ' 11' ' ' TYR . 12.4 m -134.19 162.29 58.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 51.6 Cg_exo -54.48 153.36 23.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.56 2.173 . . . . 0.0 112.291 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.11 162.49 34.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.08 -177.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.806 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.436 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.12 136.41 58.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.161 0.505 . . . . 0.0 111.019 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.78 169.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.243 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.9 -75.4 1.26 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.564 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 11.3 p-80 -167.75 129.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.726 ' CD2' HG12 ' A' ' 48' ' ' VAL . 84.1 m-85 61.4 68.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.423 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -131.8 168.84 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.873 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -79.72 125.71 30.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.064 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.28 31.71 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.0 t -87.34 -68.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.433 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.43 -35.1 63.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.47 174.58 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -170.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 11.7 ttpp -129.64 53.74 12.47 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.438 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.7 Cg_endo -87.46 102.08 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.607 2.205 . . . . 0.0 111.995 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.3 m -130.15 96.84 4.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 m -69.69 -178.48 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.945 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 t -109.86 162.89 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -133.02 122.69 24.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 34' ' ' VAL . 3.0 t -97.14 120.17 37.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.33 127.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -126.27 120.71 30.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.45 -51.25 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.55 -56.08 0.87 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.94 -178.9 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -66.35 81.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -79.19 -179.3 6.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -81.44 -174.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 25' ' ' THR . 8.9 m -98.93 179.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 114.16 19.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 170.79 10.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 16.0 m-85 -149.6 103.13 3.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 50' ' ' PHE . 41.2 pt -98.81 163.02 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.233 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.7 t -100.81 108.63 20.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.09 126.95 41.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 23.45 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.16 37.4 1.55 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.52 -37.02 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.631 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -59.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 115.78 54.68 0.36 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.39 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.59 159.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.61 119.42 30.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.273 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.726 HG12 ' CD2' ' A' ' 11' ' ' TYR . 11.6 m -122.07 163.29 32.54 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.2 Cg_exo -54.54 155.61 16.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.59 2.193 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.07 169.56 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.82 105.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.459 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -145.0 130.56 18.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.47 164.09 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.181 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -108.05 -99.22 2.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 20.3 p-80 -140.07 125.9 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' CYS . 39.0 m-85 58.79 55.31 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.416 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.34 161.84 13.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.905 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HA ' HG12 ' A' ' 46' ' ' VAL . 1.1 mptp? -79.84 113.35 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -41.69 23.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -77.9 -53.91 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -45.2 95.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -112.12 126.76 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -93.28 80.26 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 30.8 mtpt -132.16 134.56 25.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 32.4 Cg_exo -57.98 142.63 96.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.422 2.081 . . . . 0.0 112.294 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 103.24 9.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.34 177.72 8.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.16 -174.1 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -160.01 140.33 11.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -139.24 134.79 33.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 11.2 p -83.71 116.18 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . 17.5 mtm105 -133.14 82.94 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 28' ' ' TYR . 21.1 t80 -163.88 31.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.12 -162.93 36.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -169.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 170.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -155.25 80.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -119.31 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 m -104.24 153.09 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.59 147.77 44.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -145.17 115.72 7.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 19.2 m-85 -90.55 133.59 34.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.421 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pt -111.41 169.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.076 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -104.96 97.05 6.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 104.29 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.83 23.36 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -99.82 -52.05 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.96 -86.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.28 -32.08 6.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.31 69.29 0.69 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 13' ' ' LYS . 11.0 m -146.7 162.56 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 111.294 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -88.19 108.44 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 1.7 m -111.17 160.43 29.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.206 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 29.5 Cg_endo -63.61 160.53 35.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -160.09 176.84 11.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.567 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 124.16 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.911 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.71 173.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.686 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -113.4 -32.23 2.2 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.056 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -179.03 140.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 63.6 79.27 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.875 ' HG3' HD13 ' A' ' 8' ' ' ILE . 3.5 tt0 -107.08 140.0 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.692 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.77 93.79 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 p -119.73 35.97 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.13 -34.39 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -106.43 -28.63 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.02 -178.06 4.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.51 87.07 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 156.44 60.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.44 110.21 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.6 t -104.61 87.6 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.05 151.78 21.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 p -98.31 -170.78 2.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -143.73 108.28 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.726 ' OG1' HG12 ' A' ' 34' ' ' VAL . 9.7 t -145.63 123.69 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.1 p -178.67 76.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -132.33 102.31 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.91 164.04 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.38 -159.57 14.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -68.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.59 139.33 49.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 105.53 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.79 96.37 10.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.726 HG12 ' OG1' ' A' ' 25' ' ' THR . 10.6 m -94.9 132.07 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -113.7 100.02 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 3.0 tptt -80.57 -167.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 12.2 m-85 -160.06 114.18 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.485 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.4 pt -113.01 156.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.281 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.2 t -89.81 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 117.42 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.982 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.77 24.72 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.968 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -104.31 -32.44 9.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.701 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.88 -76.32 1.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.4 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.04 27.77 1.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.51 60.62 8.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.647 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 47' ' ' CYS . 6.8 t -129.02 159.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -97.09 104.32 16.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.5 m -110.75 164.61 14.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.366 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 42.8 Cg_exo -56.99 163.05 8.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.618 2.212 . . . . 0.0 112.614 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.19 -178.63 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.936 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.96 104.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.422 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -149.02 130.67 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 110.965 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.74 163.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.15 -88.5 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.466 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -157.13 127.74 6.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.354 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD2' HG12 ' A' ' 48' ' ' VAL . 41.5 m-85 61.09 62.89 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -105.43 145.12 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.82 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -79.92 115.54 19.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 p -122.92 31.76 5.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -78.68 -56.11 8.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.072 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -98.03 -25.64 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.17 93.12 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.049 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.47 142.96 38.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.07 170.43 9.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.98 119.08 5.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.533 2.155 . . . . 0.0 112.457 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.07 82.24 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.05 -178.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -102.55 133.1 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.69 107.96 20.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -111.39 131.37 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.88 53.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 161.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -116.22 145.5 43.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.23 30.81 0.48 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.05 32.91 19.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -172.76 36.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.48 -177.52 5.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -146.71 179.36 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.2 p -102.06 158.72 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG22 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -125.44 107.91 11.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.019 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 11.9 tttt -87.51 166.5 14.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -138.42 109.45 6.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.465 HG12 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -102.87 153.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.83 93.57 9.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 125.45 29.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -120.02 23.71 10.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.965 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -97.12 39.5 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.14 -53.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -124.93 -63.9 1.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 118.29 61.39 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.4 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 13' ' ' LYS . 18.4 m -138.99 167.16 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.06 112.78 24.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.554 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 11' ' ' TYR . 35.1 m -120.12 162.19 34.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.211 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.2 Cg_exo -54.15 154.95 16.67 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.607 2.205 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.03 168.47 25.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.54 106.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.02 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.485 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.886 0.375 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 129.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.201 0.524 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.7 155.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.117 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.01 -72.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -171.38 137.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.485 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.6 m-85 56.37 52.54 9.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HG2' HD11 ' A' ' 8' ' ' ILE . 4.1 tp60 -86.88 153.37 21.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.661 ' HA ' HG12 ' A' ' 46' ' ' VAL . 4.0 tptt -79.94 117.95 21.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.99 -24.49 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' VAL . 29.8 t -90.2 49.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -178.66 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.65 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.42 41.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.635 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -78.72 147.72 71.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.21 125.69 11.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.414 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.9 m -82.72 75.29 9.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.13 155.27 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.51 161.01 25.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -145.1 108.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 34' ' ' VAL . 4.9 t -94.11 125.77 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 26' ' ' VAL . 10.2 m -75.79 126.86 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -100.04 43.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -128.1 113.94 16.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.81 -168.41 16.93 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.22 -60.74 2.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 p -79.07 160.17 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -114.25 90.61 3.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 142.97 26.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 25' ' ' THR . 19.2 t -105.35 140.62 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.81 121.69 45.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 6.3 ttpp -97.55 167.92 10.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 39.1 m-85 -139.76 123.97 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.512 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.4 pt -117.12 140.22 40.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.161 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.01 91.58 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -82.24 124.98 30.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.84 23.59 10.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.16 37.03 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.79 -69.91 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.625 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.95 -59.11 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.87 59.04 0.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.6 m -142.47 166.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.54 105.96 18.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.7 m -110.88 161.88 23.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.363 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 52.6 Cg_exo -53.32 149.71 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.655 2.237 . . . . 0.0 112.486 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.09 -167.27 1.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -169.59 95.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.84 120.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.196 0.522 . . . . 0.0 110.999 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.874 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.79 169.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.271 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -110.07 -37.74 1.78 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.277 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 178.75 144.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 62.09 68.34 0.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.874 ' HG3' HD13 ' A' ' 8' ' ' ILE . 5.7 tm0? -96.88 151.19 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.597 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.67 107.11 12.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.889 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.08 29.48 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 45' ' ' GLY . 20.4 t -111.06 -53.29 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.132 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -118.82 31.33 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.16 -173.13 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.23 32.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -66.05 148.19 98.49 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 133.21 22.25 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.522 2.148 . . . . 0.0 112.235 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.98 167.58 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 m -121.53 163.7 18.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 115.2 11.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.61 ' HA ' HG13 ' A' ' 34' ' ' VAL . 6.3 p -95.58 153.16 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 30' ' ' ASP . 22.3 t 60.9 108.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -170.25 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.39 32.02 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.16 44.84 2.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.544 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.2 m-20 60.34 31.61 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.63 178.51 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -93.89 48.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.93 140.1 51.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 25' ' ' THR . 22.0 t -107.35 128.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -96.17 120.32 36.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -105.45 168.54 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.628 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -141.54 127.24 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.557 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.7 pp -127.37 160.01 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.01 103.51 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 48' ' ' VAL . 1.2 t70 -89.98 101.23 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -115.47 81.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -149.35 -47.13 0.14 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.59 -31.85 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -115.53 -65.79 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.969 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 109.7 43.51 1.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 13' ' ' LYS . 5.5 m -143.17 173.67 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 111.346 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' CB ' ' HB3' ' A' ' 12' ' ' GLN . 8.0 t -90.42 105.55 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.419 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 40' ' ' ASP . 3.5 m -112.26 162.88 19.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 75.9 Cg_exo -50.5 154.22 6.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.637 2.225 . . . . 0.0 112.534 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.06 -168.12 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.38 30.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.821 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 134.21 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.74 166.14 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.15 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.71 -83.89 1.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 27.2 p-80 -156.18 132.94 10.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 59.48 66.42 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' CB ' HG12 ' A' ' 8' ' ' ILE . 1.8 tm0? -117.83 142.16 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 46' ' ' VAL . 2.7 mttp -79.97 122.71 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 m -85.27 -36.92 20.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.47 -44.02 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -75.82 -31.08 59.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -152.98 100.78 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.44 105.72 8.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -138.85 157.64 71.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.72 136.16 44.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.612 2.208 . . . . 0.0 112.195 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.4 m -90.28 127.46 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.85 172.07 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.64 146.6 28.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 117.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 128.32 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.91 127.63 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -69.3 158.48 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.72 122.44 14.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.26 -79.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -56.16 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.73 175.93 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.48 65.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -126.61 137.61 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.3 t -129.22 139.57 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.018 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 163.06 40.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -103.87 177.71 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.677 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 27.7 m-85 -148.23 105.77 3.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -105.87 154.49 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 53.2 t -94.92 107.52 19.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -101.04 135.42 42.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -104.55 23.82 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.72 -58.26 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.35 -47.71 12.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.27 -47.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.33 72.9 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 13' ' ' LYS . 28.5 m -140.32 165.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 3.8 t -94.03 113.72 25.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 28.5 m -118.92 162.01 33.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.188 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 53.9 Cg_exo -52.62 140.64 55.15 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.626 2.217 . . . . 0.0 112.545 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.12 -172.33 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.55 138.29 8.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' THR . 8.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.831 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.51 131.29 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.848 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.409 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.59 156.68 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.129 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.96 -70.38 0.87 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.61 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 31.2 p-80 -173.01 133.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 59.08 57.01 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.821 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.9 tp-100 -95.85 157.06 16.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.888 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HA ' HG12 ' A' ' 46' ' ' VAL . 5.4 mttt -79.87 113.35 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 -20.1 11.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.316 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.38 -32.6 58.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.259 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.59 -28.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.36 170.19 9.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -139.15 99.25 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -125.33 155.51 71.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 6' ' ' THR . 50.5 Cg_endo -69.19 123.04 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' SG ' HD13 ' A' ' 8' ' ' ILE . 54.5 m -97.9 73.36 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.8 p -59.8 169.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.36 165.16 15.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.31 105.51 7.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.515 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.9 t -84.8 93.9 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.9 m -86.81 101.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.089 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.14 -176.03 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.54 93.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.04 -46.37 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.16 -53.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.777 0.322 . . . . 0.0 110.971 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.22 -65.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -143.56 132.85 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.39 107.17 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HB ' ' A' ' 25' ' ' THR . 5.4 m -109.75 122.0 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.71 138.63 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -117.96 109.98 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 52.9 m-85 -84.37 129.17 34.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.51 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -119.79 142.99 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -75.88 95.22 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.695 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.91 119.23 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -33.83 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -78.26 64.09 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.24 -53.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.442 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.1 -71.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.578 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.9 m -144.12 166.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.8 t -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -125.11 163.28 38.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.9 Cg_exo -54.15 156.57 12.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.601 2.201 . . . . 0.0 112.382 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.1 165.36 31.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.96 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.97 130.25 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.217 0.532 . . . . 0.0 111.03 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.81 167.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.254 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -102.24 -86.88 1.97 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.45 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.6 p-80 -158.14 132.4 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.971 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 48' ' ' VAL . 70.7 m-85 59.45 55.89 3.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.78 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 8' ' ' ILE . 2.9 mm-40 -110.03 166.84 10.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -79.93 128.77 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.0 t -110.7 -30.83 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.64 -60.34 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -72.61 -38.79 67.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.54 128.21 54.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.75 38.53 1.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 8' ' ' ILE . 10.9 mttp -78.23 127.36 81.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.52 148.67 42.44 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.415 2.077 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.4 m -103.43 105.44 15.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -178.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.48 28.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -117.51 -178.87 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -144.73 84.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.11 159.69 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.21 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 60.98 156.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -177.01 102.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.8 -94.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.413 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -97.62 -33.69 11.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 m -101.95 172.28 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.04 128.56 49.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.46 136.14 34.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.3 p -122.9 154.92 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 6.6 tpt180 -123.12 106.13 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -117.28 119.88 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 67.8 m-85 -88.77 115.0 25.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.453 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.0 pt -103.65 148.14 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.41 93.25 5.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 112.33 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 -31.53 15.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.83 -30.55 69.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.798 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.43 -79.89 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.53 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.29 27.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 47.05 86.54 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.664 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.63 159.28 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.03 114.49 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 11' ' ' TYR . 5.2 m -122.03 161.81 40.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 57.3 Cg_exo -52.25 155.23 9.6 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.574 2.183 . . . . 0.0 112.542 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.13 -174.11 4.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.38 29.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.13 132.68 39.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.71 168.17 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.211 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.87 -79.92 1.02 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.613 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 33.5 p-80 -161.77 131.68 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 48' ' ' VAL . 60.4 m-85 60.67 65.52 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -122.08 142.08 50.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HA ' HG12 ' A' ' 46' ' ' VAL . 17.9 pttp -79.7 116.3 19.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -111.94 24.23 12.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 45' ' ' GLY . 26.1 t -76.77 -56.61 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.19 30.99 3.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.96 115.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.76 100.8 12.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -141.81 142.61 25.91 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 144.21 32.25 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.583 2.189 . . . . 0.0 112.405 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.4 m -92.82 102.21 14.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.4 154.13 36.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -108.93 158.99 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -138.15 109.35 6.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 34' ' ' VAL . 42.9 p -84.38 116.25 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 65.16 126.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.046 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -92.81 47.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 61.12 156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.79 -127.61 8.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.21 144.65 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 t -69.52 142.58 53.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -154.82 -178.36 7.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -80.21 -176.8 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG23 HG22 ' A' ' 25' ' ' THR . 11.1 p -79.91 154.86 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 4.4 tpm_? -117.48 92.92 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 1.2 tptm -79.97 166.47 21.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 38.1 m-85 -143.03 106.06 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 50' ' ' PHE . 4.3 pt -100.53 146.45 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.25 100.82 10.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -86.63 117.75 25.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -119.6 24.48 10.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.26 -26.76 42.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.53 -60.19 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.647 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.471 ' OE1' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -113.05 -69.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 111.062 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 135.07 58.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.547 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG13 ' OE1' ' A' ' 44' ' ' GLU . 33.5 m -132.67 157.72 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.3 118.17 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 16.8 m -120.09 161.84 36.54 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.257 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 70.5 Cg_exo -51.54 149.98 17.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.624 2.216 . . . . 0.0 112.438 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.04 -168.95 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.66 148.91 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.811 0.339 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 133.91 56.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.65 167.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.138 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.81 -95.36 1.95 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.527 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 39.7 p-80 -147.39 126.74 13.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.982 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.502 ' CD2' HG12 ' A' ' 48' ' ' VAL . 76.4 m-85 61.79 59.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -123.19 176.97 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.843 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 132.74 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.5 t -115.15 -7.69 12.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.414 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 15' ' ' VAL . 21.6 t -89.82 50.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.875 0.369 . . . . 0.0 111.22 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -176.97 36.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.27 -165.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.58 34.61 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 44.3 pttt 44.32 51.24 7.92 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.768 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.8 Cg_endo -86.64 102.53 0.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.535 2.157 . . . . 0.0 112.135 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.9 m -126.36 105.35 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.8 m -73.03 177.16 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -115.49 129.19 56.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 93.35 7.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.727 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.6 t -113.8 115.13 27.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.38 152.58 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -64.65 177.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -60.84 129.35 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.22 -142.79 3.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.2 -67.31 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -99.9 146.23 26.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -106.66 109.5 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -141.81 133.68 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.727 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -123.35 122.47 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -98.58 108.91 21.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 -176.66 5.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m-85 -158.35 126.82 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.8 pp -129.41 167.39 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.208 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.9 m -94.42 126.31 39.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.61 118.61 30.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . 2.8 ttm105 -116.57 24.11 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.44 -30.36 53.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.95 -49.0 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.49 -67.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.33 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.93 62.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.41 155.23 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 111.229 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' TYR . 48.6 t -85.45 115.93 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.228 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' A' ' 11' ' ' TYR . 27.4 m -119.92 163.76 26.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.9 Cg_exo -53.38 154.6 14.52 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.554 2.17 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.49 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -136.93 -46.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.502 HG23 ' HG2' ' A' ' 20' ' ' PRO . 20.6 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -170.09 126.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.187 0.518 . . . . 0.0 110.994 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.745 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.64 166.71 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.228 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.37 -68.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -173.86 120.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.9 m-85 62.02 62.19 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -108.19 166.69 10.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -79.82 122.04 26.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.34 -28.96 10.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.48 103.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.155 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.08 61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.889 ' HB1' ' HE2' ' A' ' 19' ' ' LYS . . . -149.16 137.61 20.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.14 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.889 ' HE2' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -121.33 95.18 48.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' HG23 ' A' ' 6' ' ' THR . 52.7 Cg_exo -54.77 152.04 29.93 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.511 2.141 . . . . 0.0 112.331 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.745 ' SG ' HD13 ' A' ' 8' ' ' ILE . 57.8 m -114.3 104.91 12.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.3 p -102.3 -176.5 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 36' ' ' LYS . 21.0 p -107.19 165.74 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 -179.29 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -127.26 148.94 50.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.02 126.22 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.14 170.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -157.95 98.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.02 -84.07 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.23 -57.24 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 p -96.66 122.63 39.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.42 115.83 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -155.73 133.24 11.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.75 152.48 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -116.59 138.32 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.5 169.9 8.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 20.0 m-85 -150.43 107.77 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 50' ' ' PHE . 43.3 pt -99.72 160.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.193 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 m -98.99 97.2 8.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 111.72 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -27.31 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 52.91 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.58 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.25 -52.99 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.05 44.75 0.99 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.624 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.08 158.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -86.52 116.78 24.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -121.65 164.17 26.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 45.6 Cg_exo -56.07 148.37 59.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.18 -169.38 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.94 94.44 2.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.698 0.285 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.38 130.54 46.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.201 0.525 . . . . 0.0 111.027 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.6 166.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.208 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.26 -75.11 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -169.86 134.44 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CD2' HG12 ' A' ' 48' ' ' VAL . 26.8 m-85 59.22 53.27 5.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.012 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 6.9 tp60 -96.9 160.55 14.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.521 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 46' ' ' VAL . 11.2 mttt -79.7 114.15 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.16 -47.98 8.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.799 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.18 129.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.84 29.93 19.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.15 86.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.87 146.23 33.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HB3' HD12 ' A' ' 8' ' ' ILE . 2.9 mttt -173.52 148.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.809 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.34 120.95 7.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.7 m -81.3 100.6 9.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 165.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.054 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -125.04 161.55 26.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -131.23 108.03 9.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.656 ' HB ' HG23 ' A' ' 34' ' ' VAL . 9.0 t -137.28 162.54 33.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.64 92.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -89.55 167.59 12.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -64.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.05 101.89 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.4 85.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -104.79 137.21 42.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -174.37 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -160.06 171.64 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.656 HG23 ' HB ' ' A' ' 25' ' ' THR . 10.6 p -136.62 145.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -120.48 121.06 37.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -111.58 165.88 11.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.402 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 12.8 m-85 -135.37 121.94 20.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -112.69 155.97 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 100.51 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.616 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.95 139.56 30.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -129.94 24.02 5.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.52 -59.47 2.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.67 -97.72 0.82 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.429 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -79.94 -56.51 4.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.9 84.81 0.88 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.58 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.8 m -150.64 161.74 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.909 0.385 . . . . 0.0 111.346 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.19 107.12 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.434 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG12 ' CD2' ' A' ' 11' ' ' TYR . 23.4 m -113.56 162.98 19.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.449 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 41.2 Cg_exo -57.38 160.35 13.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.22 -170.36 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -156.61 -45.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.59 133.39 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.211 0.529 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.68 167.04 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.156 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.09 -93.39 2.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -149.28 126.98 11.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.2 m-85 61.28 61.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HB3' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -111.71 148.72 32.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.709 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -79.74 105.5 11.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.1 p -97.76 23.49 7.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.2 t -102.89 -47.88 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.105 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.48 -32.1 73.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.32 -175.05 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -127.2 85.31 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.954 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' CB ' HD12 ' A' ' 8' ' ' ILE . 30.8 mttt -115.76 139.9 25.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.6 143.87 31.07 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.522 2.148 . . . . 0.0 112.274 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.5 m -96.74 105.06 17.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -179.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.85 173.19 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -145.29 106.13 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.405 ' HB ' HG23 ' A' ' 34' ' ' VAL . 1.7 t -132.82 123.4 26.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.94 174.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -166.56 156.93 12.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.42 140.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.74 3.17 71.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.898 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.16 104.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 t -171.84 122.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 88.58 6.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -143.58 118.49 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 25' ' ' THR . 11.0 p -142.16 137.72 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -123.77 126.72 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 158.9 21.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -130.84 113.76 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.5 pp -114.85 153.86 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.183 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 5.7 m -87.18 111.23 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.59 107.39 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -100.91 24.63 9.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 50.53 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.25 -33.46 1.02 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -147.98 -70.33 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 128.37 59.24 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.37 155.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.8 t -88.95 114.36 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.632 HG12 ' CD2' ' A' ' 11' ' ' TYR . 28.5 m -123.91 163.58 34.48 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.17 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.1 Cg_exo -53.91 153.26 20.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.55 2.167 . . . . 0.0 112.428 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.543 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.0 172.85 16.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 59.57 108.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.48 133.25 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.543 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.62 163.99 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.109 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.52 -87.9 1.96 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.549 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 10.5 p80 -152.57 129.09 10.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 61.38 66.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 139.4 42.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -79.82 105.77 11.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -112.95 29.06 8.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -62.77 -63.83 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.8 31.07 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.68 130.24 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -102.37 114.06 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.1 150.77 73.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 119.7 6.58 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.577 2.185 . . . . 0.0 112.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.1 m -80.1 96.41 6.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.33 155.55 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -101.99 165.26 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.61 92.7 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 43.6 p -104.41 146.74 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.09 132.16 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.25 87.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.55 158.89 25.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.18 -46.13 3.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.508 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -99.52 157.53 16.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.8 m 60.33 177.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -137.16 95.02 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.92 74.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 25' ' ' THR . 16.7 m -96.21 135.06 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 113.72 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -170.52 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.815 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 19.7 m-85 -160.05 123.1 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.952 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -130.55 157.92 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.04 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.84 100.99 12.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.81 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -91.61 133.14 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 23.96 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.55 -41.01 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -67.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -160.01 33.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.831 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 59.05 64.1 4.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.563 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 44' ' ' GLU . 16.2 t -130.05 154.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -93.66 102.05 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.35 160.91 25.33 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.08 159.59 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.631 2.221 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.02 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -154.74 -63.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.428 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m 63.59 131.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.278 0.561 . . . . 0.0 110.929 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.659 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.211 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.17 -98.0 2.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.511 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.6 p-80 -140.32 126.0 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CD2' HG12 ' A' ' 48' ' ' VAL . 39.4 m-85 58.39 51.96 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -92.88 156.56 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.619 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.93 122.5 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.44 -53.49 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.1 135.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 m120 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -155.91 91.96 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.72 84.14 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.659 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.92 116.92 6.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.43 146.66 82.23 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -80.07 102.08 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 170.91 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -127.24 136.09 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -111.26 168.1 9.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -143.32 176.8 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.836 HG22 ' HG2' ' A' ' 27' ' ' ARG . 14.1 p -151.15 140.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.836 ' HG2' HG22 ' A' ' 26' ' ' VAL . 1.0 OUTLIER 65.26 168.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -84.28 165.78 18.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.17 120.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.04 121.62 44.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.786 0.327 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -156.39 -50.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.98 35.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.47 31.29 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.91 171.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.85 110.33 12.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -99.86 106.05 17.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 44.5 m-85 -81.64 137.26 35.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -131.0 153.85 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.45 127.17 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.94 119.67 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 24.37 11.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.42 50.18 1.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.69 -65.78 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -127.31 -45.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.92 73.36 0.74 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 13' ' ' LYS . 29.0 m -138.63 160.14 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 111.274 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.3 t -95.06 112.21 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.628 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.3 m -116.3 164.89 16.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 51.0 Cg_exo -54.18 146.93 47.01 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.43 2.086 . . . . 0.0 112.267 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.588 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.83 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -156.71 172.73 18.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.8 p -166.13 146.4 6.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.607 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.575 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.77 172.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.501 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.538 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -87.23 -99.58 0.85 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.673 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 20.0 p-80 -147.1 129.01 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' CYS . 74.7 m-85 61.12 59.97 1.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.425 ' CB ' HG12 ' A' ' 8' ' ' ILE . 4.3 mm-40 -116.42 171.74 7.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -79.55 114.78 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -116.06 -12.82 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.363 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.44 -33.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.221 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.28 29.67 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.014 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.55 148.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 37.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.575 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.42 126.66 84.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.33 154.0 75.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.25 175.26 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.77 -165.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.146 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -159.68 114.95 2.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.728 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 86.98 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.02 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 34' ' ' VAL . 67.0 p -110.51 88.55 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.8 124.08 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.85 165.43 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -175.33 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.2 85.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 60.82 40.32 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 170.21 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 41.65 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -97.9 36.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.2 p -118.03 110.01 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.19 134.77 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.751 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -120.75 109.35 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 9.2 m-85 -81.81 138.11 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.2 pp -134.36 178.25 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 111.483 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.42 120.66 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.697 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -103.98 93.47 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.5 23.81 9.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 -51.5 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.59 -67.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -127.3 -46.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.72 52.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.588 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -143.27 156.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.401 . . . . 0.0 111.429 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -83.27 117.29 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.9 m -128.93 165.73 29.92 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.246 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 32.2 Cg_exo -58.36 165.89 6.8 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.566 2.177 . . . . 0.0 112.527 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.56 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -160.08 166.44 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.57 90.08 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.466 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.769 0.319 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.86 127.38 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.76 166.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.171 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.86 -78.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.463 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 21.9 p-80 -166.79 133.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 48' ' ' VAL . 24.1 m-85 58.18 61.85 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.694 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' CB ' HG12 ' A' ' 8' ' ' ILE . 5.1 tp-100 -105.82 159.25 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 115.71 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -84.24 -29.98 26.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -70.01 -38.44 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.98 -37.17 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.53 117.75 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.29 74.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -121.19 158.39 53.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 134.35 63.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.634 2.223 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.9 m -96.07 101.87 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.703 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.32 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.043 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -110.24 163.66 13.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 114.68 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' HG13 ' A' ' 34' ' ' VAL . 10.2 t -118.13 147.05 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 32' ' ' LYS . 21.5 t -81.01 154.59 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 26' ' ' VAL . 2.1 mtt-85 -97.47 38.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.3 164.74 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.83 -94.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.56 -29.68 65.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.031 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 109.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.026 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 26' ' ' VAL . 9.7 mttt 60.23 175.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.95 -177.84 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.6 t -80.13 144.65 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.92 130.14 39.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -99.47 -165.57 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.4 m-85 -142.86 142.42 31.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.457 . . . . 0.0 111.645 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 50' ' ' PHE . 5.1 pt -120.79 152.02 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 97.14 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.46 116.1 27.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -106.03 -31.3 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.95 -30.23 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.68 -98.88 0.23 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.66 -33.97 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 41' ' ' ARG . . . 104.09 47.44 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -143.54 154.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 t -96.97 106.51 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 11' ' ' TYR . 2.2 m -114.52 161.26 29.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.961 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 60.1 Cg_endo -73.06 151.37 49.81 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.319 2.013 . . . . 0.0 112.633 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.948 ' CD1' HG23 ' A' ' 38' ' ' ILE . 1.6 p90 -149.35 170.48 18.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 -54.99 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.47 128.33 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.096 0.474 . . . . 0.0 111.006 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.894 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.58 170.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.367 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -118.01 -35.04 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.507 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -177.36 142.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 61.08 71.49 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.894 ' HG3' HD13 ' A' ' 8' ' ' ILE . 9.0 tm0? -102.3 141.51 35.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.802 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -79.88 108.74 13.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.65 24.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.18 118.98 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 m120 59.66 54.04 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -170.59 145.88 2.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.17 32.6 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.05 112.71 29.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.98 132.28 48.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -93.16 92.27 7.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -178.62 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -178.34 4.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -144.05 95.34 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.0 t -124.13 116.36 22.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.38 128.05 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -122.61 91.85 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -152.64 81.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.14 179.96 18.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 150.72 27.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.8 t 60.33 102.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.53 123.17 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -84.33 134.92 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.4 t -89.29 113.85 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -82.67 126.03 31.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -129.84 169.99 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 34.1 m-85 -136.86 118.92 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.454 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.3 pt -107.24 147.73 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.277 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.71 92.04 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.706 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.03 126.46 31.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -105.53 24.04 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.41 -32.07 12.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.5 -64.7 1.06 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.525 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -156.52 27.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.001 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.15 62.33 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.582 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 47' ' ' CYS . 12.8 t -128.68 158.5 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 t -94.31 105.86 17.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 24.9 m -111.47 162.24 21.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.3 Cg_exo -55.37 160.11 9.35 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.656 2.237 . . . . 0.0 112.516 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.08 173.64 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 60.19 163.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.964 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.856 0.36 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.75 135.68 50.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.232 0.539 . . . . 0.0 111.019 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.728 HD12 ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 170.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.214 -179.532 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.58 -91.04 2.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.614 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 27.2 p80 -152.18 128.69 10.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 58.26 61.21 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -107.62 152.71 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.712 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.4 mttp -79.73 120.95 24.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 -34.49 20.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.9 -35.55 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -107.88 34.78 3.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -171.82 141.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.09 90.56 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -157.62 137.18 8.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.925 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 145.94 65.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.373 2.049 . . . . 0.0 112.419 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.0 m -87.8 95.04 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 174.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.1 p -148.56 128.07 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -84.31 153.07 23.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -150.8 96.87 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.68 139.33 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 120.13 26.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -132.68 -48.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.82 -161.3 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.12 -53.87 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -71.04 124.26 23.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -80.68 137.62 36.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -114.83 95.14 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.6 p -112.33 113.54 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.86 100.93 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -98.57 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 39.0 m-85 -79.89 147.59 31.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -135.98 148.85 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.91 104.87 16.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.51 116.97 33.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -111.14 -30.27 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.0 -25.96 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 -43.45 3.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.58 -74.58 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.07 46.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.586 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.12 153.78 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.202 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.72 113.72 25.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 m -121.77 164.9 22.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.188 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.9 Cg_exo -54.98 159.75 9.01 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.586 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.95 160.37 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.782 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 86.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.433 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 m 62.59 130.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.216 0.531 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.829 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.76 170.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.331 -179.439 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.33 -40.85 1.86 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.331 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -179.04 144.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.79 0.329 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 62.52 74.29 0.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.829 ' HG3' HD13 ' A' ' 8' ' ' ILE . 8.6 tm0? -98.49 132.24 44.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -79.89 110.22 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.58 22.86 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.997 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.97 -31.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.56 30.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.99 -173.93 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.1 128.46 24.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.15 141.07 6.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.84 114.47 3.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.411 2.074 . . . . 0.0 112.428 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.9 t -93.03 82.79 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.818 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.03 -173.38 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.08 168.32 9.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.09 128.06 29.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -110.25 126.22 53.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.804 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.03 151.37 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.68 139.73 26.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -165.93 -54.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.68 -159.29 35.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.97 -55.22 17.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 t -120.48 138.97 53.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -149.85 123.77 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.58 161.21 20.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.55 144.63 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -100.56 133.86 44.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 178.97 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -152.61 129.08 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -124.84 144.61 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.194 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.16 119.8 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.87 111.75 24.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.52 26.21 8.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.48 54.65 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.57 -24.72 8.41 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.799 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -120.11 -78.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.69 58.37 0.57 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.413 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 47' ' ' CYS . 20.1 t -137.82 160.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.5 t -96.61 101.09 12.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -104.37 161.74 21.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 86.9 Cg_exo -46.75 144.67 7.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.672 2.248 . . . . 0.0 112.694 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.01 -167.66 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -166.02 102.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 m -57.65 140.53 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 111.177 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.51 165.35 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.228 -179.493 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -105.95 -76.77 1.06 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.8 p-80 -168.28 130.0 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.28 60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.04 157.02 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -79.83 116.45 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 m -79.89 -39.51 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.28 136.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 58.96 31.06 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.38 149.67 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -124.22 37.13 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.12 125.44 48.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 132.85 23.71 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.516 2.144 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.03 94.94 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.4 m -84.79 -178.21 6.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 175.94 5.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -154.86 169.0 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.433 ' HB ' HG12 ' A' ' 34' ' ' VAL . 9.8 t -140.38 141.0 35.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.44 145.32 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.7 110.79 10.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -150.26 98.26 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.26 -116.53 8.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.47 -31.15 8.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.5 m -67.4 86.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 144.08 31.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -160.0 138.03 10.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.6 m -102.84 163.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -159.13 160.33 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.9 ttpp -126.06 179.9 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 40.1 m-85 -129.32 150.49 50.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.013 0.435 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.884 HG23 ' CD1' ' A' ' 50' ' ' PHE . 3.2 pt -122.35 153.04 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.943 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.22 91.99 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.01 110.75 19.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -109.79 24.66 12.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.34 -50.97 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.59 -66.61 1.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.7 -47.2 0.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.07 78.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.42 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.29 154.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 104.55 16.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.84 157.74 36.85 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 62.5 Cg_endo -73.55 137.39 25.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.551 2.167 . . . . 0.0 112.64 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 38' ' ' ILE . 3.1 p90 -135.23 176.76 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.91 99.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.05 136.44 33.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.63 164.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.24 -68.18 0.66 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.394 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 22.1 p-80 -170.83 126.95 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' CD2' HG12 ' A' ' 48' ' ' VAL . 22.1 m-85 57.07 60.53 2.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -114.38 169.52 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.576 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -79.5 121.06 24.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 t -122.52 -59.4 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.431 ' HB ' ' CA ' ' A' ' 45' ' ' GLY . 3.5 t -63.16 -26.32 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.143 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.35 -35.29 12.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.39 50.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.82 126.35 29.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HG2' HD12 ' A' ' 8' ' ' ILE . 14.2 tttt -177.12 98.65 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.09 144.1 23.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.165 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -105.39 94.51 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.5 m -81.43 169.37 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -99.94 135.98 40.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -106.59 -179.51 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.502 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.5 t -152.37 121.52 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.98 123.37 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 60.19 161.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.79 158.71 26.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.31 -121.59 1.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.71 177.01 4.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.13 122.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -72.8 102.4 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -125.2 68.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -98.61 168.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.58 115.88 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.0 170.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.793 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 31.7 m-85 -154.0 129.56 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -127.55 156.06 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.9 m -90.39 111.82 23.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.32 -172.22 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 60.93 81.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -33.02 72.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.697 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.53 -63.41 4.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.333 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -58.19 3.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.513 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . . . 96.52 77.28 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.9 179.493 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -135.67 151.61 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -102.59 114.51 28.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.458 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.513 HG12 ' CD2' ' A' ' 11' ' ' TYR . 8.8 m -111.79 162.43 21.18 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.312 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' CE1' ' A' ' 11' ' ' TYR . 52.0 Cg_exo -54.14 158.83 8.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.635 2.223 . . . . 0.0 112.454 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.603 ' CG ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -155.42 174.53 15.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t0 59.84 54.59 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' HG22 ' A' ' 6' ' ' THR . 38.5 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 20' ' ' PRO . 23.9 p -166.09 140.03 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.402 0.62 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.84 160.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.602 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.14 -87.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.698 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 31.6 p-80 -157.98 138.38 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 48' ' ' VAL . 56.0 m-85 59.3 58.01 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB2' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -121.15 171.27 8.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.643 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -79.42 120.71 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 0.0 111.188 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t -101.75 21.52 14.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 15' ' ' VAL . 15.2 t -109.61 30.34 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.091 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -147.78 29.74 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.33 -170.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.21 -77.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -170.73 52.93 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.434 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 53.5 Cg_endo -68.77 114.28 3.48 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.642 2.228 . . . . 0.0 112.404 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -153.04 104.54 2.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.733 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.433 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 7.2 m -67.14 -175.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.833 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -148.55 145.86 28.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -115.7 104.53 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 34' ' ' VAL . 1.8 t -109.11 93.83 4.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.35 168.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 177.37 8.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.02 -46.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.33 -107.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.04 -35.47 76.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.936 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.68 141.98 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.55 132.81 24.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -123.75 123.59 40.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -111.9 116.98 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 125.04 38.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -108.58 167.36 10.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 14.4 m-85 -140.85 111.24 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.423 HG12 ' CG ' ' A' ' 50' ' ' PHE . 6.1 pt -103.24 166.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.9 m -103.5 107.39 18.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -94.15 135.15 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.03 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 -24.69 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.49 -35.95 63.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -113.06 0.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.506 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.92 26.04 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.58 63.81 4.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 12' ' ' GLN . 33.1 m -139.64 155.36 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' TYR . 49.0 t -90.1 121.26 32.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.209 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.664 HG12 ' CD2' ' A' ' 11' ' ' TYR . 26.2 m -125.29 166.51 20.29 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.216 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 45.5 Cg_exo -56.92 158.19 17.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.485 2.124 . . . . 0.0 112.347 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -176.44 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.62 164.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.515 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -163.61 132.53 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.227 0.537 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.67 167.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.194 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.52 -99.05 2.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.56 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.2 p-80 -144.29 125.68 14.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD2' HG12 ' A' ' 48' ' ' VAL . 62.0 m-85 61.44 52.42 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.5 mm-40 -107.1 175.37 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.564 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 1.6 mmtp -79.64 127.55 32.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.5 t -103.44 -29.04 11.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.9 -30.59 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.204 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -105.56 37.87 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . . . -166.81 172.3 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.098 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.08 -166.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt 64.21 132.87 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.54 -179.43 4.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.506 2.137 . . . . 0.0 112.384 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.0 m -97.61 119.18 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -170.5 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -137.35 132.72 33.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 10.2 mptt -100.98 81.06 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -124.9 123.4 39.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 26' ' ' VAL . 14.3 p -95.93 41.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 55.91 -176.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 129.16 44.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.79 -74.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -135.45 -61.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 m -96.38 -175.48 3.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -102.07 102.76 13.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.91 30.04 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.85 141.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.86 115.09 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 106.96 16.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.432 ' CE1' ' HD3' ' A' ' 24' ' ' LYS . 37.4 m-85 -80.15 100.79 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -83.37 -174.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 1.9 m -122.85 98.01 5.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.04 122.35 29.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.66 13.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -40.8 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.71 -93.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.442 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.8 25.25 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.305 . . . . 0.0 111.009 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.37 61.02 7.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.6 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.3 157.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.298 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' TYR . 4.1 t -87.54 119.62 28.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.598 HG12 ' CD2' ' A' ' 11' ' ' TYR . 12.4 m -134.19 162.29 58.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 51.6 Cg_exo -54.48 153.36 23.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.56 2.173 . . . . 0.0 112.291 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.11 162.49 34.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.08 -177.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.806 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.436 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.12 136.41 58.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.161 0.505 . . . . 0.0 111.019 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.78 169.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.243 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.9 -75.4 1.26 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.564 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 11.3 p-80 -167.75 129.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.726 ' CD2' HG12 ' A' ' 48' ' ' VAL . 84.1 m-85 61.4 68.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.423 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -131.8 168.84 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.873 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -79.72 125.71 30.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.064 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.28 31.71 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.0 t -87.34 -68.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.433 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.43 -35.1 63.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.47 174.58 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -170.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 11.7 ttpp -129.64 53.74 12.47 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.438 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.7 Cg_endo -87.46 102.08 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.607 2.205 . . . . 0.0 111.995 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.3 m -130.15 96.84 4.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 m -69.69 -178.48 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.945 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 t -109.86 162.89 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -133.02 122.69 24.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 34' ' ' VAL . 3.0 t -97.14 120.17 37.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.33 127.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -126.27 120.71 30.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.45 -51.25 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.55 -56.08 0.87 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.94 -178.9 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -66.35 81.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -79.19 -179.3 6.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -81.44 -174.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 25' ' ' THR . 8.9 m -98.93 179.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 114.16 19.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 170.79 10.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 16.0 m-85 -149.6 103.13 3.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 50' ' ' PHE . 41.2 pt -98.81 163.02 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.233 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.7 t -100.81 108.63 20.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.09 126.95 41.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 23.45 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.16 37.4 1.55 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.52 -37.02 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.631 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -59.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 115.78 54.68 0.36 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.39 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.59 159.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.61 119.42 30.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.273 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.726 HG12 ' CD2' ' A' ' 11' ' ' TYR . 11.6 m -122.07 163.29 32.54 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.2 Cg_exo -54.54 155.61 16.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.59 2.193 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.07 169.56 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.82 105.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.459 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -145.0 130.56 18.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.47 164.09 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.181 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -108.05 -99.22 2.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 20.3 p-80 -140.07 125.9 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' CYS . 39.0 m-85 58.79 55.31 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.416 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.34 161.84 13.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.905 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HA ' HG12 ' A' ' 46' ' ' VAL . 1.1 mptp? -79.84 113.35 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -41.69 23.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -77.9 -53.91 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -45.2 95.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -112.12 126.76 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -93.28 80.26 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 30.8 mtpt -132.16 134.56 25.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 32.4 Cg_exo -57.98 142.63 96.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.422 2.081 . . . . 0.0 112.294 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 103.24 9.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.34 177.72 8.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.16 -174.1 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -160.01 140.33 11.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -139.24 134.79 33.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 11.2 p -83.71 116.18 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . 17.5 mtm105 -133.14 82.94 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 28' ' ' TYR . 21.1 t80 -163.88 31.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.12 -162.93 36.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -169.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 170.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -155.25 80.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -119.31 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 m -104.24 153.09 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.59 147.77 44.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -145.17 115.72 7.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 19.2 m-85 -90.55 133.59 34.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.421 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pt -111.41 169.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.076 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -104.96 97.05 6.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 104.29 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.83 23.36 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -99.82 -52.05 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.96 -86.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.28 -32.08 6.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.31 69.29 0.69 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 13' ' ' LYS . 11.0 m -146.7 162.56 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 111.294 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -88.19 108.44 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 1.7 m -111.17 160.43 29.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.206 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 29.5 Cg_endo -63.61 160.53 35.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -160.09 176.84 11.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.567 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 124.16 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.911 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.71 173.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.686 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -113.4 -32.23 2.2 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.056 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -179.03 140.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 63.6 79.27 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.875 ' HG3' HD13 ' A' ' 8' ' ' ILE . 3.5 tt0 -107.08 140.0 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.692 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.77 93.79 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 p -119.73 35.97 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.13 -34.39 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -106.43 -28.63 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.02 -178.06 4.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.51 87.07 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 156.44 60.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.44 110.21 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.6 t -104.61 87.6 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.05 151.78 21.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 p -98.31 -170.78 2.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -143.73 108.28 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.726 ' OG1' HG12 ' A' ' 34' ' ' VAL . 9.7 t -145.63 123.69 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.1 p -178.67 76.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -132.33 102.31 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.91 164.04 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.38 -159.57 14.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -68.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.59 139.33 49.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 105.53 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.79 96.37 10.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.726 HG12 ' OG1' ' A' ' 25' ' ' THR . 10.6 m -94.9 132.07 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -113.7 100.02 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 3.0 tptt -80.57 -167.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 12.2 m-85 -160.06 114.18 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.485 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.4 pt -113.01 156.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.281 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.2 t -89.81 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 117.42 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.982 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.77 24.72 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.968 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -104.31 -32.44 9.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.701 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.88 -76.32 1.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.4 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.04 27.77 1.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.51 60.62 8.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.647 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 47' ' ' CYS . 6.8 t -129.02 159.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -97.09 104.32 16.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.5 m -110.75 164.61 14.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.366 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 42.8 Cg_exo -56.99 163.05 8.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.618 2.212 . . . . 0.0 112.614 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.19 -178.63 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.936 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.96 104.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.422 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -149.02 130.67 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 110.965 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.74 163.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.15 -88.5 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.466 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -157.13 127.74 6.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.354 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD2' HG12 ' A' ' 48' ' ' VAL . 41.5 m-85 61.09 62.89 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -105.43 145.12 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.82 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -79.92 115.54 19.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 p -122.92 31.76 5.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -78.68 -56.11 8.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.072 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -98.03 -25.64 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.17 93.12 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.049 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.47 142.96 38.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.07 170.43 9.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.98 119.08 5.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.533 2.155 . . . . 0.0 112.457 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.07 82.24 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.05 -178.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -102.55 133.1 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.69 107.96 20.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -111.39 131.37 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.88 53.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 161.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -116.22 145.5 43.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.23 30.81 0.48 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.05 32.91 19.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -172.76 36.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.48 -177.52 5.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -146.71 179.36 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.2 p -102.06 158.72 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG22 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -125.44 107.91 11.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.019 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 11.9 tttt -87.51 166.5 14.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -138.42 109.45 6.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.465 HG12 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -102.87 153.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.83 93.57 9.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 125.45 29.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -120.02 23.71 10.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.965 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -97.12 39.5 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.14 -53.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -124.93 -63.9 1.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 118.29 61.39 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.4 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 13' ' ' LYS . 18.4 m -138.99 167.16 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.06 112.78 24.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.554 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 11' ' ' TYR . 35.1 m -120.12 162.19 34.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.211 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.2 Cg_exo -54.15 154.95 16.67 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.607 2.205 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.03 168.47 25.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.54 106.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.02 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.485 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.886 0.375 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 129.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.201 0.524 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.7 155.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.117 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.01 -72.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -171.38 137.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.485 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.6 m-85 56.37 52.54 9.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HG2' HD11 ' A' ' 8' ' ' ILE . 4.1 tp60 -86.88 153.37 21.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.661 ' HA ' HG12 ' A' ' 46' ' ' VAL . 4.0 tptt -79.94 117.95 21.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.99 -24.49 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' VAL . 29.8 t -90.2 49.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -178.66 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.65 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.42 41.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.635 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -78.72 147.72 71.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.21 125.69 11.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.414 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.9 m -82.72 75.29 9.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.13 155.27 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.51 161.01 25.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -145.1 108.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 34' ' ' VAL . 4.9 t -94.11 125.77 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 26' ' ' VAL . 10.2 m -75.79 126.86 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -100.04 43.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -128.1 113.94 16.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.81 -168.41 16.93 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.22 -60.74 2.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 p -79.07 160.17 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -114.25 90.61 3.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 142.97 26.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 25' ' ' THR . 19.2 t -105.35 140.62 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.81 121.69 45.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 6.3 ttpp -97.55 167.92 10.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 39.1 m-85 -139.76 123.97 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.512 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.4 pt -117.12 140.22 40.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.161 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.01 91.58 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -82.24 124.98 30.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.84 23.59 10.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.16 37.03 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.79 -69.91 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.625 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.95 -59.11 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.87 59.04 0.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.6 m -142.47 166.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.54 105.96 18.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.7 m -110.88 161.88 23.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.363 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 52.6 Cg_exo -53.32 149.71 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.655 2.237 . . . . 0.0 112.486 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.09 -167.27 1.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -169.59 95.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.84 120.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.196 0.522 . . . . 0.0 110.999 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.874 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.79 169.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.271 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -110.07 -37.74 1.78 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.277 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 178.75 144.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 62.09 68.34 0.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.874 ' HG3' HD13 ' A' ' 8' ' ' ILE . 5.7 tm0? -96.88 151.19 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.597 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.67 107.11 12.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.889 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.08 29.48 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 45' ' ' GLY . 20.4 t -111.06 -53.29 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.132 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -118.82 31.33 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.16 -173.13 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.23 32.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -66.05 148.19 98.49 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 133.21 22.25 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.522 2.148 . . . . 0.0 112.235 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.98 167.58 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 m -121.53 163.7 18.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 115.2 11.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.61 ' HA ' HG13 ' A' ' 34' ' ' VAL . 6.3 p -95.58 153.16 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 30' ' ' ASP . 22.3 t 60.9 108.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -170.25 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.39 32.02 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.16 44.84 2.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.544 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.2 m-20 60.34 31.61 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.63 178.51 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -93.89 48.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.93 140.1 51.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 25' ' ' THR . 22.0 t -107.35 128.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -96.17 120.32 36.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -105.45 168.54 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.628 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -141.54 127.24 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.557 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.7 pp -127.37 160.01 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.01 103.51 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 48' ' ' VAL . 1.2 t70 -89.98 101.23 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -115.47 81.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -149.35 -47.13 0.14 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.59 -31.85 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -115.53 -65.79 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.969 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 109.7 43.51 1.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 13' ' ' LYS . 5.5 m -143.17 173.67 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 111.346 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' CB ' ' HB3' ' A' ' 12' ' ' GLN . 8.0 t -90.42 105.55 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.419 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 40' ' ' ASP . 3.5 m -112.26 162.88 19.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 75.9 Cg_exo -50.5 154.22 6.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.637 2.225 . . . . 0.0 112.534 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.06 -168.12 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.38 30.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.821 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 134.21 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.74 166.14 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.15 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.71 -83.89 1.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 27.2 p-80 -156.18 132.94 10.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 59.48 66.42 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' CB ' HG12 ' A' ' 8' ' ' ILE . 1.8 tm0? -117.83 142.16 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 46' ' ' VAL . 2.7 mttp -79.97 122.71 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 m -85.27 -36.92 20.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.47 -44.02 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -75.82 -31.08 59.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -152.98 100.78 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.44 105.72 8.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -138.85 157.64 71.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.72 136.16 44.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.612 2.208 . . . . 0.0 112.195 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.4 m -90.28 127.46 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.85 172.07 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.64 146.6 28.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 117.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 128.32 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.91 127.63 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -69.3 158.48 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.72 122.44 14.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.26 -79.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -56.16 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.73 175.93 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.48 65.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -126.61 137.61 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.3 t -129.22 139.57 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.018 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 163.06 40.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -103.87 177.71 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.677 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 27.7 m-85 -148.23 105.77 3.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -105.87 154.49 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 53.2 t -94.92 107.52 19.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -101.04 135.42 42.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -104.55 23.82 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.72 -58.26 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.35 -47.71 12.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.27 -47.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.33 72.9 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 13' ' ' LYS . 28.5 m -140.32 165.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 3.8 t -94.03 113.72 25.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 28.5 m -118.92 162.01 33.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.188 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 53.9 Cg_exo -52.62 140.64 55.15 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.626 2.217 . . . . 0.0 112.545 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.12 -172.33 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.55 138.29 8.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' THR . 8.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.831 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.51 131.29 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.848 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.409 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.59 156.68 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.129 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.96 -70.38 0.87 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.61 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 31.2 p-80 -173.01 133.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 59.08 57.01 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.821 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.9 tp-100 -95.85 157.06 16.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.888 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HA ' HG12 ' A' ' 46' ' ' VAL . 5.4 mttt -79.87 113.35 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 -20.1 11.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.316 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.38 -32.6 58.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.259 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.59 -28.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.36 170.19 9.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -139.15 99.25 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -125.33 155.51 71.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 6' ' ' THR . 50.5 Cg_endo -69.19 123.04 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.409 ' SG ' HD13 ' A' ' 8' ' ' ILE . 54.5 m -97.9 73.36 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.8 p -59.8 169.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.36 165.16 15.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.31 105.51 7.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.515 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.9 t -84.8 93.9 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.9 m -86.81 101.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.089 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.14 -176.03 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.54 93.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.04 -46.37 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.16 -53.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.777 0.322 . . . . 0.0 110.971 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.22 -65.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -143.56 132.85 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.39 107.17 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HB ' ' A' ' 25' ' ' THR . 5.4 m -109.75 122.0 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.71 138.63 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -117.96 109.98 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 52.9 m-85 -84.37 129.17 34.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.51 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -119.79 142.99 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -75.88 95.22 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.695 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.91 119.23 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -33.83 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -78.26 64.09 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.24 -53.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.442 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.1 -71.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.578 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.9 m -144.12 166.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.8 t -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -125.11 163.28 38.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.9 Cg_exo -54.15 156.57 12.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.601 2.201 . . . . 0.0 112.382 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.1 165.36 31.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.96 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.97 130.25 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.217 0.532 . . . . 0.0 111.03 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.81 167.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.254 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -102.24 -86.88 1.97 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.45 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.6 p-80 -158.14 132.4 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.971 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 48' ' ' VAL . 70.7 m-85 59.45 55.89 3.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.78 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 8' ' ' ILE . 2.9 mm-40 -110.03 166.84 10.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -79.93 128.77 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.0 t -110.7 -30.83 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.64 -60.34 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -72.61 -38.79 67.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.54 128.21 54.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.75 38.53 1.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 8' ' ' ILE . 10.9 mttp -78.23 127.36 81.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.52 148.67 42.44 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.415 2.077 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.4 m -103.43 105.44 15.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -178.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.48 28.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -117.51 -178.87 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -144.73 84.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.11 159.69 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.21 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 60.98 156.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -177.01 102.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.8 -94.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.413 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -97.62 -33.69 11.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 m -101.95 172.28 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.04 128.56 49.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.46 136.14 34.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.3 p -122.9 154.92 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 6.6 tpt180 -123.12 106.13 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -117.28 119.88 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 67.8 m-85 -88.77 115.0 25.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.453 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.0 pt -103.65 148.14 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.41 93.25 5.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 112.33 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 -31.53 15.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.83 -30.55 69.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.798 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.43 -79.89 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.53 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.29 27.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 47.05 86.54 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.664 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.63 159.28 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.03 114.49 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 11' ' ' TYR . 5.2 m -122.03 161.81 40.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 57.3 Cg_exo -52.25 155.23 9.6 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.574 2.183 . . . . 0.0 112.542 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.13 -174.11 4.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.38 29.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.13 132.68 39.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.71 168.17 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.211 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.495 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.87 -79.92 1.02 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.613 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 33.5 p-80 -161.77 131.68 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 48' ' ' VAL . 60.4 m-85 60.67 65.52 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -122.08 142.08 50.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HA ' HG12 ' A' ' 46' ' ' VAL . 17.9 pttp -79.7 116.3 19.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -111.94 24.23 12.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 45' ' ' GLY . 26.1 t -76.77 -56.61 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.19 30.99 3.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.96 115.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.76 100.8 12.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -141.81 142.61 25.91 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 144.21 32.25 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.583 2.189 . . . . 0.0 112.405 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.4 m -92.82 102.21 14.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.4 154.13 36.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -108.93 158.99 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -138.15 109.35 6.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 34' ' ' VAL . 42.9 p -84.38 116.25 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 65.16 126.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.046 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -92.81 47.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 61.12 156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.79 -127.61 8.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.21 144.65 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 t -69.52 142.58 53.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -154.82 -178.36 7.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -80.21 -176.8 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.642 HG23 HG22 ' A' ' 25' ' ' THR . 11.1 p -79.91 154.86 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 4.4 tpm_? -117.48 92.92 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 1.2 tptm -79.97 166.47 21.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 38.1 m-85 -143.03 106.06 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 50' ' ' PHE . 4.3 pt -100.53 146.45 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.25 100.82 10.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -86.63 117.75 25.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -119.6 24.48 10.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.26 -26.76 42.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.53 -60.19 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.647 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.471 ' OE1' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -113.05 -69.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 111.062 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 135.07 58.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.547 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG13 ' OE1' ' A' ' 44' ' ' GLU . 33.5 m -132.67 157.72 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.3 118.17 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 16.8 m -120.09 161.84 36.54 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.257 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 70.5 Cg_exo -51.54 149.98 17.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.624 2.216 . . . . 0.0 112.438 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.442 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.04 -168.95 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.66 148.91 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.811 0.339 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 133.91 56.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.65 167.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.138 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.81 -95.36 1.95 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.527 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 39.7 p-80 -147.39 126.74 13.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.982 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.502 ' CD2' HG12 ' A' ' 48' ' ' VAL . 76.4 m-85 61.79 59.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.428 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -123.19 176.97 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.843 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 132.74 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.5 t -115.15 -7.69 12.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.414 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 15' ' ' VAL . 21.6 t -89.82 50.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.875 0.369 . . . . 0.0 111.22 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -176.97 36.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.27 -165.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.58 34.61 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 44.3 pttt 44.32 51.24 7.92 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.768 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.8 Cg_endo -86.64 102.53 0.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.535 2.157 . . . . 0.0 112.135 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.9 m -126.36 105.35 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.8 m -73.03 177.16 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -115.49 129.19 56.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 93.35 7.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.727 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.6 t -113.8 115.13 27.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.38 152.58 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -64.65 177.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -60.84 129.35 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.22 -142.79 3.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.2 -67.31 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -99.9 146.23 26.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -106.66 109.5 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -141.81 133.68 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.727 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -123.35 122.47 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -98.58 108.91 21.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 -176.66 5.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m-85 -158.35 126.82 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.8 pp -129.41 167.39 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.208 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.9 m -94.42 126.31 39.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.61 118.61 30.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . 2.8 ttm105 -116.57 24.11 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.44 -30.36 53.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.95 -49.0 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.49 -67.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.33 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.93 62.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.41 155.23 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 111.229 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' TYR . 48.6 t -85.45 115.93 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.228 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' A' ' 11' ' ' TYR . 27.4 m -119.92 163.76 26.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.9 Cg_exo -53.38 154.6 14.52 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.554 2.17 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.49 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.49 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -136.93 -46.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.502 HG23 ' HG2' ' A' ' 20' ' ' PRO . 20.6 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -170.09 126.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.187 0.518 . . . . 0.0 110.994 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.745 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.64 166.71 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.228 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.37 -68.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -173.86 120.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.9 m-85 62.02 62.19 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -108.19 166.69 10.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -79.82 122.04 26.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.34 -28.96 10.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.48 103.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.155 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.08 61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.889 ' HB1' ' HE2' ' A' ' 19' ' ' LYS . . . -149.16 137.61 20.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.14 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.889 ' HE2' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -121.33 95.18 48.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' HG23 ' A' ' 6' ' ' THR . 52.7 Cg_exo -54.77 152.04 29.93 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.511 2.141 . . . . 0.0 112.331 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.745 ' SG ' HD13 ' A' ' 8' ' ' ILE . 57.8 m -114.3 104.91 12.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.3 p -102.3 -176.5 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 36' ' ' LYS . 21.0 p -107.19 165.74 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 -179.29 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -127.26 148.94 50.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.02 126.22 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.14 170.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -157.95 98.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.02 -84.07 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.23 -57.24 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 p -96.66 122.63 39.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.42 115.83 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -155.73 133.24 11.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.75 152.48 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -116.59 138.32 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.5 169.9 8.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 20.0 m-85 -150.43 107.77 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 50' ' ' PHE . 43.3 pt -99.72 160.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.193 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 m -98.99 97.2 8.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 111.72 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -27.31 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 52.91 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.58 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.25 -52.99 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.05 44.75 0.99 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.624 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.08 158.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -86.52 116.78 24.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -121.65 164.17 26.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 45.6 Cg_exo -56.07 148.37 59.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.18 -169.38 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.94 94.44 2.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.698 0.285 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.38 130.54 46.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.201 0.525 . . . . 0.0 111.027 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.6 166.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.208 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.26 -75.11 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -169.86 134.44 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CD2' HG12 ' A' ' 48' ' ' VAL . 26.8 m-85 59.22 53.27 5.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.012 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 6.9 tp60 -96.9 160.55 14.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.521 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 46' ' ' VAL . 11.2 mttt -79.7 114.15 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.16 -47.98 8.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.799 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.18 129.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.84 29.93 19.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.15 86.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.87 146.23 33.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HB3' HD12 ' A' ' 8' ' ' ILE . 2.9 mttt -173.52 148.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.809 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.34 120.95 7.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.7 m -81.3 100.6 9.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 165.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.054 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -125.04 161.55 26.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -131.23 108.03 9.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.656 ' HB ' HG23 ' A' ' 34' ' ' VAL . 9.0 t -137.28 162.54 33.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.64 92.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -89.55 167.59 12.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -64.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.05 101.89 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.4 85.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -104.79 137.21 42.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -174.37 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -160.06 171.64 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.656 HG23 ' HB ' ' A' ' 25' ' ' THR . 10.6 p -136.62 145.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -120.48 121.06 37.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -111.58 165.88 11.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.402 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 12.8 m-85 -135.37 121.94 20.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -112.69 155.97 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 100.51 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.616 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.95 139.56 30.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -129.94 24.02 5.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.52 -59.47 2.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.67 -97.72 0.82 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.429 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -79.94 -56.51 4.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.9 84.81 0.88 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.58 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.8 m -150.64 161.74 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.909 0.385 . . . . 0.0 111.346 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.19 107.12 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.434 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.451 HG12 ' CD2' ' A' ' 11' ' ' TYR . 23.4 m -113.56 162.98 19.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.449 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 41.2 Cg_exo -57.38 160.35 13.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.22 -170.36 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -156.61 -45.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.59 133.39 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.211 0.529 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.68 167.04 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.156 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.09 -93.39 2.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -149.28 126.98 11.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.2 m-85 61.28 61.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HB3' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -111.71 148.72 32.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.709 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -79.74 105.5 11.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.1 p -97.76 23.49 7.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.2 t -102.89 -47.88 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.105 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.48 -32.1 73.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.32 -175.05 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -127.2 85.31 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.954 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.413 ' CB ' HD12 ' A' ' 8' ' ' ILE . 30.8 mttt -115.76 139.9 25.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.6 143.87 31.07 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.522 2.148 . . . . 0.0 112.274 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.5 m -96.74 105.06 17.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -179.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.85 173.19 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -145.29 106.13 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.405 ' HB ' HG23 ' A' ' 34' ' ' VAL . 1.7 t -132.82 123.4 26.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.94 174.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -166.56 156.93 12.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.42 140.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.74 3.17 71.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.898 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.16 104.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 t -171.84 122.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 88.58 6.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -143.58 118.49 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 25' ' ' THR . 11.0 p -142.16 137.72 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -123.77 126.72 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 158.9 21.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -130.84 113.76 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.5 pp -114.85 153.86 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.183 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 5.7 m -87.18 111.23 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.59 107.39 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -100.91 24.63 9.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 50.53 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.25 -33.46 1.02 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -147.98 -70.33 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 128.37 59.24 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.37 155.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.8 t -88.95 114.36 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.632 HG12 ' CD2' ' A' ' 11' ' ' TYR . 28.5 m -123.91 163.58 34.48 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.17 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.1 Cg_exo -53.91 153.26 20.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.55 2.167 . . . . 0.0 112.428 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.543 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.0 172.85 16.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 59.57 108.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.48 133.25 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.543 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.62 163.99 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.109 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.52 -87.9 1.96 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.549 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 4.2 p-80 -152.57 129.09 10.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 61.38 66.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 139.4 42.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -79.82 105.77 11.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -112.95 29.06 8.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.425 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -62.77 -63.83 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.8 31.07 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.68 130.24 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -102.37 114.06 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.1 150.77 73.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 119.7 6.58 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.577 2.185 . . . . 0.0 112.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.1 m -80.1 96.41 6.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.33 155.55 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -101.99 165.26 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.61 92.7 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 43.6 p -104.41 146.74 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.09 132.16 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.25 87.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.55 158.89 25.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.18 -46.13 3.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.508 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -99.52 157.53 16.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.8 m 60.33 177.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -137.16 95.02 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.92 74.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 25' ' ' THR . 16.7 m -96.21 135.06 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 113.72 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -170.52 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.815 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 19.7 m-85 -160.05 123.1 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.952 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -130.55 157.92 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.04 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.84 100.99 12.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.81 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -91.61 133.14 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 23.96 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.55 -41.01 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -67.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -160.01 33.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.831 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 59.05 64.1 4.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.563 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 44' ' ' GLU . 16.2 t -130.05 154.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -93.66 102.05 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.35 160.91 25.33 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.08 159.59 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.631 2.221 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.02 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -154.74 -63.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.428 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m 63.59 131.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.278 0.561 . . . . 0.0 110.929 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.659 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.211 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.17 -98.0 2.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.511 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.6 p-80 -140.32 126.0 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CD2' HG12 ' A' ' 48' ' ' VAL . 39.4 m-85 58.39 51.96 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.412 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -92.88 156.56 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.619 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.93 122.5 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.44 -53.49 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.1 135.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 m120 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -155.91 91.96 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.72 84.14 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.659 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.92 116.92 6.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.43 146.66 82.23 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -80.07 102.08 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 170.91 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -127.24 136.09 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -111.26 168.1 9.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -143.32 176.8 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.836 HG22 ' HG2' ' A' ' 27' ' ' ARG . 14.1 p -151.15 140.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.836 ' HG2' HG22 ' A' ' 26' ' ' VAL . 1.0 OUTLIER 65.26 168.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -84.28 165.78 18.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.17 120.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.04 121.62 44.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.786 0.327 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -156.39 -50.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.98 35.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.47 31.29 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.91 171.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.85 110.33 12.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -99.86 106.05 17.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 44.5 m-85 -81.64 137.26 35.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -131.0 153.85 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.45 127.17 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.94 119.67 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 24.37 11.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.42 50.18 1.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.69 -65.78 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -127.31 -45.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.92 73.36 0.74 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 13' ' ' LYS . 29.0 m -138.63 160.14 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 111.274 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.3 t -95.06 112.21 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.628 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.3 m -116.3 164.89 16.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 51.0 Cg_exo -54.18 146.93 47.01 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.43 2.086 . . . . 0.0 112.267 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.588 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.83 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -156.71 172.73 18.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.8 p -166.13 146.4 6.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.607 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.575 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.77 172.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.501 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.538 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -87.23 -99.58 0.85 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.673 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 20.0 p-80 -147.1 129.01 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' CYS . 74.7 m-85 61.12 59.97 1.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.425 ' CB ' HG12 ' A' ' 8' ' ' ILE . 4.3 mm-40 -116.42 171.74 7.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -79.55 114.78 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -116.06 -12.82 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.363 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.44 -33.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.221 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.28 29.67 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.014 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.55 148.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 37.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.575 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.42 126.66 84.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.33 154.0 75.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.25 175.26 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.77 -165.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.146 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -159.68 114.95 2.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.728 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 86.98 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.02 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 34' ' ' VAL . 67.0 p -110.51 88.55 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.8 124.08 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.85 165.43 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -175.33 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.2 85.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 60.82 40.32 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 170.21 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 41.65 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -97.9 36.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.2 p -118.03 110.01 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.19 134.77 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.751 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -120.75 109.35 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 9.2 m-85 -81.81 138.11 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.2 pp -134.36 178.25 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 111.483 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.42 120.66 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.697 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -103.98 93.47 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.5 23.81 9.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 -51.5 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.59 -67.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -127.3 -46.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.72 52.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.588 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -143.27 156.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.401 . . . . 0.0 111.429 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -83.27 117.29 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.9 m -128.93 165.73 29.92 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.246 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 32.2 Cg_exo -58.36 165.89 6.8 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.566 2.177 . . . . 0.0 112.527 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.56 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -160.08 166.44 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.57 90.08 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.466 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.769 0.319 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.86 127.38 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.76 166.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.171 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.86 -78.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.463 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 21.9 p-80 -166.79 133.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 48' ' ' VAL . 24.1 m-85 58.18 61.85 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.694 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' CB ' HG12 ' A' ' 8' ' ' ILE . 23.3 tp60 -105.82 159.25 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 115.71 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -84.24 -29.98 26.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -70.01 -38.44 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.98 -37.17 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.53 117.75 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.29 74.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -121.19 158.39 53.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 134.35 63.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.634 2.223 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.9 m -96.07 101.87 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.703 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.32 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.043 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -110.24 163.66 13.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 114.68 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' HG13 ' A' ' 34' ' ' VAL . 10.2 t -118.13 147.05 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 32' ' ' LYS . 21.5 t -81.01 154.59 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 26' ' ' VAL . 2.1 mtt-85 -97.47 38.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.3 164.74 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.83 -94.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.56 -29.68 65.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.031 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 109.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.026 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 26' ' ' VAL . 9.7 mttt 60.23 175.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.95 -177.84 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.6 t -80.13 144.65 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.92 130.14 39.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -99.47 -165.57 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.4 m-85 -142.86 142.42 31.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.457 . . . . 0.0 111.645 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 50' ' ' PHE . 5.1 pt -120.79 152.02 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 97.14 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.46 116.1 27.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -106.03 -31.3 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.95 -30.23 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.68 -98.88 0.23 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.66 -33.97 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 41' ' ' ARG . . . 104.09 47.44 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -143.54 154.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 t -96.97 106.51 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 11' ' ' TYR . 2.2 m -114.52 161.26 29.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.961 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 60.1 Cg_endo -73.06 151.37 49.81 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.319 2.013 . . . . 0.0 112.633 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.948 ' CD1' HG23 ' A' ' 38' ' ' ILE . 1.6 p90 -149.35 170.48 18.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 -54.99 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.47 128.33 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.096 0.474 . . . . 0.0 111.006 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.894 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.58 170.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.367 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -118.01 -35.04 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.507 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -177.36 142.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 61.08 71.49 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.894 ' HG3' HD13 ' A' ' 8' ' ' ILE . 9.0 tm0? -102.3 141.51 35.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.802 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -79.88 108.74 13.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.65 24.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.18 118.98 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 m120 59.66 54.04 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -170.59 145.88 2.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.17 32.6 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.05 112.71 29.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.98 132.28 48.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -93.16 92.27 7.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -178.62 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -178.34 4.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -144.05 95.34 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.0 t -124.13 116.36 22.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.38 128.05 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -122.61 91.85 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -152.64 81.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.14 179.96 18.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 150.72 27.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.8 t 60.33 102.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.53 123.17 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -84.33 134.92 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.4 t -89.29 113.85 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -82.67 126.03 31.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -129.84 169.99 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 34.1 m-85 -136.86 118.92 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.454 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.3 pt -107.24 147.73 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.277 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.71 92.04 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.706 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.03 126.46 31.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -105.53 24.04 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.41 -32.07 12.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.5 -64.7 1.06 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.525 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -156.52 27.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.001 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.15 62.33 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.582 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 47' ' ' CYS . 12.8 t -128.68 158.5 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.449 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 t -94.31 105.86 17.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 24.9 m -111.47 162.24 21.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.3 Cg_exo -55.37 160.11 9.35 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.656 2.237 . . . . 0.0 112.516 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.08 173.64 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 60.19 163.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.964 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.856 0.36 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.75 135.68 50.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.232 0.539 . . . . 0.0 111.019 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.728 HD12 ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 170.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.214 -179.532 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.58 -91.04 2.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.614 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 11.2 p-80 -152.18 128.69 10.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 58.26 61.21 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -107.62 152.71 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.712 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.4 mttp -79.73 120.95 24.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 -34.49 20.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.9 -35.55 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -107.88 34.78 3.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -171.82 141.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.09 90.56 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -157.62 137.18 8.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 145.94 65.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.373 2.049 . . . . 0.0 112.419 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.0 m -87.8 95.04 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 174.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.1 p -148.56 128.07 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -84.31 153.07 23.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -150.8 96.87 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.68 139.33 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 120.13 26.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -132.68 -48.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.82 -161.3 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.12 -53.87 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -71.04 124.26 23.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -80.68 137.62 36.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -114.83 95.14 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.6 p -112.33 113.54 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.86 100.93 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -98.57 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 39.0 m-85 -79.89 147.59 31.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.586 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -135.98 148.85 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.91 104.87 16.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.51 116.97 33.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -111.14 -30.27 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.0 -25.96 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 -43.45 3.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.58 -74.58 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.07 46.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.586 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.12 153.78 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.202 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.72 113.72 25.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 m -121.77 164.9 22.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.188 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.9 Cg_exo -54.98 159.75 9.01 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.586 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.95 160.37 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.782 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 86.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.433 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 m 62.59 130.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.216 0.531 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.829 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.76 170.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.331 -179.439 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.33 -40.85 1.86 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.331 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -179.04 144.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.79 0.329 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 62.52 74.29 0.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.829 ' HG3' HD13 ' A' ' 8' ' ' ILE . 8.6 tm0? -98.49 132.24 44.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -79.89 110.22 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.58 22.86 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.997 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.97 -31.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.56 30.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.99 -173.93 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.1 128.46 24.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.15 141.07 6.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.84 114.47 3.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.411 2.074 . . . . 0.0 112.428 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.9 t -93.03 82.79 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.818 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.03 -173.38 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.08 168.32 9.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.09 128.06 29.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -110.25 126.22 53.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.804 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.03 151.37 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.68 139.73 26.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -165.93 -54.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.68 -159.29 35.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.97 -55.22 17.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 t -120.48 138.97 53.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -149.85 123.77 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.58 161.21 20.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.55 144.63 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -100.56 133.86 44.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 178.97 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -152.61 129.08 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -124.84 144.61 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.194 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.16 119.8 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.87 111.75 24.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.52 26.21 8.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.48 54.65 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.57 -24.72 8.41 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.799 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -120.11 -78.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.69 58.37 0.57 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.413 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 47' ' ' CYS . 20.1 t -137.82 160.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.5 t -96.61 101.09 12.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -104.37 161.74 21.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 86.9 Cg_exo -46.75 144.67 7.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.672 2.248 . . . . 0.0 112.694 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.01 -167.66 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -166.02 102.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 m -57.65 140.53 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 111.177 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.51 165.35 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.228 -179.493 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -105.95 -76.77 1.06 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.8 p-80 -168.28 130.0 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.28 60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.04 157.02 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -79.83 116.45 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 m -79.89 -39.51 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.28 136.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 58.96 31.06 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.38 149.67 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -124.22 37.13 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.12 125.44 48.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 132.85 23.71 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.516 2.144 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.03 94.94 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.4 m -84.79 -178.21 6.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 175.94 5.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -154.86 169.0 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.433 ' HB ' HG12 ' A' ' 34' ' ' VAL . 9.8 t -140.38 141.0 35.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.44 145.32 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.7 110.79 10.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -150.26 98.26 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.26 -116.53 8.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.47 -31.15 8.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.5 m -67.4 86.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 144.08 31.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -160.0 138.03 10.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.6 m -102.84 163.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -159.13 160.33 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.9 ttpp -126.06 179.9 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 40.1 m-85 -129.32 150.49 50.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.013 0.435 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.884 HG23 ' CD1' ' A' ' 50' ' ' PHE . 3.2 pt -122.35 153.04 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.943 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.22 91.99 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.01 110.75 19.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -109.79 24.66 12.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.34 -50.97 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.59 -66.61 1.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.7 -47.2 0.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.07 78.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.42 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.29 154.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 104.55 16.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.84 157.74 36.85 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 62.5 Cg_endo -73.55 137.39 25.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.551 2.167 . . . . 0.0 112.64 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 38' ' ' ILE . 3.1 p90 -135.23 176.76 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.91 99.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.05 136.44 33.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.63 164.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.24 -68.18 0.66 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.394 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 22.1 p-80 -170.83 126.95 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.513 ' CD2' HG12 ' A' ' 48' ' ' VAL . 22.1 m-85 57.07 60.53 2.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -114.38 169.52 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.576 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -79.5 121.06 24.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 t -122.52 -59.4 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.431 ' HB ' ' CA ' ' A' ' 45' ' ' GLY . 3.5 t -63.16 -26.32 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.143 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.35 -35.29 12.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.39 50.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.82 126.35 29.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HG2' HD12 ' A' ' 8' ' ' ILE . 14.2 tttt -177.12 98.65 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.09 144.1 23.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.165 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -105.39 94.51 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.5 m -81.43 169.37 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -99.94 135.98 40.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -106.59 -179.51 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.502 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.5 t -152.37 121.52 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.98 123.37 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 60.19 161.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.79 158.71 26.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.31 -121.59 1.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.71 177.01 4.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.13 122.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -72.8 102.4 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -125.2 68.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -98.61 168.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.58 115.88 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.0 170.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.793 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 31.7 m-85 -154.0 129.56 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -127.55 156.06 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.9 m -90.39 111.82 23.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.32 -172.22 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 60.93 81.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -33.02 72.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.697 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.53 -63.41 4.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.333 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -58.19 3.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.513 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . . . 96.52 77.28 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.9 179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -135.67 151.61 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -102.59 114.51 28.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.458 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.513 HG12 ' CD2' ' A' ' 11' ' ' TYR . 8.8 m -111.79 162.43 21.18 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.312 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' CE1' ' A' ' 11' ' ' TYR . 52.0 Cg_exo -54.14 158.83 8.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.635 2.223 . . . . 0.0 112.454 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.603 ' CG ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -155.42 174.53 15.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t0 59.84 54.59 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.564 ' O ' HG22 ' A' ' 6' ' ' THR . 38.5 m . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.874 0.369 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 20' ' ' PRO . 23.9 p -166.09 140.03 4.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.402 0.62 . . . . 0.0 111.067 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.462 HG21 ' HB2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.84 160.72 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.602 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -69.14 -87.18 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.905 -0.665 . . . . 0.0 112.698 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 31.6 p-80 -157.98 138.38 12.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.774 0.321 . . . . 0.0 111.179 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.664 ' CD2' HG12 ' A' ' 48' ' ' VAL . 56.0 m-85 59.3 58.01 3.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.462 ' HB2' HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -121.15 171.27 8.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.643 179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -79.42 120.71 24.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.01 0.434 . . . . 0.0 111.188 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 t -101.75 21.52 14.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.961 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.572 ' O ' HG12 ' A' ' 15' ' ' VAL . 15.2 t -109.61 30.34 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 111.091 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -147.78 29.74 0.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -177.33 -170.22 0.27 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.909 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.21 -77.52 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -170.73 52.93 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.434 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 53.5 Cg_endo -68.77 114.28 3.48 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.642 2.228 . . . . 0.0 112.404 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.1 m -153.04 104.54 2.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.733 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.433 ' N ' ' HB2' ' A' ' 7' ' ' CYS . 7.2 m -67.14 -175.5 0.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.833 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -148.55 145.86 28.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt -115.7 104.53 11.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.871 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 ' HB ' HG13 ' A' ' 34' ' ' VAL . 1.8 t -109.11 93.83 4.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.5 m -78.35 168.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.193 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.69 177.37 8.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.982 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -174.02 -46.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.33 -107.57 0.27 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.522 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -69.04 -35.47 76.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.871 0.367 . . . . 0.0 110.936 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -96.68 141.98 29.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.975 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -142.55 132.81 24.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -123.75 123.59 40.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.907 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.568 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -111.9 116.98 54.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.053 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -93.91 125.04 38.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -108.58 167.36 10.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 14.4 m-85 -140.85 111.24 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.842 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.423 HG12 ' CG ' ' A' ' 50' ' ' PHE . 6.1 pt -103.24 166.97 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.216 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 6.9 m -103.5 107.39 18.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.56 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -94.15 135.15 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.03 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.4 -24.69 10.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -54.49 -35.95 63.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.053 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -113.06 0.6 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.506 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -109.92 26.04 11.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.74 0.305 . . . . 0.0 110.89 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.58 63.81 4.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 12' ' ' GLN . 33.1 m -139.64 155.36 25.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 111.319 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.414 ' O ' ' N ' ' A' ' 11' ' ' TYR . 49.0 t -90.1 121.26 32.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.209 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.664 HG12 ' CD2' ' A' ' 11' ' ' TYR . 26.2 m -125.29 166.51 20.29 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.216 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 45.5 Cg_exo -56.92 158.19 17.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.485 2.124 . . . . 0.0 112.347 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.423 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -176.44 5.67 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.93 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.62 164.71 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.022 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.515 179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 31.6 p . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.832 0.349 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -163.61 132.53 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.227 0.537 . . . . 0.0 111.036 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.67 167.69 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.194 -179.656 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.486 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.52 -99.05 2.55 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.56 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.43 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.2 p-80 -144.29 125.68 14.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD2' HG12 ' A' ' 48' ' ' VAL . 62.0 m-85 61.44 52.42 3.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.725 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.422 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.5 mm-40 -107.1 175.37 5.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.564 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HB2' ' HB2' ' A' ' 17' ' ' ALA . 1.6 mmtp -79.64 127.55 32.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.5 t -103.44 -29.04 11.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.9 -30.59 2.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.204 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -105.56 37.87 2.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 13' ' ' LYS . . . -166.81 172.3 10.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.098 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.08 -166.47 1.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.92 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt 64.21 132.87 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.902 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -74.54 -179.43 4.83 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.506 2.137 . . . . 0.0 112.384 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.0 m -97.61 119.18 35.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.88 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.14 -170.5 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -137.35 132.72 33.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.432 ' HD3' ' CE1' ' A' ' 37' ' ' PHE . 10.2 mptt -100.98 81.06 2.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -124.9 123.4 39.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 26' ' ' VAL . 14.3 p -95.93 41.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.212 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 mmt-85 55.91 -176.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.072 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.71 129.16 44.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -137.79 -74.28 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.515 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -135.45 -61.97 0.72 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 0.0 110.912 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.3 m -96.38 -175.48 3.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.881 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -102.07 102.76 13.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.91 30.04 7.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.4 m -81.85 141.56 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -141.86 115.09 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.847 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 106.96 16.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.432 ' CE1' ' HD3' ' A' ' 24' ' ' LYS . 37.4 m-85 -80.15 100.79 8.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.618 HG23 ' N ' ' A' ' 39' ' ' CYS . 0.2 OUTLIER -83.37 -174.6 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.976 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.618 ' N ' HG23 ' A' ' 38' ' ' ILE . 1.9 m -122.85 98.01 5.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.807 0.337 . . . . 0.0 110.866 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -85.04 122.35 29.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.2 -28.66 13.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.937 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.3 -40.8 82.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.71 -93.23 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.442 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -134.8 25.25 3.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.742 0.305 . . . . 0.0 111.009 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.37 61.02 7.94 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.6 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.8 m -136.3 157.52 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.298 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 11' ' ' TYR . 4.1 t -87.54 119.62 28.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.409 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.598 HG12 ' CD2' ' A' ' 11' ' ' TYR . 12.4 m -134.19 162.29 58.58 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.218 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 51.6 Cg_exo -54.48 153.36 23.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.56 2.173 . . . . 0.0 112.291 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -160.11 162.49 34.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.08 -177.47 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.806 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.436 179.927 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.12 136.41 58.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.161 0.505 . . . . 0.0 111.019 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.78 169.73 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.243 -179.414 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.518 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.9 -75.4 1.26 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.564 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 11.3 p-80 -167.75 129.61 1.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.012 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.726 ' CD2' HG12 ' A' ' 48' ' ' VAL . 84.1 m-85 61.4 68.2 0.73 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.984 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.423 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -131.8 168.84 17.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.873 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -79.72 125.71 30.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.064 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.1 p -136.28 31.71 2.89 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.823 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.0 t -87.34 -68.09 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.433 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -74.43 -35.1 63.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.195 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -86.47 174.58 8.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -170.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.751 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.462 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 11.7 ttpp -129.64 53.74 12.47 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.438 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.462 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.7 Cg_endo -87.46 102.08 0.51 Allowed 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.607 2.205 . . . . 0.0 111.995 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.3 m -130.15 96.84 4.28 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.888 0.375 . . . . 0.0 110.97 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 m -69.69 -178.48 1.49 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.945 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 36.2 t -109.86 162.89 14.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -133.02 122.69 24.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.489 ' HB ' HG12 ' A' ' 34' ' ' VAL . 3.0 t -97.14 120.17 37.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.916 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.8 t -108.33 127.4 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.043 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 mtp180 -126.27 120.71 30.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -134.45 -51.25 0.8 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.876 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.55 -56.08 0.87 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.491 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -143.94 -178.9 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 p -66.35 81.23 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.909 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -79.19 -179.3 6.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.922 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -81.44 -174.97 5.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 25' ' ' THR . 8.9 m -98.93 179.61 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.148 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.29 114.16 19.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.69 170.79 10.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.869 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.423 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 16.0 m-85 -149.6 103.13 3.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.865 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 50' ' ' PHE . 41.2 pt -98.81 163.02 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.233 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 37.7 t -100.81 108.63 20.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.829 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -96.09 126.95 41.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.991 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 23.45 10.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -99.16 37.4 1.55 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.959 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 176.52 -37.02 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.631 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -59.09 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.791 0.329 . . . . 0.0 111.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 115.78 54.68 0.36 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.39 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 27.7 m -130.59 159.84 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.866 0.365 . . . . 0.0 111.295 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 7.2 t -89.61 119.42 30.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.273 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.726 HG12 ' CD2' ' A' ' 11' ' ' TYR . 11.6 m -122.07 163.29 32.54 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.189 -179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.2 Cg_exo -54.54 155.61 16.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.59 2.193 . . . . 0.0 112.402 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.07 169.56 23.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.897 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.82 105.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.894 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.459 -179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 24.2 p . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.871 0.367 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m -145.0 130.56 18.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.085 0.469 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.47 164.09 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.181 -179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -108.05 -99.22 2.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.458 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 20.3 p-80 -140.07 125.9 19.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.781 0.324 . . . . 0.0 110.966 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' N ' ' O ' ' A' ' 47' ' ' CYS . 39.0 m-85 58.79 55.31 4.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.746 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.416 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -98.34 161.84 13.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.905 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.496 ' HA ' HG12 ' A' ' 46' ' ' VAL . 1.1 mptp? -79.84 113.35 17.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.7 -41.69 23.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.792 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -77.9 -53.91 13.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.093 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.45 -45.2 95.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.874 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -112.12 126.76 55.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -93.28 80.26 4.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 30.8 mtpt -132.16 134.56 25.22 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 19' ' ' LYS . 32.4 Cg_exo -57.98 142.63 96.75 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.422 2.081 . . . . 0.0 112.294 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.0 103.24 9.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.34 177.72 8.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.16 -174.1 3.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -160.01 140.33 11.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.015 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -139.24 134.79 33.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.862 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 11.2 p -83.71 116.18 27.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.112 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.409 ' HB3' ' NH1' ' A' ' 27' ' ' ARG . 17.5 mtm105 -133.14 82.94 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.4 ' CG ' ' O ' ' A' ' 28' ' ' TYR . 21.1 t80 -163.88 31.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.12 -162.93 36.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.06 -169.56 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.822 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.68 170.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 13.7 mttt -155.25 80.81 1.05 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 66.3 m-80 -119.31 118.51 31.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.84 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.9 m -104.24 153.09 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.142 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.59 147.77 44.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -145.17 115.72 7.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.794 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 19.2 m-85 -90.55 133.59 34.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.421 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.5 pt -111.41 169.33 4.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.076 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.0 t -104.96 97.05 6.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.784 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -83.64 104.29 13.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.958 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.83 23.36 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -99.82 -52.05 3.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.835 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.96 -86.92 0.12 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.563 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -111.28 -32.08 6.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.813 0.34 . . . . 0.0 110.975 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.31 69.29 0.69 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.452 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 13' ' ' LYS . 11.0 m -146.7 162.56 9.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.868 0.366 . . . . 0.0 111.294 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.8 OUTLIER -88.19 108.44 19.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.435 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.43 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 1.7 m -111.17 160.43 29.11 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.206 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.43 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 29.5 Cg_endo -63.61 160.53 35.75 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.559 2.173 . . . . 0.0 112.333 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.421 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -160.09 176.84 11.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.878 179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 58.61 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.955 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.567 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.796 0.331 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.67 124.16 23.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.087 0.47 . . . . 0.0 110.911 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.875 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.71 173.49 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.686 -179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.605 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -113.4 -32.23 2.2 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.999 -0.619 . . . . 0.0 112.056 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -179.03 140.29 0.16 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.744 0.307 . . . . 0.0 110.883 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 63.6 79.27 0.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.221 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.875 ' HG3' HD13 ' A' ' 8' ' ' ILE . 3.5 tt0 -107.08 140.0 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.692 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.7 mmtt -79.77 93.79 5.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.041 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.7 p -119.73 35.97 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.735 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -78.13 -34.39 18.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -106.43 -28.63 10.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.02 -178.06 4.92 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.51 87.07 2.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.801 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.11 156.44 60.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.975 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.44 110.21 0.46 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.603 2.202 . . . . 0.0 112.323 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.6 t -104.61 87.6 2.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.788 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -59.05 151.78 21.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.889 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 p -98.31 -170.78 2.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.3 mtpt -143.73 108.28 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.929 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.726 ' OG1' HG12 ' A' ' 34' ' ' VAL . 9.7 t -145.63 123.69 12.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.89 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' HG13 ' A' ' 26' ' ' VAL . 7.1 p -178.67 76.71 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.3 tpt85 -132.33 102.31 5.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.853 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -78.91 164.04 24.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.858 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.38 -159.57 14.93 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.484 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.22 -68.95 0.38 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.836 0.35 . . . . 0.0 110.88 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.5 m -71.59 139.33 49.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.07 105.53 12.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.79 96.37 10.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.966 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.726 HG12 ' OG1' ' A' ' 25' ' ' THR . 10.6 m -94.9 132.07 39.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.178 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -113.7 100.02 8.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.402 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 3.0 tptt -80.57 -167.95 1.55 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.418 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 12.2 m-85 -160.06 114.18 2.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.766 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.485 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.4 pt -113.01 156.63 13.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.281 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 49.2 t -89.81 98.29 11.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.504 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.92 117.42 20.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.982 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.77 24.72 12.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.968 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -104.31 -32.44 9.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.701 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -90.88 -76.32 1.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.4 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.04 27.77 1.95 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.92 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.51 60.62 8.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.647 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 47' ' ' CYS . 6.8 t -129.02 159.63 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.774 0.321 . . . . 0.0 111.161 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.444 ' N ' HG12 ' A' ' 46' ' ' VAL . 4.2 t -97.09 104.32 16.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.448 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.422 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.5 m -110.75 164.61 14.46 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.366 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 42.8 Cg_exo -56.99 163.05 8.14 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.618 2.212 . . . . 0.0 112.614 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.485 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.19 -178.63 7.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.936 179.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 59.96 104.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.971 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.422 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.84 0.352 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.5 m -149.02 130.67 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.196 0.522 . . . . 0.0 110.965 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.436 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.74 163.72 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.427 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -95.15 -88.5 1.73 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.466 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -157.13 127.74 6.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.354 . . . . 0.0 110.898 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' CD2' HG12 ' A' ' 48' ' ' VAL . 41.5 m-85 61.09 62.89 1.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -105.43 145.12 31.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.878 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.82 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -79.92 115.54 19.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.818 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.2 p -122.92 31.76 5.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.999 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.528 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -78.68 -56.11 8.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.072 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -98.03 -25.64 14.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -127.17 93.12 3.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.049 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -77.47 142.96 38.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.0 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.07 170.43 9.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.761 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.98 119.08 5.23 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.533 2.155 . . . . 0.0 112.457 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.0 m -99.07 82.24 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.862 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.2 m -60.05 -178.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.908 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.0 t -102.55 133.1 48.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.69 107.96 20.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.806 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.2 t -111.39 131.37 55.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.927 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.88 53.15 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.14 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.2 161.36 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -116.22 145.5 43.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.845 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.23 30.81 0.48 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.502 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.05 32.91 19.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.851 0.358 . . . . 0.0 110.929 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -172.76 36.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.788 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.48 -177.52 5.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.0 m-80 -146.71 179.36 7.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.935 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.2 p -102.06 158.72 4.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' N ' HG22 ' A' ' 34' ' ' VAL . 0.5 OUTLIER -125.44 107.91 11.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.019 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 11.9 tttt -87.51 166.5 14.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.766 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -138.42 109.45 6.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.901 0.382 . . . . 0.0 110.889 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.465 HG12 ' CG ' ' A' ' 50' ' ' PHE . 3.2 pt -102.87 153.1 5.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -90.83 93.57 9.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.643 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.52 125.45 29.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.977 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -120.02 23.71 10.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.965 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -97.12 39.5 1.18 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.957 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.14 -53.24 0.17 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.524 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -124.93 -63.9 1.13 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.528 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 118.29 61.39 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.4 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.82 HG12 ' HA ' ' A' ' 13' ' ' LYS . 18.4 m -138.99 167.16 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.359 . . . . 0.0 111.209 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.06 112.78 24.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.554 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 11' ' ' TYR . 35.1 m -120.12 162.19 34.81 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.211 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.2 Cg_exo -54.15 154.95 16.67 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.607 2.205 . . . . 0.0 112.461 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.465 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.03 168.47 25.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.006 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 t0 58.54 106.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.02 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.485 -179.934 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 22.9 p . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.886 0.375 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.16 129.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.201 0.524 . . . . 0.0 110.914 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.635 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.7 155.43 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.117 -179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -103.01 -72.04 0.9 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.466 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -171.38 137.88 1.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.896 0.379 . . . . 0.0 110.941 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.485 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.6 m-85 56.37 52.54 9.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.921 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' HG2' HD11 ' A' ' 8' ' ' ILE . 4.1 tp60 -86.88 153.37 21.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.847 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.661 ' HA ' HG12 ' A' ' 46' ' ' VAL . 4.0 tptt -79.94 117.95 21.25 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.93 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.99 -24.49 17.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.045 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.558 ' O ' HG12 ' A' ' 15' ' ' VAL . 29.8 t -90.2 49.66 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.073 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -178.66 -39.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.798 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.85 -177.65 3.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.033 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -147.42 41.95 1.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.635 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -78.72 147.72 71.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.856 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.21 125.69 11.05 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.51 2.14 . . . . 0.0 112.414 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.9 m -82.72 75.29 9.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.4 p -70.13 155.27 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.51 161.01 25.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 mttm -145.1 108.83 4.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.781 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.429 ' HB ' HG13 ' A' ' 34' ' ' VAL . 4.9 t -94.11 125.77 38.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 26' ' ' VAL . 10.2 m -75.79 126.86 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.149 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 6.5 ptt-85 -100.04 43.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -128.1 113.94 16.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 124.81 -168.41 16.93 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -80.22 -60.74 2.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.912 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 p -79.07 160.17 27.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.872 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 25.0 mttt -114.25 90.61 3.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.44 142.97 26.84 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.991 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.429 HG13 ' HB ' ' A' ' 25' ' ' THR . 19.2 t -105.35 140.62 22.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.065 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.81 121.69 45.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.066 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 6.3 ttpp -97.55 167.92 10.68 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.709 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.433 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 39.1 m-85 -139.76 123.97 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.512 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.4 pt -117.12 140.22 40.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.161 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.01 91.58 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.639 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -82.24 124.98 30.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.981 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.84 23.59 10.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -98.16 37.03 1.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.928 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.79 -69.91 0.11 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.625 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -101.95 -59.11 1.76 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.843 0.354 . . . . 0.0 110.983 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.87 59.04 0.51 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.527 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.661 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.6 m -142.47 166.79 15.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.123 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.54 105.96 18.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.504 179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.7 m -110.88 161.88 23.02 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.363 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 36' ' ' LYS . 52.6 Cg_exo -53.32 149.71 28.44 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.655 2.237 . . . . 0.0 112.486 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.512 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.09 -167.27 1.9 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.916 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -169.59 95.7 0.3 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.448 -179.969 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.82 0.343 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 62.84 120.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.196 0.522 . . . . 0.0 110.999 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.874 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.79 169.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.271 -179.558 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.523 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -110.07 -37.74 1.78 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.277 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 41.0 p-80 178.75 144.48 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.752 0.311 . . . . 0.0 110.874 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 62.09 68.34 0.69 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.236 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.874 ' HG3' HD13 ' A' ' 8' ' ' ILE . 5.7 tm0? -96.88 151.19 19.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.514 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.597 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.67 107.11 12.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.889 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.08 29.48 6.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 45' ' ' GLY . 20.4 t -111.06 -53.29 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.132 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -118.82 31.33 6.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.16 -173.13 4.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -159.23 32.04 0.2 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.976 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 mttt -66.05 148.19 98.49 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.34 133.21 22.25 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.522 2.148 . . . . 0.0 112.235 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -95.21 100.65 12.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.98 167.58 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.901 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.1 m -121.53 163.7 18.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.91 115.2 11.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.908 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.61 ' HA ' HG13 ' A' ' 34' ' ' VAL . 6.3 p -95.58 153.16 17.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 30' ' ' ASP . 22.3 t 60.9 108.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.094 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.7 -170.25 3.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 61.39 32.02 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.16 44.84 2.94 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.539 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.544 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.2 m-20 60.34 31.61 20.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -73.63 178.51 4.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.879 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -93.89 48.38 1.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -129.93 140.1 51.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.897 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 25' ' ' THR . 22.0 t -107.35 128.31 62.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.011 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -96.17 120.32 36.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.018 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 tptm -105.45 168.54 9.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.628 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -141.54 127.24 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.864 0.364 . . . . 0.0 111.009 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.557 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.7 pp -127.37 160.01 37.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.01 103.51 10.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.807 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 48' ' ' VAL . 1.2 t70 -89.98 101.23 13.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.984 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.404 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -115.47 81.56 1.61 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -149.35 -47.13 0.14 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.923 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -116.59 -31.85 1.72 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.564 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -115.53 -65.79 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.969 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.54 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 109.7 43.51 1.13 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.457 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 13' ' ' LYS . 5.5 m -143.17 173.67 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 0.0 111.346 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' CB ' ' HB3' ' A' ' 12' ' ' GLN . 8.0 t -90.42 105.55 17.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.419 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 40' ' ' ASP . 3.5 m -112.26 162.88 19.39 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.237 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 75.9 Cg_exo -50.5 154.22 6.58 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.637 2.225 . . . . 0.0 112.534 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.53 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.06 -168.12 2.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.811 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -145.38 30.87 1.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.821 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.49 179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.795 0.331 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.77 134.21 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.184 0.516 . . . . 0.0 111.038 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.456 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.74 166.14 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.15 -179.584 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.456 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.71 -83.89 1.6 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.551 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 27.2 p-80 -156.18 132.94 10.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 59.48 66.42 1.02 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.915 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' CB ' HG12 ' A' ' 8' ' ' ILE . 1.8 tm0? -117.83 142.16 47.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 46' ' ' VAL . 2.7 mttp -79.97 122.71 27.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.113 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.9 m -85.27 -36.92 20.58 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.791 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.47 -44.02 88.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -75.82 -31.08 59.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.853 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.7 ' HB1' ' HE3' ' A' ' 19' ' ' LYS . . . -152.98 100.78 2.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.44 105.72 8.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.7 ' HE3' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -138.85 157.64 71.35 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.72 136.16 44.64 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.612 2.208 . . . . 0.0 112.195 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 56.4 m -90.28 127.46 36.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.964 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.85 172.07 8.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.846 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.64 146.6 28.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.92 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.89 117.21 32.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.918 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.2 t -137.97 128.32 26.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.91 127.63 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.027 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -69.3 158.48 34.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.836 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.72 122.44 14.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.26 -79.57 0.15 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.55 -56.16 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.73 175.93 8.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.96 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -149.48 65.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.774 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -126.61 137.61 53.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.3 t -129.22 139.57 51.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.018 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 163.06 40.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -103.87 177.71 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.677 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 27.7 m-85 -148.23 105.77 3.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.703 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -105.87 154.49 7.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 -179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 53.2 t -94.92 107.52 19.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.813 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -101.04 135.42 42.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.943 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.8 ttt-85 -104.55 23.82 12.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.085 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.72 -58.26 3.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.35 -47.71 12.24 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.528 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.27 -47.26 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.82 0.343 . . . . 0.0 110.94 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.33 72.9 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 13' ' ' LYS . 28.5 m -140.32 165.34 21.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 111.236 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 39' ' ' CYS . 3.8 t -94.03 113.72 25.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.559 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.414 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 28.5 m -118.92 162.01 33.44 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.188 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.414 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 53.9 Cg_exo -52.62 140.64 55.15 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.626 2.217 . . . . 0.0 112.545 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.493 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.12 -172.33 3.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.965 179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -161.55 138.29 8.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.471 179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.569 ' O ' HG23 ' A' ' 6' ' ' THR . 8.7 t . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.831 0.348 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.51 131.29 50.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.167 0.508 . . . . 0.0 110.848 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.409 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.59 156.68 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.129 -179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -101.96 -70.38 0.87 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.61 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 31.2 p-80 -173.01 133.02 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.854 0.359 . . . . 0.0 110.974 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 59.08 57.01 3.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.821 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 8' ' ' ILE . 1.9 tp-100 -95.85 157.06 16.07 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.888 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.509 ' HA ' HG12 ' A' ' 46' ' ' VAL . 5.4 mttt -79.87 113.35 17.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.34 -20.1 11.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.316 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.4 p -65.38 -32.6 58.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.259 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -107.59 -28.36 9.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.056 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.36 170.19 9.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.207 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -139.15 99.25 3.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.858 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -125.33 155.51 71.42 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 6' ' ' THR . 50.5 Cg_endo -69.19 123.04 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.594 2.196 . . . . 0.0 112.316 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.409 ' SG ' HD13 ' A' ' 8' ' ' ILE . 54.5 m -97.9 73.36 2.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.8 p -59.8 169.87 1.3 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.36 165.16 15.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.764 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mttt -130.31 105.51 7.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.515 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.9 t -84.8 93.9 8.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.985 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 26' ' ' VAL . 7.9 m -86.81 101.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.089 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -75.14 -176.03 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 60.54 93.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.902 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 173.04 -46.37 0.16 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.489 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -158.16 -53.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.777 0.322 . . . . 0.0 110.971 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.22 -65.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.965 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -143.56 132.85 23.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.39 107.17 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.903 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.515 HG12 ' HB ' ' A' ' 25' ' ' THR . 5.4 m -109.75 122.0 63.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.111 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -90.71 138.63 31.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 tttp -117.96 109.98 17.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.929 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.449 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 52.9 m-85 -84.37 129.17 34.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.93 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.51 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -119.79 142.99 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.131 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 18.5 m -75.88 95.22 3.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.695 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -79.91 119.23 22.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.086 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.95 -33.83 6.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.5 p30 -78.26 64.09 3.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.888 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 167.24 -53.73 0.24 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.442 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -135.1 -71.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.835 0.35 . . . . 0.0 110.844 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.85 42.7 0.18 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.578 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.9 m -144.12 166.42 12.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 3.8 t -93.57 117.11 29.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.808 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.417 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -125.11 163.28 38.79 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.143 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 50.9 Cg_exo -54.15 156.57 12.88 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.601 2.201 . . . . 0.0 112.382 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.51 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.1 165.36 31.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.96 107.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.458 -179.972 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.797 0.332 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -117.97 130.25 56.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.217 0.532 . . . . 0.0 111.03 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.486 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.81 167.01 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.254 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -102.24 -86.88 1.97 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.45 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 15.6 p-80 -158.14 132.4 8.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.862 0.363 . . . . 0.0 110.971 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CD2' HG12 ' A' ' 48' ' ' VAL . 70.7 m-85 59.45 55.89 3.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.78 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.45 ' HB2' HG12 ' A' ' 8' ' ' ILE . 2.9 mm-40 -110.03 166.84 10.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.2 mttm -79.93 128.77 33.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 9.0 t -110.7 -30.83 7.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.01 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -63.64 -60.34 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.17 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -72.61 -38.79 67.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.93 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.54 128.21 54.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.124 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -97.75 38.53 1.28 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' HD12 ' A' ' 8' ' ' ILE . 10.9 mttp -78.23 127.36 81.45 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.52 148.67 42.44 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.415 2.077 . . . . 0.0 112.144 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 89.4 m -103.43 105.44 15.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.73 -178.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.964 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.66 137.48 28.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.708 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mmtp -117.51 -178.87 3.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.4 t -144.73 84.42 1.73 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.846 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.11 159.69 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.21 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 60.98 156.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -177.01 102.02 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -167.8 -94.53 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.413 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -97.62 -33.69 11.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.854 0.359 . . . . 0.0 110.913 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 m -101.95 172.28 7.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.899 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.04 128.56 49.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.792 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -139.46 136.14 34.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.888 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 35' ' ' ARG . 11.3 p -122.9 154.92 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.082 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 6.6 tpt180 -123.12 106.13 10.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.906 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HD2' ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -117.28 119.88 36.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.951 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 67.8 m-85 -88.77 115.0 25.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.453 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.0 pt -103.65 148.14 8.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.125 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.1 m -79.41 93.25 5.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.617 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.0 112.33 17.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.969 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.412 HH11 ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -91.56 -31.53 15.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 -179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -67.83 -30.55 69.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.798 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.43 -79.89 0.63 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.53 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -148.29 27.16 0.94 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.796 0.332 . . . . 0.0 111.128 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.49 47.05 86.54 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.664 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 17.0 m -137.63 159.28 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.826 0.346 . . . . 0.0 111.147 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.03 114.49 27.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.607 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.669 HG12 ' CD2' ' A' ' 11' ' ' TYR . 5.2 m -122.03 161.81 40.61 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.067 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 37' ' ' PHE . 57.3 Cg_exo -52.25 155.23 9.6 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.574 2.183 . . . . 0.0 112.542 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.13 -174.11 4.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -162.38 29.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.972 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.504 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.8 t . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -95.13 132.68 39.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.163 0.506 . . . . 0.0 110.914 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.495 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.71 168.17 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.211 -179.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.495 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.87 -79.92 1.02 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.613 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 33.5 p-80 -161.77 131.68 4.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.949 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' CD2' HG12 ' A' ' 48' ' ' VAL . 60.4 m-85 60.67 65.52 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.823 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -122.08 142.08 50.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.455 ' HA ' HG12 ' A' ' 46' ' ' VAL . 17.9 pttp -79.7 116.3 19.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.904 0.383 . . . . 0.0 110.844 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.1 p -111.94 24.23 12.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.182 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 45' ' ' GLY . 26.1 t -76.77 -56.61 7.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.048 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.19 30.99 3.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.851 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -161.96 115.64 1.85 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.144 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.76 100.8 12.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -141.81 142.61 25.91 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.818 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 144.21 32.25 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.583 2.189 . . . . 0.0 112.405 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 87.4 m -92.82 102.21 14.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.4 154.13 36.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.926 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.0 m -108.93 158.99 17.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.796 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.1 mtmm -138.15 109.35 6.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.948 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.642 HG22 HG23 ' A' ' 34' ' ' VAL . 42.9 p -84.38 116.25 22.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 65.16 126.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.046 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -92.81 47.92 1.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 61.12 156.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.79 -127.61 8.06 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.517 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -61.21 144.65 53.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.853 0.358 . . . . 0.0 110.974 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.2 t -69.52 142.58 53.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.92 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -154.82 -178.36 7.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.0 p30 -80.21 -176.8 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.642 HG23 HG22 ' A' ' 25' ' ' THR . 11.1 p -79.91 154.86 4.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.01 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' N ' HG22 ' A' ' 34' ' ' VAL . 4.4 tpm_? -117.48 92.92 3.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.107 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 1.2 tptm -79.97 166.47 21.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.659 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 38.1 m-85 -143.03 106.06 4.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.942 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.442 HG12 ' CG ' ' A' ' 50' ' ' PHE . 4.3 pt -100.53 146.45 9.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.079 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -83.25 100.82 10.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -86.63 117.75 25.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.017 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.4 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -119.6 24.48 10.6 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 179.939 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -79.26 -26.76 42.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -121.53 -60.19 0.22 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.647 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.471 ' OE1' HG13 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -113.05 -69.37 0.87 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 111.062 -179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 135.07 58.34 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.547 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG13 ' OE1' ' A' ' 44' ' ' GLU . 33.5 m -132.67 157.72 43.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.815 0.34 . . . . 0.0 111.231 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.3 118.17 29.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.454 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 16.8 m -120.09 161.84 36.54 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.257 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 70.5 Cg_exo -51.54 149.98 17.04 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.624 2.216 . . . . 0.0 112.438 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.442 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.4 OUTLIER -160.04 -168.95 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.97 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -154.66 148.91 26.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.464 -179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.811 0.339 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.87 133.91 56.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.255 0.55 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.475 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.65 167.32 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.138 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.475 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.81 -95.36 1.95 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.527 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 39.7 p-80 -147.39 126.74 13.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.809 0.338 . . . . 0.0 110.982 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.502 ' CD2' HG12 ' A' ' 48' ' ' VAL . 76.4 m-85 61.79 59.68 1.72 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.428 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.4 OUTLIER -123.19 176.97 5.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.843 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 132.74 36.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.973 0.416 . . . . 0.0 110.937 -179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.5 t -115.15 -7.69 12.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.414 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.505 ' O ' HG12 ' A' ' 15' ' ' VAL . 21.6 t -89.82 50.62 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.875 0.369 . . . . 0.0 111.22 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -176.97 36.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.27 -165.38 0.46 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.067 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -96.58 34.61 1.62 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' N ' ' HD3' ' A' ' 20' ' ' PRO . 44.3 pttt 44.32 51.24 7.92 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.768 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' A' ' 19' ' ' LYS . 66.8 Cg_endo -86.64 102.53 0.6 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.535 2.157 . . . . 0.0 112.135 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 90.9 m -126.36 105.35 8.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.8 m -73.03 177.16 5.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.5 m -115.49 129.19 56.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.822 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.64 93.35 7.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.727 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.6 t -113.8 115.13 27.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.902 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -70.38 152.58 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.16 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.9 ttt-85 -64.65 177.36 0.93 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.936 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -60.84 129.35 41.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -158.22 -142.79 3.49 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.454 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -73.2 -67.31 0.59 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.824 0.345 . . . . 0.0 110.913 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.7 p -99.9 146.23 26.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -106.66 109.5 21.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.4 m-20 -141.81 133.68 27.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.727 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.5 t -123.35 122.47 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.027 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 -98.58 108.91 21.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.984 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 -176.66 5.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.798 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' A' ' 10' ' ' HIS . 22.4 m-85 -158.35 126.82 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.796 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 HD12 ' C ' ' A' ' 38' ' ' ILE . 2.8 pp -129.41 167.39 24.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.208 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 66.9 m -94.42 126.31 39.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.61 118.61 30.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.97 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 41' ' ' ARG . 2.8 ttm105 -116.57 24.11 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.073 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -77.44 -30.36 53.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.78 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -112.95 -49.0 0.59 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.49 -67.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.792 0.33 . . . . 0.0 110.984 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.93 62.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.438 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.41 155.23 40.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.847 0.356 . . . . 0.0 111.229 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' A' ' 11' ' ' TYR . 48.6 t -85.45 115.93 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.228 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.502 HG12 ' CD2' ' A' ' 11' ' ' TYR . 27.4 m -119.92 163.76 26.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.9 Cg_exo -53.38 154.6 14.52 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.554 2.17 . . . . 0.0 112.363 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.49 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.49 2.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.018 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -136.93 -46.9 0.59 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.873 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.991 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.502 HG23 ' HG2' ' A' ' 20' ' ' PRO . 20.6 m . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.965 0.412 . . . . 0.0 111.209 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -170.09 126.26 0.81 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.187 0.518 . . . . 0.0 110.994 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.745 HD13 ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -79.64 166.71 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.228 -179.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.482 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.37 -68.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.518 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 53.9 p-80 -173.86 120.4 0.29 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.815 0.34 . . . . 0.0 110.94 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.9 m-85 62.02 62.19 1.26 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -108.19 166.69 10.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.817 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -79.82 122.04 26.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.935 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.34 -28.96 10.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.48 103.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.155 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 61.08 61.78 1.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.889 ' HB1' ' HE2' ' A' ' 19' ' ' LYS . . . -149.16 137.61 20.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.042 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.14 57.18 2.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.862 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.889 ' HE2' ' HB1' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -121.33 95.18 48.57 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.916 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' HG23 ' A' ' 6' ' ' THR . 52.7 Cg_exo -54.77 152.04 29.93 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.511 2.141 . . . . 0.0 112.331 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.745 ' SG ' HD13 ' A' ' 8' ' ' ILE . 57.8 m -114.3 104.91 12.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.3 p -102.3 -176.5 3.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 36' ' ' LYS . 21.0 p -107.19 165.74 11.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.16 -179.29 5.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.946 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 t -127.26 148.94 50.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.914 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -114.02 126.22 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.133 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 61.14 170.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -157.95 98.25 1.6 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.94 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.02 -84.07 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.489 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.23 -57.24 3.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.876 0.37 . . . . 0.0 110.841 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.2 p -96.66 122.63 39.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.42 115.83 21.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -155.73 133.24 11.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.9 m -94.75 152.48 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.18 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -116.59 138.32 51.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' SER . 0.0 OUTLIER -99.5 169.9 8.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.413 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 20.0 m-85 -150.43 107.77 3.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.807 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.708 HD13 ' CD2' ' A' ' 50' ' ' PHE . 43.3 pt -99.72 160.92 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.193 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.1 m -98.99 97.2 8.38 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.851 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 111.72 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.944 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.01 -27.31 11.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.989 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -88.57 52.91 2.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.869 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.58 -45.7 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.475 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.25 -52.99 0.24 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 0.0 110.885 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.05 44.75 0.99 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.624 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 m -146.08 158.28 11.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.911 0.386 . . . . 0.0 111.232 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -86.52 116.78 24.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.366 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.411 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -121.65 164.17 26.46 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.302 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 37' ' ' PHE . 45.6 Cg_exo -56.07 148.37 59.16 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.523 2.149 . . . . 0.0 112.34 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.708 ' CD2' HD13 ' A' ' 38' ' ' ILE . 0.5 OUTLIER -160.18 -169.38 2.47 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.923 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -148.94 94.44 2.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.469 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.698 0.285 . . . . 0.0 111.278 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -57.38 130.54 46.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.201 0.525 . . . . 0.0 111.027 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.653 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.6 166.65 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.208 -179.609 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.473 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.26 -75.11 0.95 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.535 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -169.86 134.44 1.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 0.0 110.994 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.451 ' CD2' HG12 ' A' ' 48' ' ' VAL . 26.8 m-85 59.22 53.27 5.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.012 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 6.9 tp60 -96.9 160.55 14.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.521 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 46' ' ' VAL . 11.2 mttt -79.7 114.15 18.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 111.032 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.16 -47.98 8.06 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.799 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 11.1 p -60.18 129.71 23.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.029 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.1 t30 60.84 29.93 19.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.15 86.16 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.079 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.87 146.23 33.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HB3' HD12 ' A' ' 8' ' ' ILE . 2.9 mttt -173.52 148.3 1.49 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.809 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.34 120.95 7.33 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.556 2.17 . . . . 0.0 112.374 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 73.7 m -81.3 100.6 9.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.885 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.08 165.11 1.4 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.054 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.8 p -125.04 161.55 26.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.977 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.9 mmtt -131.23 108.03 9.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.656 ' HB ' HG23 ' A' ' 34' ' ' VAL . 9.0 t -137.28 162.54 33.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t 63.64 92.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.188 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -89.55 167.59 12.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -85.69 -64.45 1.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.89 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -83.05 101.89 2.35 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.535 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.4 85.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 p -104.79 137.21 42.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -174.37 36.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -160.06 171.64 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.887 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.656 HG23 ' HB ' ' A' ' 25' ' ' THR . 10.6 p -136.62 145.11 30.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.126 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -120.48 121.06 37.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.9 tttp -111.58 165.88 11.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.936 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.402 ' CE1' ' HG3' ' A' ' 49' ' ' PRO . 12.8 m-85 -135.37 121.94 20.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.75 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.1 pt -112.69 155.97 13.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.214 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.13 100.51 10.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.616 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -93.95 139.56 30.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 10.1 mtp180 -129.94 24.02 5.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.03 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -73.52 -59.47 2.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.909 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -86.67 -97.72 0.82 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.429 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -79.94 -56.51 4.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 119.9 84.81 0.88 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.58 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 13' ' ' LYS . 16.8 m -150.64 161.74 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.909 0.385 . . . . 0.0 111.346 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.0 t -94.19 107.12 19.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.434 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.451 HG12 ' CD2' ' A' ' 11' ' ' TYR . 23.4 m -113.56 162.98 19.73 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.449 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 41.2 Cg_exo -57.38 160.35 13.92 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.685 2.257 . . . . 0.0 112.368 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.496 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.22 -170.36 2.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.003 179.764 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -156.61 -45.86 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.828 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 179.995 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 120.75 0.309 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.59 133.39 55.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.211 0.529 . . . . 0.0 111.106 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.68 167.04 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.156 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -104.09 -93.39 2.28 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.581 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -149.28 126.98 11.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.816 0.341 . . . . 0.0 110.955 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CD2' HG12 ' A' ' 48' ' ' VAL . 21.2 m-85 61.28 61.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.409 ' HB3' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -111.71 148.72 32.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.709 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -79.74 105.5 11.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.876 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.1 p -97.76 23.49 7.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.091 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 45' ' ' GLY . 21.2 t -102.89 -47.88 10.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.105 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -66.48 -32.1 73.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.32 -175.05 3.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -127.2 85.31 2.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.954 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.413 ' CB ' HD12 ' A' ' 8' ' ' ILE . 30.8 mttt -115.76 139.9 25.44 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.897 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.6 143.87 31.07 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.522 2.148 . . . . 0.0 112.274 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 81.5 m -96.74 105.06 17.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.819 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -179.8 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -137.85 173.19 11.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.919 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.7 mmtt -145.29 106.13 4.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.904 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.405 ' HB ' HG23 ' A' ' 34' ' ' VAL . 1.7 t -132.82 123.4 26.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -70.94 174.78 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 36.7 ptt85 -166.56 156.93 12.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 63.42 140.78 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.929 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.74 3.17 71.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.898 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 59.16 104.53 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.746 0.308 . . . . 0.0 110.932 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 t -171.84 122.91 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.17 88.58 6.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -143.58 118.49 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 ' HB ' ' A' ' 25' ' ' THR . 11.0 p -142.16 137.72 29.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.079 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 6.3 tpp180 -123.77 126.72 46.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.47 158.9 21.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.673 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -130.84 113.76 14.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.86 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.588 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.5 pp -114.85 153.86 16.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.183 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 5.7 m -87.18 111.23 20.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -89.59 107.39 19.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -100.91 24.63 9.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -91.08 50.53 1.79 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.856 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 150.25 -33.46 1.02 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.507 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -147.98 -70.33 0.22 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.776 0.322 . . . . 0.0 110.949 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.573 ' O ' HG23 ' A' ' 15' ' ' VAL . . . 128.37 59.24 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.523 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 35.3 m -116.37 155.41 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.807 0.337 . . . . 0.0 111.181 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 11' ' ' TYR . 1.8 t -88.95 114.36 25.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.51 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.632 HG12 ' CD2' ' A' ' 11' ' ' TYR . 28.5 m -123.91 163.58 34.48 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.17 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.1 Cg_exo -53.91 153.26 20.68 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.55 2.167 . . . . 0.0 112.428 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.543 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.0 172.85 16.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 59.57 108.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.953 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.501 -179.955 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.773 0.321 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -163.48 133.25 4.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.239 0.543 . . . . 0.0 111.09 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.43 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.62 163.99 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.109 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.416 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.52 -87.9 1.96 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.549 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 4.2 p-80 -152.57 129.09 10.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 0.0 110.962 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 61.38 66.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.869 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.8 139.4 42.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.823 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 8.6 mttp -79.82 105.77 11.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.9 p -112.95 29.06 8.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.425 HG22 ' HA3' ' A' ' 45' ' ' GLY . 21.4 t -62.77 -63.83 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.087 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -102.8 31.07 4.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -159.68 130.24 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.107 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -102.37 114.06 27.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.3 OUTLIER -135.1 150.77 73.88 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.842 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.01 119.7 6.58 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.577 2.185 . . . . 0.0 112.308 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.1 m -80.1 96.41 6.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.33 155.55 14.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.5 m -101.99 165.26 11.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.61 92.7 2.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.511 HG22 ' HB ' ' A' ' 34' ' ' VAL . 43.6 p -104.41 146.74 28.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.913 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.09 132.16 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.25 87.08 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -119.55 158.89 25.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -94.18 -46.13 3.14 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.508 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -99.52 157.53 16.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.799 0.333 . . . . 0.0 110.933 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.8 m 60.33 177.46 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.942 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -137.16 95.02 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.839 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -114.92 74.37 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 25' ' ' THR . 16.7 m -96.21 135.06 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.12 113.72 27.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.77 -170.52 2.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.815 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 19.7 m-85 -160.05 123.1 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.952 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.517 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -130.55 157.92 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.04 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.84 100.99 12.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.81 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -91.61 133.14 35.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.04 23.96 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.01 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.55 -41.01 12.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.03 -67.36 1.45 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.467 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.535 ' HG3' HG23 ' A' ' 46' ' ' VAL . 0.8 OUTLIER -160.01 33.77 0.18 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.848 0.356 . . . . 0.0 110.831 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 15' ' ' VAL . . . 59.05 64.1 4.59 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.563 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG23 ' HG3' ' A' ' 44' ' ' GLU . 16.2 t -130.05 154.48 40.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -93.66 102.05 14.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.576 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.0 m -108.35 160.91 25.33 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -49.08 159.59 0.98 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.631 2.221 . . . . 0.0 112.454 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.02 -173.92 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.96 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -154.74 -63.73 0.13 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.916 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.428 -179.969 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.781 0.324 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m 63.59 131.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.278 0.561 . . . . 0.0 110.929 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.659 HD12 ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 164.45 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.211 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -111.17 -98.0 2.43 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.511 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.437 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 16.6 p-80 -140.32 126.0 19.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 111.005 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CD2' HG12 ' A' ' 48' ' ' VAL . 39.4 m-85 58.39 51.96 7.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 ' CB ' HG12 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -92.88 156.56 16.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.727 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.619 ' HA ' HG12 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -79.93 122.5 26.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.995 -179.913 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 m -82.44 -53.49 5.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.783 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.2 t -59.1 135.63 23.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.141 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.3 m120 60.17 31.83 20.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -155.91 91.96 1.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -76.72 84.14 3.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.659 ' HB3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -141.92 116.92 6.87 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.43 146.66 82.23 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.393 2.062 . . . . 0.0 112.228 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 19.5 m -80.07 102.08 9.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.85 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -72.14 170.91 12.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.0 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.7 m -127.24 136.09 51.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.807 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 16.9 mttt -111.26 168.1 9.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.99 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.1 t -143.32 176.8 8.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.897 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.836 HG22 ' HG2' ' A' ' 27' ' ' ARG . 14.1 p -151.15 140.05 14.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.836 ' HG2' HG22 ' A' ' 26' ' ' VAL . 1.0 OUTLIER 65.26 168.73 0.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -84.28 165.78 18.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.17 120.35 0.24 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.507 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.04 121.62 44.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.786 0.327 . . . . 0.0 110.869 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.4 m -156.39 -50.96 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.98 35.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.858 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -124.47 31.29 5.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.91 171.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.084 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.85 110.33 12.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.4 tttt -99.86 106.05 17.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.954 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.437 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 44.5 m-85 -81.64 137.26 35.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.014 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.588 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.8 pp -131.0 153.85 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.128 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.1 t -88.45 127.17 35.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.94 119.67 34.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.47 24.37 11.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.42 50.18 1.7 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.948 0.404 . . . . 0.0 110.867 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 162.69 -65.78 0.25 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -127.31 -45.25 1.53 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.783 0.325 . . . . 0.0 110.89 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.92 73.36 0.74 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 13' ' ' LYS . 29.0 m -138.63 160.14 30.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.857 0.36 . . . . 0.0 111.274 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 6.3 t -95.06 112.21 23.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.569 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.628 HG12 ' CD2' ' A' ' 11' ' ' TYR . 4.3 m -116.3 164.89 16.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 51.0 Cg_exo -54.18 146.93 47.01 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.43 2.086 . . . . 0.0 112.267 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.588 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.07 -169.83 2.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.988 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -156.71 172.73 18.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.807 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.508 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 p . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.876 0.369 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 27.8 p -166.13 146.4 6.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.374 0.607 . . . . 0.0 111.069 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.575 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.77 172.33 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.501 -179.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.538 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -87.23 -99.58 0.85 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.673 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 20.0 p-80 -147.1 129.01 15.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 0.0 111.058 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' CYS . 74.7 m-85 61.12 59.97 1.88 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.754 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.425 ' CB ' HG12 ' A' ' 8' ' ' ILE . 4.3 mm-40 -116.42 171.74 7.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.846 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -79.55 114.78 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 50.5 t -116.06 -12.82 11.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.363 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.7 p -78.44 -33.03 16.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.793 0.33 . . . . 0.0 111.221 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -98.28 29.67 3.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.014 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -178.55 148.79 0.46 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.166 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -97.26 37.26 1.35 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.816 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.575 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -77.42 126.66 84.5 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.826 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.33 154.0 75.89 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.417 2.078 . . . . 0.0 112.228 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.25 175.26 6.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.879 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -113.77 -165.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.146 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.4 m -159.68 114.95 2.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.728 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.24 86.98 7.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.02 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.525 HG22 HG23 ' A' ' 34' ' ' VAL . 67.0 p -110.51 88.55 2.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.884 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.8 124.08 45.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.154 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.85 165.43 24.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -175.33 -49.95 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 133.2 85.75 0.27 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.541 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.8 t0 60.82 40.32 16.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.814 0.34 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -112.18 170.21 8.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.84 41.65 1.11 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -97.9 36.81 1.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.588 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.2 p -118.03 110.01 29.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.084 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.3 tpp180 -123.19 134.77 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.751 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 tttt -120.75 109.35 15.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.069 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.452 ' CZ ' ' HG3' ' A' ' 49' ' ' PRO . 9.2 m-85 -81.81 138.11 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.56 HG12 ' CG ' ' A' ' 50' ' ' PHE . 1.2 pp -134.36 178.25 5.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.369 . . . . 0.0 111.483 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -103.42 120.66 41.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.697 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -103.98 93.47 4.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.5 23.81 9.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.76 -51.5 2.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -67.59 -67.67 1.91 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.444 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -127.3 -46.43 1.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 0.0 110.857 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 123.72 52.76 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.588 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 13.7 m -143.27 156.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.941 0.401 . . . . 0.0 111.429 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' O ' ' N ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -83.27 117.29 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.114 179.376 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 26.9 m -128.93 165.73 29.92 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.246 -179.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 32.2 Cg_exo -58.36 165.89 6.8 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.566 2.177 . . . . 0.0 112.527 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.56 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -160.08 166.44 29.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.871 179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.57 90.08 0.05 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.466 179.965 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.769 0.319 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.86 127.38 35.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.184 0.516 . . . . 0.0 110.999 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.484 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.76 166.67 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 CA-C-N 115.395 -0.82 . . . . 0.0 111.171 -179.583 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.484 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -97.86 -78.93 1.43 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.516 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.463 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 21.9 p-80 -166.79 133.62 2.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.954 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.456 ' CE2' HG12 ' A' ' 48' ' ' VAL . 24.1 m-85 58.18 61.85 2.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.694 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' CB ' HG12 ' A' ' 8' ' ' ILE . 23.3 tp60 -105.82 159.25 16.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.72 115.71 19.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.833 0.349 . . . . 0.0 110.882 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -84.24 -29.98 26.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.5 t -70.01 -38.44 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.151 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -87.98 -37.17 16.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.933 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -125.53 117.75 24.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.164 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -106.29 74.0 1.01 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.798 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -121.19 158.39 53.11 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.15 134.35 63.25 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.634 2.223 . . . . 0.0 112.336 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.9 m -96.07 101.87 13.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.703 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -57.81 172.32 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.043 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.7 t -110.24 163.66 13.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.35 114.68 19.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' HG13 ' A' ' 34' ' ' VAL . 10.2 t -118.13 147.05 43.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.867 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG21 ' HB3' ' A' ' 32' ' ' LYS . 21.5 t -81.01 154.59 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 26' ' ' VAL . 2.1 mtt-85 -97.47 38.09 1.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 16.0 m-85 -136.3 164.74 27.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.887 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.83 -94.96 0.19 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.442 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 -71.56 -29.68 65.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.031 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.28 109.05 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.026 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.414 ' HB3' HG21 ' A' ' 26' ' ' VAL . 9.7 mttt 60.23 175.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -129.95 -177.84 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.594 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.6 t -80.13 144.65 10.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.151 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -132.92 130.14 39.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.824 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.456 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 0.3 OUTLIER -99.47 -165.57 1.24 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.4 m-85 -142.86 142.42 31.78 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.061 0.457 . . . . 0.0 111.645 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 50' ' ' PHE . 5.1 pt -120.79 152.02 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.873 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.04 97.14 6.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.727 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.46 116.1 27.38 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HA ' ' HA2' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -106.03 -31.3 8.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.849 -179.942 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -71.95 -30.23 65.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -78.68 -98.88 0.23 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.501 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.66 -33.97 10.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.824 0.345 . . . . 0.0 110.924 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 41' ' ' ARG . . . 104.09 47.44 1.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.461 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -143.54 154.46 16.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 0.0 111.28 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 t -96.97 106.51 18.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.57 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.456 HG12 ' CE2' ' A' ' 11' ' ' TYR . 2.2 m -114.52 161.26 29.58 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.961 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 60.1 Cg_endo -73.06 151.37 49.81 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.319 2.013 . . . . 0.0 112.633 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.948 ' CD1' HG23 ' A' ' 38' ' ' ILE . 1.6 p90 -149.35 170.48 18.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.907 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 -54.99 3.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' HA2' ' CE2' ' A' ' 50' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 13.4 p . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.786 0.327 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.47 128.33 56.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.096 0.474 . . . . 0.0 111.006 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.894 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.58 170.45 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.367 -179.54 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.533 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -118.01 -35.04 1.07 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.507 179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.428 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -177.36 142.05 0.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 111.035 179.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 61.08 71.49 0.56 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.964 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.894 ' HG3' HD13 ' A' ' 8' ' ' ILE . 9.0 tm0? -102.3 141.51 35.02 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.802 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.474 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 0.1 OUTLIER -79.88 108.74 13.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.843 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.75 -28.65 24.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.931 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -76.18 118.98 23.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.12 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 m120 59.66 54.04 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -170.59 145.88 2.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -116.17 32.6 6.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.86 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.05 112.71 29.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -57.98 132.28 48.6 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.468 2.112 . . . . 0.0 112.338 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.5 t -93.16 92.27 7.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.709 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.38 -178.62 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 179.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -132.05 -178.34 4.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -144.05 95.34 2.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.907 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.562 ' HB ' HG13 ' A' ' 34' ' ' VAL . 3.0 t -124.13 116.36 22.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.38 128.05 59.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.104 179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -122.61 91.85 3.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.908 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -152.64 81.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.14 179.96 18.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.448 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 150.72 27.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.823 0.344 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.8 t 60.33 102.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.898 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.53 123.17 6.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -84.33 134.92 34.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.562 HG13 ' HB ' ' A' ' 25' ' ' THR . 21.4 t -89.29 113.85 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.6 tpt180 -82.67 126.03 31.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -129.84 169.99 14.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 34.1 m-85 -136.86 118.92 15.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.912 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.454 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.3 pt -107.24 147.73 12.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.277 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -88.71 92.04 9.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.706 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -80.03 126.46 31.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.895 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -105.53 24.04 12.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.967 179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -96.41 -32.07 12.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.85 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -93.5 -64.7 1.06 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.525 179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -156.52 27.15 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.756 0.312 . . . . 0.0 111.001 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.15 62.33 6.49 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.582 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 47' ' ' CYS . 12.8 t -128.68 158.5 41.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 0.0 111.135 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.449 ' N ' HG12 ' A' ' 46' ' ' VAL . 1.5 t -94.31 105.86 17.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 24.9 m -111.47 162.24 21.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 52.3 Cg_exo -55.37 160.11 9.35 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.656 2.237 . . . . 0.0 112.516 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.454 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -160.08 173.64 15.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.868 179.752 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 60.19 163.64 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.91 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.453 179.964 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.856 0.36 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -127.75 135.68 50.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.232 0.539 . . . . 0.0 111.019 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.728 HD12 ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.57 170.4 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.214 -179.532 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.525 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -109.58 -91.04 2.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.614 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.448 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 11.2 p-80 -152.18 128.69 10.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.783 0.325 . . . . 0.0 110.925 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 58.26 61.21 2.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.715 179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -107.62 152.71 23.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.712 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 1.4 mttp -79.73 120.95 24.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.967 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -86.4 -34.49 20.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.908 -179.999 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.9 -35.55 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -107.88 34.78 3.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 13' ' ' LYS . . . -171.82 141.94 1.46 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -123.09 90.56 3.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.038 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.728 ' HG3' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -157.62 137.18 8.44 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.783 179.925 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -55.46 145.94 65.68 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.373 2.049 . . . . 0.0 112.419 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 23.0 m -87.8 95.04 9.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.676 179.786 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.06 174.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.212 -179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 63.1 p -148.56 128.07 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -84.31 153.07 23.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.956 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -150.8 96.87 2.41 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.1 p -108.68 139.33 31.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.052 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -128.1 120.13 26.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -132.68 -48.44 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.82 -161.3 18.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.46 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -64.12 -53.87 42.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.381 . . . . 0.0 110.954 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.6 t -71.04 124.26 23.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 17.7 tttp -80.68 137.62 36.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.1 t-20 -114.83 95.14 5.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.6 p -112.33 113.54 44.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.436 ' HG2' ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -92.86 100.93 13.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.869 -179.923 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 11.9 tptm -98.57 105.42 17.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.448 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 39.0 m-85 -79.89 147.59 31.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.586 HG12 ' CG ' ' A' ' 50' ' ' PHE . 2.7 pp -135.98 148.85 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.196 -179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.91 104.87 16.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.722 179.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.51 116.97 33.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.916 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -111.14 -30.27 7.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -59.0 -25.96 64.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.984 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -95.59 -43.45 3.39 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.539 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.58 -74.58 0.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 111.003 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 146.07 46.95 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.586 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.12 153.78 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.846 0.355 . . . . 0.0 111.202 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.72 113.72 25.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.623 179.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.4 m -121.77 164.9 22.25 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.188 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 50.9 Cg_exo -54.98 159.75 9.01 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.581 2.187 . . . . 0.0 112.49 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.586 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -159.95 160.37 33.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.782 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 86.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.9 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.433 -179.957 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.6 m 62.59 130.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.216 0.531 . . . . 0.0 111.123 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.829 HD13 ' HG3' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -79.76 170.66 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.331 -179.439 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.537 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -106.33 -40.85 1.86 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.331 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -179.04 144.54 0.24 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.79 0.329 . . . . 0.0 110.986 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 62.52 74.29 0.44 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.204 179.773 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.829 ' HG3' HD13 ' A' ' 8' ' ' ILE . 8.6 tm0? -98.49 132.24 44.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.726 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -79.89 110.22 15.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.9 p -122.58 22.86 9.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.997 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -99.97 -31.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.015 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -142.56 30.93 1.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -162.99 -173.93 3.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.939 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -139.1 128.46 24.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -163.15 141.07 6.18 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.84 114.47 3.95 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.411 2.074 . . . . 0.0 112.428 -179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 35.9 t -93.03 82.79 4.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.818 179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.03 -173.38 3.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.08 168.32 9.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.848 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.09 128.06 29.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.981 179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 t -110.25 126.22 53.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.804 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.03 151.37 12.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.183 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -145.68 139.73 26.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -165.93 -54.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.68 -159.29 35.3 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -65.97 -55.22 17.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.887 0.375 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.2 t -120.48 138.97 53.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -149.85 123.77 9.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.924 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.58 161.21 20.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -87.55 144.63 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 14.0 ttm-85 -100.56 133.86 44.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.055 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.63 178.97 4.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -152.61 129.08 10.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.754 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.804 HD12 ' O ' ' A' ' 38' ' ' ILE . 2.8 pp -124.84 144.61 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.194 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.16 119.8 24.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -107.87 111.75 24.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.844 179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -103.52 26.21 8.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -86.48 54.65 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.57 -24.72 8.41 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.799 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -120.11 -78.17 0.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.331 . . . . 0.0 111.174 -179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 107.69 58.37 0.57 Allowed Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.413 -179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 47' ' ' CYS . 20.1 t -137.82 160.18 33.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 111.006 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.48 ' N ' HG12 ' A' ' 46' ' ' VAL . 2.5 t -96.61 101.09 12.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.44 ' HB ' ' HD2' ' A' ' 49' ' ' PRO . 3.7 m -104.37 161.74 21.94 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 48' ' ' VAL . 86.9 Cg_exo -46.75 144.67 7.57 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.672 2.248 . . . . 0.0 112.694 179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.476 ' CG ' HG12 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -160.01 -167.66 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.785 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -166.02 102.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.477 -179.966 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.827 0.346 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.1 m -57.65 140.53 50.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 111.177 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.429 HG23 ' N ' ' A' ' 9' ' ' GLY . 0.0 OUTLIER -79.51 165.35 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.228 -179.493 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -105.95 -76.77 1.06 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.538 -180.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.466 ' HA ' ' CE2' ' A' ' 37' ' ' PHE . 19.8 p-80 -168.28 130.0 1.39 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.958 179.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 59.28 60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.623 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -102.04 157.02 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.88 -179.929 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 tttt -79.83 116.45 20.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.907 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 m -79.89 -39.51 30.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.87 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.28 136.56 26.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 58.96 31.06 21.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.38 149.67 41.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.062 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -124.22 37.13 4.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG2' HD12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -96.12 125.44 48.15 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 132.85 23.71 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.516 2.144 . . . . 0.0 112.459 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -80.03 94.94 6.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.841 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 90.4 m -84.79 -178.21 6.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.924 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.95 175.94 5.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.909 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -154.86 169.0 25.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.953 179.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.433 ' HB ' HG12 ' A' ' 34' ' ' VAL . 9.8 t -140.38 141.0 35.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.44 145.32 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.081 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -132.7 110.79 10.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -150.26 98.26 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.26 -116.53 8.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.461 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -106.47 -31.15 8.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.739 0.304 . . . . 0.0 110.898 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.5 m -67.4 86.47 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.922 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.23 144.08 31.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -160.0 138.03 10.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.991 -179.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.433 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.6 m -102.84 163.16 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.052 179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 7.7 ptt-85 -159.13 160.33 35.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.13 -179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' CE1' ' A' ' 50' ' ' PHE . 1.9 ttpp -126.06 179.9 5.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.231 179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.466 ' CE2' ' HA ' ' A' ' 10' ' ' HIS . 40.1 m-85 -129.32 150.49 50.66 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.013 0.435 . . . . 0.0 111.762 -179.39 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.884 HG23 ' CD1' ' A' ' 50' ' ' PHE . 3.2 pt -122.35 153.04 26.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.943 179.813 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.22 91.99 4.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.503 179.593 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.01 110.75 19.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.036 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 14.6 mtp180 -109.79 24.66 12.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.097 179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.34 -50.97 5.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.59 -66.61 1.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 -179.992 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -132.7 -47.2 0.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 125.07 78.36 0.33 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.42 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.9 t -143.29 154.53 16.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.888 0.375 . . . . 0.0 111.163 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.02 104.55 16.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.478 179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.6 m -109.84 157.74 36.85 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.226 -179.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 37' ' ' PHE . 62.5 Cg_endo -73.55 137.39 25.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.551 2.167 . . . . 0.0 112.64 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.884 ' CD1' HG23 ' A' ' 38' ' ' ILE . 3.1 p90 -135.23 176.76 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 63.91 99.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.895 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.485 179.913 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.336 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.0 m -91.05 136.44 33.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 110.937 179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.567 HD12 ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -79.63 164.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.293 -179.455 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 8' ' ' ILE . . . -107.24 -68.18 0.66 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.394 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HA ' ' CE1' ' A' ' 37' ' ' PHE . 22.1 p-80 -170.83 126.95 0.73 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.875 0.369 . . . . 0.0 110.976 179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.513 ' CD2' HG12 ' A' ' 48' ' ' VAL . 22.1 m-85 57.07 60.53 2.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' VAL . 0.8 OUTLIER -114.38 169.52 8.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.576 179.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -79.5 121.06 24.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.766 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 t -122.52 -59.4 1.63 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.344 -179.663 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.431 ' HB ' ' CA ' ' A' ' 45' ' ' GLY . 3.5 t -63.16 -26.32 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.143 -179.793 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -94.35 -35.29 12.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.032 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.79 144.39 50.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.109 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -69.82 126.35 29.45 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.567 ' HG2' HD12 ' A' ' 8' ' ' ILE . 14.2 tttt -177.12 98.65 0.23 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -50.09 144.1 23.29 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.547 2.165 . . . . 0.0 112.488 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -105.39 94.51 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.919 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.5 m -81.43 169.37 17.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 p -99.94 135.98 40.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.973 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -106.59 -179.51 3.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.818 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.502 ' HB ' HG12 ' A' ' 34' ' ' VAL . 2.5 t -152.37 121.52 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.876 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -80.98 123.37 37.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.4 mtt-85 60.19 161.74 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.859 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -120.79 158.71 26.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 145.31 -121.59 1.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.461 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.71 177.01 4.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.78 0.324 . . . . 0.0 110.924 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 63.13 122.61 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -72.8 102.4 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -125.2 68.78 1.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.502 HG12 ' HB ' ' A' ' 25' ' ' THR . 22.2 m -98.61 168.64 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.58 115.88 18.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.958 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -81.0 170.73 15.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.793 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.442 ' CE1' ' HA ' ' A' ' 10' ' ' HIS . 31.7 m-85 -154.0 129.56 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.801 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.603 HD12 ' CG ' ' A' ' 50' ' ' PHE . 0.1 OUTLIER -127.55 156.06 39.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.306 179.965 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.9 m -90.39 111.82 23.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.32 -172.22 2.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.89 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 60.93 81.98 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.955 -179.84 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.51 -33.02 72.02 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.697 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.53 -63.41 4.3 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.333 179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -79.89 -58.19 3.29 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.879 0.371 . . . . 0.0 110.513 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 15' ' ' VAL . . . 96.52 77.28 1.35 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.9 179.493 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 12' ' ' GLN . 4.1 t -135.67 151.61 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.3 t -102.59 114.51 28.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.458 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.513 HG12 ' CD2' ' A' ' 11' ' ' TYR . 8.8 m -111.79 162.43 21.18 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.312 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.434 ' CD ' ' CE1' ' A' ' 11' ' ' TYR . 52.0 Cg_exo -54.14 158.83 8.61 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.635 2.223 . . . . 0.0 112.454 -179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.603 ' CG ' HD12 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -155.42 174.53 15.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.912 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 t0 59.84 54.59 4.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 -179.964 . . . . . . . . 0 0 . 1 stop_ save_